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GENERATION OF CONDITIONAL MUTANTS TO DISSECT ESSENTIAL 
GENE FUNCTION IN CHLAMYDIA TRACHOMATIS 
 
Chlamydia trachomatis is the leading cause of bacterial sexually transmitted 
disease.  Chlamydia spp. are all obligate intracellular organisms that undergo a biphasic 
developmental cycle within a vacuole termed the inclusion.  Infectious, non-
metabolically active elementary bodies (EBs) are endocytosed and differentiate into non-
infectious, metabolically active reticulate bodies (RBs) before re-differentiating back into 
EBs.  The chlamydial factors that mediate these differentiation events are mostly 
unknown.  Comparative genomics revealed that Chlamydia spp. have small, highly 
conserved genomes, suggesting that many of their genes may be essential.  Genetic 
manipulation strategies for Chlamydia spp. are in their infancy, and most of these cannot 
be used to inactivate essential genes.  We generated a clonal ethyl methanesulfonate 
(EMS)-mutagenized C. trachomatis library and screened it for temperature sensitive (TS) 
mutants that produced fewer inclusions at either 32°C or 40°C compared to 37°C.  
Because EMS mutagenesis elicited multiple mutations in most of the library isolates, we 
also developed a novel lateral gene transfer strategy for mapping mutations linked to TS 
phenotypes.  We identified TS alleles of genes that are essential in other bacteria and that 
are involved in diverse biological processes including DNA replication, protein synthesis, 
carbohydrate metabolism, fatty acid biosynthesis, and energy generation, as well as in 
vi 
highly conserved chlamydial hypothetical genes.  TS DNA polymerase (dnaEts) and 
glutamyl-tRNA synthestase (gltXts) mutants were characterized further.  Both the dnaEts 
and gltXts mutants failed to replicate their genomes at 40°C but exhibited unique signs of 
stress.  Chlamydial DNA replication begins by 12 hpi and protein synthesis begins by 2 
hpi.  However, inclusion expansion and replication of both of the mutants could be 
rescued by shifting to them to 37°C prior to mid-late development.  Since gltXts is likely 
unable to produce aminoacyl-tRNAs at 40°C, our observation suggests that de novo 
chlamydial translation uses a pre-existing pool of aminoacyl-tRNA in EBs.  Genetic 
suppressor analysis indicated that the inability of the dnaEts mutant to replicate its 
genome at 40°C might be linked to an inability of mutant DnaE to bind the DNA 
template.  The tools and mutants we have identified will be invaluable assets for 
investigating many essential aspects of chlamydial biology. 
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CHAPTER I: Introduction 
Section I: Chlamydial Disease and Pathogenesis 
The Chlamydiales are obligate intracellular pathogens 
Bacteria in the phylum Chlamydiae have been evolving with their respective hosts 
for over 700 million years.  The first Chlamydiae were obligate intracellular symbionts in 
amoebae and are termed the environmental chlamydia.  Genome sequences of chlamydia 
isolated from Acanthamoebae, such as the Parachlamydiae, share high sequence 
similarity with today’s medically relevant, pathogenic Chlamydia spp. (1).  This indicates 
that the early chlamydiae evolved to parasitize higher order organisms only recently.  
Examples of these animal pathogens include Chlamydia psittaci, C. abortus, C. caviae, 
and C. muridarum, which naturally infect birds, sheep, guinea pigs, and mice, 
respectively.  At least three species in the genus Chlamydia—C. pneumoniae, C. 
trachomatis, and C. psittaci—naturally infect humans.   
Chlamydiae can also exhibit distinct tissue tropisms in the same natural host.  C. 
pneumoniae, C. psittaci, and C. muridarum infect the respiratory tract.  C. abortus is a 
natural pathogen of the reproductive tract.  C. caviae infects both the eye and the 
reproductive tract.  C. trachomatis also infects the eye and genital tract and can be further 
divided into biovars that have distinct in vivo tissue tropisms.  C. trachomatis serovars A-
C infect the conjunctival epithelium.  Serovars D-K are the leading cause of bacterial 
sexually transmitted infection (STI) and primarily infect epithelial cells of the 
genitourinary tract.  Serovars L1-L3 cause lymphogranuloma venereum (LGV) and can 
productively infect genital tract macrophages and disseminate to other body sites. 
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Genomes of diverse chlamydia strains and species have been sequenced (2-10).  
One of most striking differences between the various species was that the genomes of the 
environmental chlamydia are much larger than those of the pathogenic isolates.  
Interestingly, the transition from amoebal to mammalian hosts occurred concomitantly 
with a reduction in genome size from ~3 Mb (7,8,10) to ~1 Mb (4,9) and a proportional 
decrease gene number (7).  This observation led to the hypothesis that the chlamydia 
genome size decreased as these pathogens became able to acquire host metabolites (11).  
Other examples of reductive evolution in chlamydia genomes include the truncation of 
three putative cytotoxins, which are homologous to large clostridial toxins, in C. 
trachomatis compared to C. muridarum (2).  The cytotoxins may mediate entry and act as 
adhesins that dictate tropism (12).  Differences in gene content of C. trachomatis biovars 
can also be seen in the inactivation of the trpBA operon in the oculotropic serovars, 
whereas the STI and LGV serovars maintain a functional operon (4).  It is hypothesized 
that tryptophan synthase (TrpAB) utilizes environmental indole produced by the vaginal 
microflora to synthesize tryptophan (13).  In environments lacking indole, such as the 
eye, TrpAB may produce toxic metabolites, such as ammonia (14).  Thus, it may be 
advantageous for the urogenital and LGV serovars, but not for oculotropic serovars, to 
maintain trpBA. 
Comparative genomics has not conclusively identified most of the genes that 
mediate known differences in chlamydial host and tissue tropism.  Genome sequencing 
revealed a potential pathogenicity island, termed the plasticity zone, that has expanded 
gene content in C. muridarum compared to C. trachomatis (2).  Another heterogenic 
region of the genome is the polymorphic membrane protein (Pmp) gene family.  The 
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number of Pmp genes in a given Chlamydia spp. varies from just one in C. felis to 21 in 
C. pneumoniae, and these proteins are hypothesized to serve as adhesins (5,15).  
Genomic reduction has led to preservation of a core set of (partial) metabolic pathways 
and the machinery required for bacterial replication (16).  However, up to one-third of the 
chlamydial genes have no known function or homologs outside of Chlamydiae (16). 
Chlamydial pathogenesis 
 Infections with a number of Chlamydia spp. can be modeled in their natural hosts, 
although experimental human infection with C. trachomatis is not permitted due to safety 
concerns.  C. trachomatis infection is, however, reportable to the CDC, which estimated 
that there were 456.1 cases per 100,000 persons in the United States in 2014 
(http://www.cdc.gov/std/stats14/chlamydia.htm).  A seven-day course of doxycycline or 
single dose of azithromycin is usually sufficient to treat chlamydia.  Despite this, many 
infections go untreated because an estimated 70% of infected women (17) and 50% of 
men (18) are asymptomatic.  These asymptomatic individuals are a major reservoir for 
infection and are at high risk for developing complications that impact fertility, especially 
in women.  Discharge and dysuria are the most common symptoms in both men and 
women.  Women may also experience pelvic pain.  Left untreated in women, the 
infection can ascend the reproductive tract and lead to severe sequelae such as pelvic 
inflammatory disease and fallopian tube scarring, increasing the risk of infertility and/or 
ectopic pregnancy.  In contrast, men rarely experience long term or severe reproductive 
sequelae. 
 Much of the pathology elicited by chlamydia infections results from infected 
epithelial cells attracting TH1 cells to the site of infection.  Once recruited, the TH1 cells 
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release inflammatory cytokines such as interleukin (IL)-1 (19-22) and tumor necrosis 
factor (TNF)-α (20,23).  This cytokine storm leads to the recruitment of neutrophils to the 
site of infection (20).  However, because chlamydia are intracellular pathogens, some 
mechanisms neutrophils use to infiltrate the tissue, such as release of matrix 
metalloproteases (24,25), are not effective at eliminating these pathogens but lead to 
damage of the host tissue causing fibrosis and scarring. 
The biphasic lifecycle 
A chlamydia infection begins when a metabolically inactive, but infectious, 
elementary body (EB) enters a host cell by pathogen-mediated endocytosis (26).  
Chlamydia remains inside a non-fusogenic endocytic vacuole within the host cell, termed 
the inclusion, until the end of the developmental cycle.  Approximately 8 hours after 
entry, the EB completes differentiation into the reticulate body (RB) (27,28).  RBs are 
non-infectious, but are metabolically active and can replicate.  As the host cell fills with 
bacteria, an unknown signal eventually prompts differentiation of RBs back into EBs.  
Eventually, the heavy chlamydia burden within the host cell leads to release of EBs so 
that a new round of infection can initiate (29). 
The metabolic capacity of EBs has recently been reconsidered (30), but attempts 
to culture C. trachomatis in anexic media by supplying the metabolites that these 
pathogens cannot synthesize have been unsuccessful for both EBs and RBs (31,32).  EBs 
take up glucose-6-phosphate (glucose-6P), and RBs can take up ATP (31).  However, 
media formulations containing these metabolites were unable to drive differentiation 
from EB to RB or from RB to EB (31).  Multiple signals and steps likely mediate these 
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transitions, and gaining a better understanding of chlamydial metabolism may be 
necessary for the development of an anexic culture system. 
The chlamydial developmental cycle 
 Attachment of C. trachomatis EBs to host cells is mediated by multiple receptors 
including the estrogen receptor (33,34), platelet-derived growth factor receptor (PDGFR) 
(35), apolipoprotein E4 (36), mannose binding proteins (37,38), cystic fibrosis 
transmembrane receptor (CFTR) (39), and heparin sulfonated proteins (40).  After 
attaching, chlamydia use a type III secretion system (T3SS) to translocate several 
effectors into host cells that induce their endocytosis.  TarP is secreted within five 
minutes of attachment and is tyrosine phosphorylated by host Src-family kinases to 
induce actin polymerization beneath the EB (35,41,42).  Type III secreted effectors that 
are delivered later, including CT694, are also phosphorylated by the host and direct actin 
polymerization near the inclusion (43).  This enhanced actin polymerizing environment 
generates an “actin pedestal” that drives endocytosis of the EB (44).  The nascent 
inclusion is then trafficked along microtubules to the perinuclear space by 6-8 hours post 
infection (hpi) (45). Other early effectors have functions unrelated to attachment and 
entry.  For example, TepP modulates the host cell innate immune response (46).  
Additional secreted effectors that decorate the inclusion, termed Inc proteins, prevent 
recognition of the nascent inclusion by cell-autonomous immune effectors and fusion 
with lysosomes (47).  Pulse chase experiments showed that de novo Inc expression begins 
by 2 hpi (48).   
After entry, the EB begins differentiation into an RB.  Key differences between 
EBs and RBs include their sizes and outer membrane protein arrangements (49).  EBs are 
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0.3 μm in diameter, have condensed genomes, and have highly disulfide-linked outer 
membrane proteins.  EBs only contain trace amounts of peptidoglycan (50), but gain 
additional structural integrity from a cysteine-rich outer membrane complex (COMC), 
which is constructed from several cysteine-rich proteins including OmpA, OmcA, and 
OmcB (reviewed in (51)).  RB differentiation may be driven by the reduction of disulfide 
bonds between different proteins in the COMC, which results in a more spacious (~1 μm 
diameter) RB, and release of the chlamydial genome from the histone-like Hc1 protein 
(52).  The signal that drives this process is unknown.  
After differentiation into RBs, chlamydiae must obtain nutrients from the host 
cell.  Chlamydiae incorporate host-derived sphingolipids that they obtain by intersecting 
lipid droplets from the endoplasmic reticulum (ER) in a ceramide transport protein 
(CERT)-dependent manner (53-56).  Chlamydiae cannot make nucleotides or amino 
acids de novo, so they utilize various transporters to siphon these building blocks from 
the host cell (2,4,57,58).  Chlamydiae derive their energy by importing of ATP from their 
host and generating ATP using a truncated tricarboxylic acid (TCA) cycle (2,4,59). 
 De novo transcription of chlamydial genes is developmentally regulated 
(27,60,61).  Transcription of the three known chlamydia sigma-factors occurs in 
sequential waves during development (61).  Housekeeping genes, such as dnaE and 
groEL, are expressed early in infection, followed by metabolic genes, such as eno, during 
mid-cycle, and primarily structural proteins, such as omcB, at the end of development 
(27,28,60).  Chlamydia encode few known transcription factors, and gene expression—
especially for early genes—is thought to be regulated by supercoiling (62).  Expression of 
early chlamydia genes may be supercoiling-independent or these genes may have a 
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distinct secondary structure that allows them to be transcribed early.  One early gene, 
euo, is a late gene repressor (63).  Other early genes include the anti-σ54 factor, whose 
ligand, σ54, is needed for late gene expression (61).  Non-coding RNAs such as lhtA 
inhibit the translation of the chlamydial histone-like proteins Hc1 and Hc2 early in 
infection (64). 
 RBs, unlike EBs, can undergo cell division, and, until recently, it was believed 
that RBs only divided by binary fission.  Chlamydiae appear to lack some key cell 
division proteins that locate the septum in other bacteria (4).  Attempts to identify 
chlamydial homologs of FtsZ and FtsB have been unsuccessful (65,66).  Despite this lack 
of characterized cell division proteins, septum formation does occur, and trace amounts 
of peptidoglycan localize to the chlamydial division plane (67).  Recently, it was shown 
that chlamydia divide by a budding mechanism rather than by binary fission at least until 
mid-development (68).  How this occurs without classical Fts proteins is unclear.  
 The end of the chlamydial developmental cycle is marked by de-repression of late 
genes by Euo, the synthesis of an anti-anti-σ54 factor, condensation of genomic DNA, and 
disulfide bonding in the COMC.  It is hypothesized that an RB must remain attached to 
the interior face of the inclusion membrane via its type III secretion apparatus to prevent 
its transitioning into an EB (69,70).  Therefore, detachment from the membrane would 
drive RB to EB differentiation.  RBs have been observed in the center of inclusions in 
electron micrographs; however, whether the differentiation process had initiated in these 
cells is not known.  If RBs divided exclusively by polar cell division and inclusion 
membrane contact is required to maintain the RB state, then, past a certain inclusion 
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surface area to volume ratio, cell division would exclusively produce EBs in a linear and 
not exponential manner. 
 Chlamydiae can exit cells by two different mechanisms, and these are used at 
similar frequency in cell culture (29).  In the first mechanism, the inclusion grows until it 
takes up the vast majority of the host cell cytosol.  The inclusion membrane then bursts in 
a protease-dependent manner, releasing the inclusion contents into the host cytoplasm.  
Thirty minutes later, an influx of cytoplasmic calcium causes the host cell plasma 
membrane to lyse, and EBs release from the host cell.  Alternatively, the inclusion can be 
extruded from the host cell in an actin-dependent manner, leaving both the inclusion and 
host cell intact (29,71).  It is unclear which mechanism is most important in vivo. 
 The developmental cycle is summarized in Figure 1. 
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Figure 1  Schematic of the chlamydial developmental cycle.  (A) Infection begins when an infectious 
elementary body (EB) attaches to the host cell via receptor-ligand and electrostatic interactions.  (B) 
Secretion of T3S effectors into the host cell induces actin polymerization that leads to the formation of a 
“pedestal” and pathogen-mediated endocytosis of the EB.  (C) The nascent inclusion is trafficked by dynein 
motors along microtubules to the perinuclear space.  (D) The EB then differentiates into a metabolically 
active reticulate body (RB), which secretes additional T3S effectors, including Incs.  (E) As RBs replicate 
the inclusion expands.  (F) Late in development, the RBs differentiate back into EBs.  (G) The inclusion 
fills the cell cytoplasm near the end of development which can cause rupture of the inclusions and host cell 
(H) or the entire inclusion can be extruded (not shown).  Adapted from (72) and (73). 
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Section II: Chlamydial Genetics 
The dawn of chlamydial genetics 
 Attempts to use comparative genomics of clinical strains to interrogate the 
molecular basis of chlamydial pathogenicity and tropism have seen limited success 
because naturally occurring mutants are rare.  Natural mutants that have been identified 
include a plasmid free variant of C. trachomatis serovar L2 (74) and an incA- variant 
(75).  The C. trachomatis L2 plasmid contains eight ORFs.  Four of these ORFs are 
important for plasmid maintenance, one is a transcription factor, and three appear to 
encode highly conserved chlamydial hypothetical proteins (76).  Loss of the plasmid 
causes a reduction in EB adherence to host cells in cell culture and a large reduction in 
virulence in mice (77,78).  IncA was the first inclusion membrane protein discovered, and 
it is required for inclusion fusion when one cell contains two or more inclusions (79,80).  
Since the mid-2000s, the field of chlamydial genetics has rapidly expanded and new 
approaches have begun to yield insights into chlamydial pathogenesis and tropism that 
were not gleaned from naturally occurring chlamydial variants (Figure 2).  Some of these 
advances are discussed below. 
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Figure 2 Timeline of genetic advances in C. trachomatis.  The “psittacosis virus” was found in the 1930s 
following a severe outbreak of psittacosis that would prompt the formation of the National Institutes of 
Health (NIH).  Moulder et al. reclassified Chlamydia spp. as bacteria as opposed to viruses given that they 
can independently make proteins and replicate DNA (81).  The advent of whole genome sequencing 
allowed sequencing of the first chlamydial genome in 1998.  From the mid-2000s on, the speed of new 
advances accelerated dramatically.  Figure adapted from (82). 
 
Lateral gene transfer (LGT) 
 A major advance in chlamydial genetics occurred when DeMars and colleagues 
determined that they could generate recombinant C. trachomatis strains using a technique 
they termed lateral gene transfer (LGT) (83).  This approach uses two parent strains with 
different endogenously encoded antibiotic resistance alleles.  LGT uses co-infection and 
cultivation in media containing both antibiotics to select for recombinants.  LGT has been 
used  to generate interspecies chlamydia chimeras, including C. muridarum and C. 
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trachomatis L2 isolates that contain a naturally occurring C. suis tetracycline resistance 
island (84).  
 Further evidence of chlamydial recombination was observed when a 
kausagomycin-resistant C. psittaci clone was isolated after the parent was transformed 
with a plasmid containing a kausagomycin resistance allele and neighboring silent 
mutations (85).  The transformant had never been passaged in the presence of antibiotic 
and contained not only the mutation that rendered it kasugamycin resistant but also the 
unselected neighboring silent mutation that had been engineered into the donor plasmid 
(85).  This provided the first evidence that chlamydiae could recombine foreign DNA 
into their genomes.  As little as 2000 bp of DNA homology was sufficient to mediate this 
recombination, although shorter constructs were not tested. 
Generation of mutant libraries 
 Several approaches for random mutagenesis of chlamydia have been developed.  
For example, N-methyl-N'-nitro-N-nitrosoguanidine (NTG), which causes insertions and 
deletions (Indels), ethyl methanesulfonate (EMS), which causes GA transitions, and N-
ethyl-N-nitrosourea (ENU), which causes AT transversions and AG transitions, have 
been used to mutagenize various Chlamydia spp. (86-88).  Cheaper genomic sequencing 
has made it feasible to identify the chemically induced mutations in chlamydia that 
induce specific phenotypes.   
 Several chlamydia mutant libraries have been constructed using EMS 
mutagenesis (87-90).  Mutants that have mutations in specific genes of interest have been 
isolated from EMS-mutagenized libraries using an approach called Targeting Induced 
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Local Lesions in Genomes (TILLING) (87).  TILLING uses PCR amplification and 
endonuclease digestion to detect specific mutants in larger pools of mutagenized 
organisms.  Following PCR amplification of an allele of interest from a pool of genomes, 
the reaction is slowly annealed.  If a mutant was present in the pool, wild type and mutant 
PCR products will generate heterodimers that contain mismatches.  These mismatches 
can be recognized by the endonuclease CelI, which generates cleavage products that can 
be visualized by gel electrophoresis.  The mutant of interest can then be purified from the 
starting mutant library. 
The first use of TILLING in chlamydia targeted trpB of C. trachomatis serovar D 
(87).  Isolation of a mutant with a nonsense mutation in trpB, whose product is the β-
subunit of tryptophan synthase, confirmed that tryptophan synthase (encoded by the 
trpBA operon) is required for indole rescue of C. trachomatis from persistence.  
TILLING was also used to test if various C. muridarum plasticity zone genes contributed 
to virulence of this organism in mice (90).  Various phospholipase, cytotoxin, and 
nucleotide transporter mutants were isolated and shown to be equally virulent to wild 
type C. muridarum in cell culture and in the murine genital tract (90).  
 Another group screened a clonal EMS-mutagenized C. trachomatis serovar L2 
rifR library (88) for mutants that had altered plaque morphologies (88).  A granular plaque 
phenotype was linked to mutations in a glycogen hydrolase (glgB) using LGT (88).  
Genomes of all the isolates in this ~800 clone library were later sequenced (91), which 
provided insight into which chlamydia genes are essential.  Nonsense mutations were 
identified in some genes that were thought to encode the essential components of the 
already truncated chlamydial biosynthetic pathways (91).  For example, C. trachomatis 
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lacks genes for the first three enzymes of the TCA cycle, but nonsense alleles of another 
TCA gene, a carbon source transporter gene, and other carbon metabolism genes were 
isolated, indicating that these pathways may be redundant for growth in cell culture (91).   
Functionalizing plasmids 
The endogenous chlamydial plasmid has been used as a backbone for 
development of several shuttle plasmids.  The first stably transformable shuttle plasmids 
spliced the C. trachomatis SW2 plasmid with pBR322 or pGFP-N1 (92).  This permitted 
the first introduction of ectopically expressed foreign DNA into C. trachomatis.  Later  
shuttle plasmids contained elements that permitted controlled expression of genes using 
the Tet-On system (93), expression of multiple fluorophores (94), and curing of the 
shuttle and endogenous plasmids (95). 
 Unstable plasmids have been used to drive directed recombination events in C. 
trachomatis LGV.  The TargeTron® system from Sigma has been successfully adapted 
for chlamydia (96).  TargeTron® was first used to disrupt incA, which confirmed that 
inactivation of this gene led to the same non-fusogenic phenotype observed in some rare, 
naturally-occurring incA- strains.  TargeTron® has important limitations, including the 
need for a specific proprietary sequence to target the insertion to a particular locus.  
Additionally, some genes do not contain a suitable Group II intron target sequence or 
may only contain targets near their 3’ ends.   
 An inducible suicide plasmid was developed to recombine DNA into the C. 
trachomatis genome using a technique termed Fluorescence-Reported Allelic Exchange 
Mutagenesis (FRAEM) (95).  The plasmid gene pgp6 is required for plasmid 
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maintenance (97).  By placing pgp6 under the control of a Tet-On promoter in the 
FRAEM plasmid, it could be downregulated in the absence of tetracycline, leading to loss 
of the plasmid.  FRAEMing was used to knock out trpA, whose gene product forms a 
dimer of dimers with TrpB to form tryptophan synthase.  The cargo on the FRAEMing 
plasmid included a GFP-ampR cassette flanked by ~3kb of homology in either direction 
of trpA to direct homologous recombination.  Ampicillin was used to select for 
recombinants, and GFP served as a secondary marker for recombinants. 
 
Section III: Genome Replication 
DNA replication 
 Cell division is preceded by genome replication so that each daughter cell inherits 
a complete set of genetic material.  The machinery required to replicate the Escherichia 
coli genome was discovered in 1972 by Arthur Kornberg (98-100).  The DNA replication 
holoenzyme contains 17 unique protein components (101).  DNA replication begins by 
the “melting” of the double helix structure by the ATP-dependent DnaA at the origin of 
replication (102,103).  The DNA replication holoenzyme then assembles on the single-
stranded DNA (104-106). 
 Six monomers of DnaB assemble on the single stranded DNA to form the 
helicase.  Binding of DnaB prompts the attachment of RNA primase, which lays down a 
single primer for the leading strand, which is polymerized continuously, since the DNA is 
read in the 3’5’ direction as the helicase unwinds the DNA (107).  RNA primase then 
binds to the tau (τ) protein, which serves to connect it to the polymerase and clamp loader 
complexes (108).  This enhances the efficiency at which RNA primase can synthesize 
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primers for the lagging strand.  This is necessary because DNA can only be synthesized 
in the 5’3’ direction, but the lagging strand is unwound from 5’3’, so multiple 
primers are synthesized in the 5’3’ direction approximately every 1 kb as more single 
stranded DNA becomes available, and DNA polymerase then uses these to polymerize 
the Okazaki fragments (109).   
The helicase is attached via the tau (τ) protein to two independent polymerase 
subunits that are responsible for either all the leading or lagging strand synthesis (105).  
DNA polymerase III, also known as DnaE, is required for genome replication (110).  The 
template strand is threaded through this “hand-shaped” protein, and dNTPs are added in 
an approximately eight nucleotide long channel (111).  DNA synthesis by DnaE is 
template-dependent and proceeds by addition of dNTPs to the free 3’-OH of the newly 
synthesized strand.  The initial 3’-OH belongs to the last nucleotide that the RNA 
primase synthesized, and DNA synthesis by DnaE continues until double stranded DNA 
is encountered. 
There are five known DNA polymerases, but only DNA polymerase III can 
replicate entire genomes.  DnaE also has the highest degree of processivity (112).  DnaE 
in the context of the holoenzyme can replicate up to 100,000 bp before falling off the 
template in vitro, but DnaE alone can only replicate approximately 100 bp before falling 
off the template.  The high processivity of the holoenzyme is conferred by the β-clamp 
(DnaN) (113,114).  Two subunits of DnaN are loaded around the single stranded template 
by the clamp loader complex (τγδ’δ), which transfers the β-clamp from the interaction 
motifs on the clamp loader complex to a similar motif on DnaE using ATP hydrolysis to 
fuel the transfer (105). 
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In addition to being highly processive, DnaE is highly accurate because it has 
exonuclease proofreading activity.  Mismatched residues are detected inside the channel 
by the polymerase and histidinol phosphatase (PHP) domain of DnaE (111,115).  
Proofreading is more accurate when DnaE is bound to the ε and θ proteins, although how 
these proteins improve the accuracy is not known, and they do not appear to have any 
catalytic domains (116,117). 
DNA replication ends in the genomic terminator sequence.  The speed of DNA 
polymerization typically slows as genome replication nears completion because the 
polymerases encounter ter sequences near the terminator (115).  Thus, DNA replication 
ends in a similar location each replication cycle even though the replisomes on each side 
encounter different obstacles (e.g., highly transcribed genes, DNA damage, etc.) (112).  
In addition, each replisome must complete replication of both the leading and lagging 
strands before dissociating, and synthesis rates of the two strands differ in vitro (118).  
The consistent location of the terminator is important, since bacteria can initiate a new 
round of replication before the previous round is complete. 
Genome replication is completed after DNA polymerase I (PolA) replaces the 
RNA primers in the leading and lagging strands with dNTPs, since DnaE cannot remove 
these, and DNA ligase seals the nicks between the PolA and DnaE synthesized strands 
(112). 
Chlamydial genome replication 
 Chlamydia contain all the homologs of the E. coli DNA replication machinery.  
The EB is assumed to be metabolically inactive, since it does not replicate its genome or 
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synthesize proteins (119), although it may transport glucose-6P (30,31).  This may be due 
to special constraints inside the EB including a high degree of DNA supercoiling and/or a 
complication of chlamydial DNA being wrapped around histone-like proteins (120,121).  
Interestingly, transcripts for dnaE are detectable by 2 hpi, although the first round of 
DNA replication is not completed until approximately 6 hpi (27).  The speed of 
chlamydial genome replication has been calculated to be either 1.45 hours (27) or nearly 
3 hours (61).  Whether the increased rate of genome replication after the first round is due 
to the absence of histones in mid-development or a more nutrient-rich environment in 
mid-development is unclear. 
 Chlamydia initiate genome replication approximately every 4.5 hours and divide 
approximately every 2-3 hours in normal conditions (61).  How stressful stimuli affect 
DNA replication is not well described.  A viable but non-cultivatable state (i.e., 
persistence) has been described in which chlamydial DNA replication proceeds in the 
absence of cell division (122,123).  Stress imposed by interferon (IFN)-γ and penicillin 
can inhibit chlamydial cell division, but does not block genome replication, resulting in 
the production of large, aberrant RB that contain many copies of the genome.  Removal 
of the stress allows persistent chlamydiae to resume cell division.  This observation 
suggests that there is a certain degree of independence between the chlamydial DNA 
replication and the cytokinesis machinery (124).   
The effects of an inhibitor (KSK120) of UhpC, a glucose-6P transporter, on 
inclusion size led the authors to conclude that chlamydial DNA replication is independent 
of inclusion expansion (125,126).  An alternative explanation for why KSK120 inhibits 
C. trachomatis genome replication is that lack of a glucose-6P inhibits DNA replication, 
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but does not inhibit inclusion expansion.  The effect of DNA replication on chlamydial 
morphology and development is investigated in Chapter IV. 
 
Section IV: Protein Synthesis 
Translation 
 Protein production is tightly regulated by several feedback loops and involves 
many proteins and RNA species.  Proteins are synthesized from genes through an RNA 
intermediate called messenger RNA (mRNA).  mRNA production of a given gene is 
dictated by the epigenetic landscape, the presence (or absence) of specific repressors 
and/or activators, supercoiling of the genome, and, in bacteria, the availability of specific 
sigma (σ) factors (127).  The level of mRNA in a cell is not only the product of active 
transcription, but also degradation.  mRNAs are degraded by ribonucleases when they are 
not protected by actively translating ribosomes, resistant secondary RNA structures, or 
RNA modifications (128). 
 Levels of a given protein do not necessarily reflect numbers of correlating 
transcripts (127).  For example, small non-coding RNAs and secondary structural 
elements can prevent ribosomal binding, and thus act as post-transcriptional regulators of 
protein synthesis. 
 In prokaryotes, mRNAs are translated by the 70S ribosome as they are 
simultaneously transcribed.  Loading of mRNA onto the 30S ribosome begins when  
initiation factor (IF)-3 binds to the 30S ribosome, preventing binding of the 50S 
ribosomal subunit as the mRNA is loaded (129).  IF-1 then binds to block the A-site as 
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the 5’ end of the mRNA begins to interact with the 16S rRNA of the 30S ribosomal 
subunit (130,131).  The reading frame is determined by interaction of the Shine-Delgarno 
sequence with the 16S rRNA contained in the 30S ribosomal subunit (132).  Met-
tRNAfMet-IF-2-GTP binds to the mRNA in the P-site of the ribosome (133), and the 50S 
ribosomal subunit can then bind the mRNA-30S ribosomal complex.  The GTP bound to 
IF-2 is then hydrolyzed, and IF-2-GDP is released (134).  Aminoacyl-tRNAs bound to 
EF-Tu-GTP can then enter the ribosome and interact with the mRNA through 
complementary basepairing of the three nucleotide (nt) anticodon of the tRNA with the 3 
nt codon in the mRNA residing in the A site of the ribosome (135,136).  Next, the amino 
acid in the A-site initiates nucleophilic attack of the amino acid in the P-site, allowing 
transfer of the growing polypeptide chain (137).  The 30S subunit then shifts relative to 
the 50S subunit from GTP hydrolysis of elongation factor (EF)-G-GTP.  This shift moves 
the tRNA originally in the P-site to the E-site and the tRNA originally in the A-site to the 
P-site (138).  This process continues for the length of the mRNA until a stop codon is 
encountered.  Release factors (RF) bind to stop codons and potentiate the disassembly of 
the ribosomal complex and release of the transcript (139). 
Regulation of translation 
 Protein synthesis is an energy intensive process, so it is highly regulated in many 
bacteria (140).  Model bacterial organisms like E. coli and Bacillus subtilis have 
organized the majority their translational machinery into operons consisting of up to 21 
genes (141,142).  This allows coordinate regulation of a variety of rRNAs, ribosomal 
proteins, and tRNAs at the transcriptional level (143).  A rapid response to nutrient 
deprivation via the stringent response, an increase in the ADP:ATP ratio, or the lack of 
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amino acids via the general amino acid stress response is key to cellular survival.  This is 
important, since the inability to complete translation of transcripts not only wastes energy 
reserves, but also leads to stalled ribosomes and the eventual release and accumulation of 
incomplete polypeptides (144), which can be detrimental (145).   
 To downregulate translation of mRNA, ribonucleases such as MazF (146-148) 
and RelE (147) degrade mRNA that is either free or ribosome-bound, respectively.  
mRNAs that are important for the stress response are not immune to this and are 
processed for leaderless protein synthesis.  This is performed on “stress” ribosomes 
containing 16S rRNA that has been cleaved to remove the Shine-Delgarno recognition 
sequence (148).   
Several ribosomal accessory proteins help regulate ribosome function and 
efficiency during the canonical stringent response.  Ribosomes can sense amino acid 
deprivation through the ratio of uncharged to charged tRNA in the cell (149).  While lack 
of any aminoacyl-tRNA can cause translational pausing, lack of aminoacylated tRNAs 
that already cause translational pausing, such as Pro-tRNAPro, can be especially 
detrimental to maintaining translation (150).  If the ratio of aminoacylated to non-
aminoacylated tRNA is too low, then lack of a donor for the growing peptide chain will 
be terminated by tmRNA, which uses a protein template to simulate a stop codon.  
Subsequent interaction of tmRNA with RFs causes peptide release from the ribosome and 
allows the ribosome to be recycled (150).  Another accessory protein, EttA, is responsive 
to ATP:ADP levels and binds to and inhibits ribosomes when ADP levels are high, 
allowing the cell to tune protein synthesis to the amount of available cellular energy 
(151).  Free ribosomes also are increased when guanosine pentaphosphate [(p)ppGpp] 
22 
stimulates ObgE, which has been shown to be essential (152) except in a relA- 
background (153).  Lack of ObgE shifts the equilibrium of ribosomes to favor the 30S 
and 50S forms rather than the 70S form, which decreases the amount of translation 
(154,155).  ObgE also has a role in rRNA processing, since pre-16S and pre-23S rRNA 
levels increase in its absence (154).  
 Rapid regulation of translation extends from the transcriptional level to the post-
translational level.  Ribosomes contain at least 27 proteins and 3 large rRNAs.  Ribosome 
assembly is regulated by the availability of mature rRNA transcripts.  For example, 
RNase J is required to trim the 16S rRNA transcript to the proper length from the 5’ end 
(156).  The endonuclease YbeY trims the 3’ end of the 16S rRNA transcript (157,158).  
Ribosomes cannot assemble without mature rRNA transcripts, so absence of these 
ribonucleases inhibits translation.  Ribosome activity can also be modulated post-
translationally.  Transcription of rmf increases in the presence of ppGpp, and Rmf 
physically holds 50S ribosomes together to form the 100S ribosome—an inactive 
ribosome dimer—which is used to reversibly inactivate mature ribosomes (159). 
 Another way to regulate translation is through the substrates—namely the tRNAs 
(160).  Decreased levels of individual tRNAs have been shown to induce accumulation of 
immature 16S rRNA transcripts, which decreases the number of functional ribosomes in 
the cell (161).  Furthermore, control of translation efficiency and accuracy is perhaps 
most closely linked to tRNA number (162-165) and modification (166-171).  Immature 
tRNA transcripts are trimmed to their mature size of 74-91 nt (depending on species and 
isoform) by RNase P at the 5’ end (172) and RNase D at the 3’ end (173).  Most tRNAs 
then require the addition of the –CCA sequence on the 3’ end by the –CCA-adding 
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enzyme to be able to accept an amino acid (174).  The aminoacyl moiety is added to the 
final adenine.   
Over 90 different tRNA modifications have been described (175).  The two most 
common are methylguanosine (mG) 18 and pseudouridine (ψ) 55, which are found in 
virtually all tRNAs from prokaryotes to eukaryotes (169).  These modifications enhance 
the base-pairing interactions between G18 in the D arm and U55 in the T arm of the 
tRNA and allow the cloverleaf-like secondary structure of the tRNA to adopt a stable 
“L”-shaped tertiary structure.  These modifications are required for optimal 
aminoacylation and translational efficiency (176).  Other common modifications aiding 
in translational efficiency include threonylation of A37 (tA37) for tRNAs using ANN 
codons and ψ34, which both create more rigid anticodon loops that enhance the rate of 
proper base pairing with codon sequences during translation and reduce the risk of 
frameshifting (177).   
The majority of known tRNA modifications have no known function.  Up to 17% 
of bases in tRNAs are modified—the highest percentage of any RNA species (178).  
Until the mid-1990s, tRNA research focused primarily on quantifying the number of 
isoacceptors, molecular sizes, and quantities of tRNA under different stimuli.  The advent 
of tRNA sequencing by mass spectrometry revealed a high number of modified bases and 
posed new questions about the roles of tRNAs and their associated enzymes in stress 
responses and disease.  Modifications are normally added to various tRNAs, and 
additional modifications may be added in response to stress.  The list of modifications 
continues to grow as new enzymes are found and more tRNA sequencing studies are 
performed.  Linking why a particular modification exists is complicated by not knowing 
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which enzyme(s) placed it there and why (166,168).  Thus, bioinformatic searches for 
tRNA interacting proteins as well as data sets from tRNA sequencing studies spur 
discovery of new modifications.  Another challenge is determining the in vivo 
significance of tRNA modifications (179,180).  Lack of essential tRNA modifications 
can cause degradation of the tRNA which suggests that these enzymes help maintain 
optimal cell health (181-183). 
Other tRNA modifications have been found using mass spectrometry (184-186), 
but the enzymes performing these modifications have not yet been identified.  
Investigating the role of tRNA modifications has often been hindered by a lack of 
obvious phenotypes.  As more information is gained regarding the regulation of the 
modification enzymes, some of the unobvious biochemical purposes of the modifications 
in response to stress are beginning to be elucidated (183).  For example, certain tRNA 
modifications are important for heat shock survival (182,187), antibiotic resistance 
(188,189), immune activation (190), and, in higher eukaryotes, cancer progression (191).   
tRNAs function as translators between the nucleic acid message and the 
functional protein.  This is accomplished by the addition of an amino acid to the terminal 
3’ adenosine residue of the –CCA motif by aminoacyl-tRNA synthetases (aaRSs).  These 
proteins recognize key features of mature tRNAs to decrease the chance of mis-
aminoacylation.  The features used by the aaRS to identify the appropriate tRNA vary 
from enzyme to enzyme.  For example, the E. coli alanyl-tRNA synthetase only 
recognizes the amino acid stem of the tRNA (192).  This is a rare case though, and most 
aaRSs recognize a certain primary sequence in the tRNA, specific combinations of tRNA 
modifications, and the anticodon (193). 
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aaRSs catalyze two enzymatic reactions using the same catalytic site (112).  The 
first is the adenylation of the incoming amino acid.  The adenylated amino acid can then 
attack the 3’-adenosine of the tRNA, which ultimately results in a labile ester bond 
between the 3’-OH of the tRNA and the carboxyl group of the amino acid.  The 
proportion of mis-aminoacylated tRNA in bacteria is typically higher than in eukaryotes 
because bacterial aaRSs typically have less stringent editing capabilities. 
Interestingly, several organisms only encode 19 or 18 aaRSs, which is less than 
what would be required to aminoacylate tRNAs for the 20 amino acids found in proteins.  
Chlamydia spp. were the first bacteria to be shown to have only 18 aaRSs (194).  In 
organisms with fewer than 20 aaRSs, AspS adds aspartate to both tRNAAsp and tRNAAsn 
and GltX adds glutamate to both tRNAGlu and tRNAGln.  These mis-acylations are 
subsequently corrected by the transamidase complex GatCAB (195).  GatCAB docks 
onto the N-terminal domain of both AspS and GltX while in complex with the mis-
aminoacylated tRNA (196).  GatC is the catalytic subunit in the complex and 
transamidates the carboxyl group of the aspartate or glutamate using the amine group 
from glutamine (195). 
Expression of translation-related genes in Chlamydia spp. 
 Translation regulation in Chlamydia spp. has not been directly investigated.  
Belland et al. conducted a time course study of C. trachomatis serovar D RNA 
throughout the development (28).  Transcription of putative tRNA modification enzymes 
and aaRSs primarily begins early in infection (3-8 hpi) (28).  Putative C. trachomatis 
homologs of known tRNA modifying enzymes are listed in Table 1.  While this 
expression pattern makes sense in terms of the order in which the genes are used, it is 
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particularly remarkable given that these genes are scattered throughout the C. trachomatis 
genome, unlike in E. coli and B. subtilis where these genes are more organized into 
multicistronic operons (Figure 3). 
 
Table 1 Predicted tRNA modifying enzymes in C. trachomatis 
Enzyme Function and Modification(s) First Transcribed a  
Pseudouridinases   
 TruA U-55 isomerase 8 hpi  
 TruB U-38, 39, & 40 isomerase 3 hpi  
 RluA U-32 isomerase 8 hpi  
Methyltransferases   
 TrmB Guanine-N7 methyltransferase 8 hpi  
 TrmD Guanine-N1 methyltransferase + DUF 3 hpi  
 TrmL C-34 2’-O-methyltransferase 3 hpi  
 TrmU 5’-methylaminomethyl-2-thiouridate methyltransferase 8 hpi  
Others   
 TilS tRNAIle lysine synthase 8 hpi  
 YrdC N6-A37-threonylcarbomoyal transferase 8 hpi  
 Tgt Quenine tRNA-ribosyl transferase 8 hpi  
 GidA Uridine 5-carboxymethylaminomethyl modifying enzyme 16 hpi  
 MiaA δ2-isopenylpyrophosphate transferase 8 hpi  
a From Belland et al. 2003 transcriptome of C. trachomatis serovar D/UW-3 
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Figure 3 Organization of tRNA modifying enzymes.  The location of genes encoding the 37 tRNAs 
(outer circle, black lines), 2 rRNA loci (outer circle, green lines), the 18 aminoacyl-tRNA synthetases 
(middle circle, purple lines), and the putative tRNA modifying enzymes (inner circle, blue lines) is shown 
on the C. trachomatis L2 434/Bu chromosome.  Notice the highly dispersed nature of these genes around 
the chromosome.  Most genes would not be predicted to fall into operons. 
 
 De novo translation of C. trachomatis proteins begins ~2 hpi, so pre-existing 
translational machinery must be present (48).  Another transcriptomics study used 
RNAseq to compare the transcripts in EBs and RBs isolated at 24 hpi (197).  Notably, the 
majority of EB transcripts were tRNAs.  If these tRNAs are functional is unknown.   
Multiple studies of chlamydial proteomes have identified peptides that correspond 
to various aaRSs (198-200).  Although no study has shown the complete set of aaRSs, 
given that Chlamydia spp. only possess the most minimal set of aaRSs, they must all be 
expressed, albeit at a low level.  A recent study of the C. caviae phosphoproteome 
detected phosphopeptides from two different aaRSs: ProS in EBs and ThrS in RBs (201).  
Because EBs quickly differentiate into RBs, the authors hypothesized that 
phosphorylation might be used to post-translationally regulate chlamydial proteins, 
28 
including the aaRSs, since Pkn kinases are active early in infection (201).  
Phosphorylation of several eukaryotic aaRSs by casein kinase reduced their enzymatic 
activities (202).  Thus, the discovery of chlamydial aaRS phosphopeptides suggests the 
tantalizing hypothesis that RB-EB transition may involve inactivation of translation by 
phosphorylation of aaRSs. 
The behavior of tRNAs and aaRSs during times of stress is ill-defined.  E. coli 
and other gram-negative bacteria can enter the stringent response, which generally 
downregulates both transcription and translation of most proteins, but increases 
expression of proteins that aid in acquiring or synthesizing the “missing” amino acid(s) 
(145).  Chlamydia spp. appear to lack the genes required for the synthesis of the second 
messenger (p)ppGpp (4), which initializes the stringent response.  Cyclic di-AMP has 
been suggested to act as a secondary messenger to trigger stress responses in Chlamydia 
spp. similar to (p)ppGpp for other bacteria, although the targets of cyclic di-AMP in 
chlamydia have not been described (203).  The transcriptome of C. trachomatis serovar D 
grown in the presence of IFN-γ showed an approximately 50% increase in the number 
transcripts for all of the aaRSs transcripts (204), suggesting that the chlamydia may be 
trying to capture all available amino acids and that, despite the apparent lack of gene 
organization, this response is highly coordinated. 
Antibiotics targeting either transcription (e.g., rifampicin) or translation (e.g., 
chloramphenicol) have been used to show that chlamydial entry into host cells does not 
require de novo bacterial transcription or translation.  Inclusions still form and are 
trafficked to the perinuclear space in the presence of these drugs but do not expand (205).  
These inclusions also resist lysosomal fusion, indicating that the effectors that uncouple 
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the inclusion from endocytic progression are not synthesized de novo.  What signals EB-
RB differentiation and, concomitantly, the switch to active metabolism is unknown.  
Whether differentiation is dependent on de novo protein synthesis is also unknown.  
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Research goal 
 To be viable, chlamydia must metabolize and replicate; however, how the genes 
that drive these core processes are regulated in the context of the chlamydial biphasic 
lifecycle is unknown.  The small genome and obligate intracellular nature of Chlamydia 
spp. suggests that many chlamydial genes are essential.  One approach for genetic 
analysis of functions of essential genes is to generate conditional alleles.  We 
hypothesized that temperature sensitive C. trachomatis mutants could be identified, and 
the contribution of individual essential genes to the developmental cycle could then be 
characterized.  We also hypothesized that mutants with temperature sensitive alleles of 
genes that mediate chlamydial metabolism and cell division would exhibit defects early 
in the developmental cycle.  DNA replication and protein synthesis are essential, and 
chlamydia mutants with defects in either of these processes have not been identified 
previously.  Here, we describe the phenotypes of heat sensitive mutants of dnaE and gltX. 
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CHAPTER II: Materials and Methods 
Chlamydial strains and cultivation 
 McCoy and HeLa 229 (HeLa) cells were obtained from the American Type 
Culture Collection and were maintained in high glucose DMEM (HyClone) 
supplemented with nonessential amino acids, HEPES, and 10% fetal bovine serum 
(DMEM-10; Atlanta biologicals).  C. trachomatis L2 434/Bu was stably transformed 
with pGFP::SW2 (a kind gift from Dr. Ian Clarke), which expresses green fluorescent 
protein (GFP) under the control of a Neisseria meningitidis promoter and is β-lacatamase 
resistant due to the presence of bla on the plasmid (92).  The transformed strain (L2-GFP) 
was plaque-purified twice prior to being mutagenized for library construction (206).  Cell 
culture was performed in a 5% CO2 humidified incubator at 37°C unless stated otherwise. 
Mutant library construction 
McCoy cell monolayers were infected with L2-GFP in sucrose phosphate 
glutamic acid buffer (SPG) at a multiplicity of infection (MOI) of 2 as described 
previously (207).  The inoculum was then replaced with DMEM-10 containing 1 µg/ml 
cycloheximide to inhibit host cell protein synthesis.  The medium was replaced at 18 
hours post infection (hpi) with 10 mL of DMEM-10 containing 4 mg/mL EMS.  Cells 
were rocked for 1 h at 37°C, washed extensively with PBS to remove excess mutagen, 
and fresh DMEM-10 + 1 µg/ml cycloheximide was added.  The medium was aspirated at 
34 hpi and mutagenized EB were harvested from the cells by mechanical disruption of 
the cell monolayer with 3 mm glass beads in SPG.  Mutants were isolated from EB stocks 
by plaque cloning and were arrayed in SPG in 96-well cell culture plates.  A portion of 
32 
each plaque was then expanded in McCoy cells in a 96-well cell culture plate for 70 h, 
which corresponds to approximately 2 developmental cycles.  The medium was then 
aspirated, SPG was added to each well, and the expanded library plates were stored 
at -80°C. 
Temperature sensitivity screen 
HeLa cells in 96-well cell culture plates were infected with equal volumes of 
expanded library isolates by centrifugation at 1600 x g for 1 h in a swinging bucket rotor 
followed by rocking at 37°C for 30 min.  Inocula were replaced with pre-warmed 
DMEM-10 + 1 µg/ml cycloheximide, and replicate plates were incubated at 32°C, 37°C, 
or 40°C.  Infected monolayers were fixed at 34 hpi (for 37°C or 40°C plates) or at 58 hpi 
(for 32°C plates) with 3.7% formaldehyde to preserve GFP fluorescence.  Chlamydial 
inclusions were imaged at 4X using an EVOS automated fluorescent microscope and 
inclusions were enumerated using a custom macro in FIJI (208).  Ratios of inclusion 
formation were calculated for individual library isolates incubated at permissive versus 
non-permissive temperatures (37°C vs. 32°C or 37°C vs. 40°C).  Isolates which had fold-
changes equal to or greater than 15 were re-screened to confirm their phenotypes. 
Mutants were plaque cloned twice and expanded prior to further characterization. 
Whole genome sequencing 
Genomes were sequenced using two strategies.  For some isolates, 1 µg of 
genomic DNA from MD-76R purified and DNase treated EB (209) was fragmented using 
NEBNext dsDNA Fragmentase (NEB) treatment to generate dsDNA fragments for 
multiplex Illumina sequencing using the TruSeq Nano DNA sample preparation kit 
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according to the manufacturer’s protocols (Illumina).  Samples were multiplexed using 
TruSeq Single Index Sequencing primers.  Equimolar concentrations of indexed libraries 
were combined into a single pool and submitted for sequencing at Tufts University 
Genomics Core Facility in Boston, MA.  Paired-end 100 bp sequencing was performed 
on an Illumina HiSeq 2500.  
For other isolates, whole genome amplification was performed on crude EB 
preparations using REPLI-g (Qiagen) as described in (210), excluding the immuno-
magnetic cell-separation step.  Sequencing libraries were prepared using the NexteraXT 
DNA Library Preparation kit according to the manufacturer’s instructions (lllumina). 
Samples were multiplexed using the NexteraXT Dual Index primer kit, combined in 
equimolar concentrations, and sequenced at the Oregon State University Center for 
Genomic Research and Biocomputing Core Sequencing Facility in Corvallis, OR for 
single-end 100 bp reads on an Illumina HiSeq 2000 or at the Tufts University Genomics 
Core Facility in Boston, MA for paired-end 100 bp sequencing on an Illumina HiSeq 
2500.  
Whole genome sequence data generated from the TruSeq Nano library was 
analyzed as described (90).  Ambiguous sequences from the dataset and mutation calls 
with low quality scores were resolved by PCR and Sanger sequencing using primers in 
Table 2.  Genome assemblies for the NexteraXT generated sample libraries were 
performed using an alternate workflow as described in (210) adding the use of ad hoc 
Python scripts and Geneious sequence manipulation software suite (version 7, 
http://www.geneious.com) (211).  Genotypes of TS isolates and recombinants are listed 
in Chapter III and Appendix II. 
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Table 2 Primers used to map recombinants 
Genome Position ROIa Forward Reverse 
14452-15184 CTL0009 gcgtatctatttcctattgtagcag acgccttaacctctaccacc 
46598-47549 CTL0039 ggcagttgcttcatcaattac caattactactaggctctgctgc 
63464-64192 CTL0052 cgagtagggttagatcgtgagc gaccgctttattgtatagaccttgag 
105701-106865 gpsA agatagttcactagcttgctactc catgaaagagactatagcctacctag 
130701-133997 FtsK ctattagtaatttacatgaccttgttcc caatctgaaccaagatcaaattctc 
155555-161373 AlaS-16S rRNA caagaaggaatatactagtggatc gcattcctggatgacctgaag 
180132-181241 CTL0136 gtaaatcctcatctagctaaagagagc aattggtagtcaaagtttgctctgg 
182244-183011 CTL0137 ccgtttggctgctacttcc gctcttcaccttttgactacttg 
188801-189574 CTL0144 cgtagactgtatgaggtgtgttatac gctgtattcctattatctcgcatctc 
214840-215464 pgsA catggctgatagtgtataccg ccgttagtaagagctacaggag 
224443-225235 ptr atagggacgcgatatacggcactgc atggacaaccaccttcctgttatcaatgaccctacc 
233317-233936 pmpD gcagaaagtaaagttcctcaatgtattc gttccatcttgaattttagcctcag 
244620-245780 sucC tgcatcttcatgagtatcaagc gctaacgacttaattgcacagc 
254809-255545 nrdA tgataacagagaagaggacggg cttgtacagtggaaagatagcaag 
267894-268667 CTL0211 ctcgttgggattagatgtgcg cgggttatcatagcatcgttc 
309407-310397 pmpF gcgtgatggtataggttgttg gctattgactgtggttacattgac 
312764-313595 pmpG gaatctggagagctcagtttatc gaccattatttgctgtattaggatcc 
318735-319675 pmpI gaactagaacctgtaagtggtcc atgtgcctcatccagaacg 
322831-323659 CTL0255 tgttgtaaaggatcgacgcatc cctaaacttcttgaaatgctgc 
394198-394950 tyrS gaacaggatagataagatgttgctag gatccagccagatagttccag 
400847-401446 CTL0322 gaacaagcagaagggtccac taccatctgtagaactagactacc 
402105-403085 CTL0323 cagaggactcttgtgtttagcagg cacaaagatcctctacggacc 
427765-428935 sctU ctactgacaaagttgagtagcttg aacatttatatacggtaacttgcgaag 
430894-431474 truB gataatcaatgccgcagccag caagtccctcctatgttctctgc 
442009-442666 fabI aacagcacgcatggaagc gatccagccagtgaatctactc 
451922-452741 pepF gatatcattctgaaatagtgctgcttc catgaccactgctactacttc 
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Genome Position ROIa Forward Reverse 
459820-460557 IncA-CTL0375 ctgtagaacgctcagcatg gtagagatgacgcacgtac 
466694-467383 CTL0384 cttgtgatactaatgacaggatagg ctttaacttcaacagtcatgcag 
472937-473695 CTL0388 ggagatccattcttccatactatc cgatccgaaacgacttatggtg 
490049-490964 CTL0402 gagtttaagcagttgatggaagagc gtaattctgcaacaccatccagc 
504404-505210 CTL0413 catagagtttagattcccgatccc caaccgacacctagccag 
526566-527387 devB gcaagaggttatatacatggctac cgacaacagatggctattcg 
535794-536425 tgt cttacggccatctcggtag cttctggtccgattgttacagctc 
539504-540168 CTL0448 caacaacagttaatcctaattactctcttc gtttacaccgatagatagggctcc 
546972-548627 CTL0456 aagtcttctcctccacagatc gagctttaaaccttatgtcttctgttaatag 
578274-578909 incC atgacgtactctatgtccgatatagc caaggctcgcaacgatcc 
602415-603281 lgt cgctttcagatgtggacgc acgtgatacattgggaccagtc 
619233-619926 murE cagctatacctttctctggc atgcatttagaccaacttcttcgg 
625234-626060 dnaA cgtttcgataatttcattgaaggtcc tacatggcaacttgtcgagc 
626662-627339 CTL0529 caaggatatgtcaaagccaatatagaac ggcggcgatgtagtaaacg 
627322-627924 nqrB gtttactacatcgccgcc cttcgcaagttcctcctacag 
652497-653126 pknD caactgccggtggattagg gctatctatgacccagccagtg 
661930-662628 atpB gttaactttatttgtgaagacatgctttagg cggttgaatgtgtattgataccag 
664673-665504 CTL0561 caaatggcattaacgtattcgcctcttc cgtttaacgcatttctcagagttagttag 
674953-675975 rpoB agctccagaatctttggcag gctcgatccacaattatgc 
677187-678281 rplL ctgttaagacgtaccgggaac ggatactagggagttgattgcg 
687036-687731 trpC ggttgccccattcttgtctc gttttagcccctttgttgtatgaag 
694629-695486 uvrA ctatgatccggttacactacac ctgagtccagtcttgttacatc 
703257-704213 ptsH-CTL0592 cattacaactctccgaatccag gtttatccgctccttatgatgtg 
709892-710559 CTL0597 cacatgacaacatcccttatctaaac gtgcatctaacacgagaaagtatagc 
714841-715866 xerC cctagttagcgcatatactgttg cggtgtagttactcctctaagttg 
724156-724918 CTL0609 tctgcaagaagtttagttattgtagc ctatgtggcctgtggttctg 
738215-738988 aroC aacaatgctctcttagtcttactcg acctgttgtattagcgagtcgg 
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Genome Position ROIa Forward Reverse 
752372-753277 phnP cttgttctaaggttaaatgcgaagg gccatctatcgctcaagttgtc 
735386-736155 CTL0619 cttgtacagcaggcaatccc gaccgtagttgctccgag 
754878-755606 CTL0638-CTL0639 gatgctattctgatccgttagac gagagatgctatcaaagtgctg 
806908-807570 obgE cctggaatatctgccatgatcc aggacgagtcatgtttgttgatc 
809833-810688 CTL0681 ttgttcctcaaattggttaattattagag cgataatagccagcagaatatatagc 
826951-827660 rpsL-CTL0699 cgaacccaagcaaccttacg ggtctgtgagatagccagttcttc 
833115-834723 gltX ctcaagcagtatttgaaatgaccttc ggttagtagcgaatgactgtcc 
858379-858952 CTL0724 ttgcatacactctaaaaccg gaggtttggcgattgtctg 
893816-895248 dnaB cctctaactatggcgaccc cttgtttatccagggaactcac 
897112-897663 lplA cgcttctttggagatggagatc cttttgaagatggagatggagtagg 
907739-908788 rplF & rpsH tgtctttacaacggataatctggg gagcatttgtacattgatatcgagcatag 
916258-916882 fmt catatagcagccatattcacctacc ctttagccgcctctggtg 
924066-924874 tRNAleu-trxA catcctgaatcgactacatgctatc gtctttgagtccaacgctgc 
927406-928190 aspS aataccgatccaaacctccaac gatgctgccgatcaacaagtc 
929021-929760 hisS-uhpC ccaacaatgcacgaacaactg gattcataggtgttagctcgattc 
929737-930808 uhpC gaatcgagctaacacctatgaatc cgagtaccccataatcccaag 
933403-934098 dnaE gaacagatggtcaaggaacg ctccttaggagagcgttgg 
940437-941632 CTL0815 aggtttctgaacttaccgatatactc cctcgtcctatagtacctgc 
952870-953831 sctR cctatagcttcgccagtac aaatgatcagaattaataagagggc 
962022-962805 gspD gttcggtaatctcgctgacag ggctatgggtttctagggac 
969410-970314 copB caagccattaagcaagctg gtcataatcagtcccatgagc 
1006911-1007649 uvrD gccgctcttatgaactatgcc gcatctgtagcatatccagtcc 
1007634-1008456 rpoN gatatgctacagatgccagttg ggatgagaactcgaaggatagc 
1009600-1010293 CTL0875 cataaaacgtgtgttctagcatatg gattgtgagtttatgtgaaggcg 
1027396-1027970 CTL0886-CTL0887 ggcatcacgaagagagattaatg gaagctttagcgattccagaaattg 
a ROI = region of interest 
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Negative selection lateral gene transfer (LGT) 
For same species crosses, HeLa cells were co-infected with different pairs of heat 
sensitive (HS) or cold sensitive (CS) mutants, with each parent at an MOI of 2, incubated 
at 37°C, and then harvested at 34 hpi by freezing and bead agitation.  Portions of the 
harvests were passed in HeLa cells grown at the appropriate non-permissive temperature 
(32°C or 40°C) to select against the parent strains and were harvested at 34 hpi.  An 
additional passage and harvest cycle was then performed.  Recombinants were isolated 
by limiting dilution, re-screened to confirm their temperature resistant phenotypes, 
plaque-cloned, and expanded in cell culture.   
Interspecies crosses between L2-GFP and C. muridarum use a similar procedure 
with the exceptions that McCoy cells were used throughout and two rounds of plaque 
cloning were performed in lieu of a round of limiting dilution and a round of plaque 
cloning. 
Genomic DNA was isolated from recombinant EBs by alkaline lysis.  Sanger 
sequencing of PCR products using the primers listed in Table 2 was used to determine 
which SNPs present in the parents were retained in the recombinants (Appendix II).  
Genomes of select recombinants were sequenced as described above. 
Immunofluorescence microscopy 
HeLa cells in 96-well plates (BD Falcon) or on glass coverslips were infected 
with TS mutants and control strains at MOI of 0.1 as described above.  Where indicated, 
cells were treated with either 12.5 μg/mL chloramphenicol or 0.2 μg/mL rifampicin.  At 
the indicated time post infection, cells were fixed with 3.7% formaldehyde.  Cells were 
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subsequently blocked and permeabilized with blocking buffer (1% BSA and 0.1% 
saponin in PBS) and labeled with conditioned EVI-H1 hybridoma supernatant, which 
contains a chlamydial LPS-specific monoclonal antibody, and a secondary DyLight 594-
conjugated goat anti-mouse IgG secondary antibody (Thermo Scientific) in blocking 
buffer.  Images at 10X were acquired on an EVOS FL Auto Microscope (Thermo 
Scientific), whereas images at 40X or 63X were acquired on a Leica inverted DMI6000B 
microscope.  Inclusion cross-sectional areas for temperature shift assays were measured 
in CellProfiler (212) using a modified pipeline (213).  Inclusion cross-sectional areas for 
antibiotic treatment experiments were measured using ImageJ.  Presented images were 
equally adjusted for brightness and contrast in Adobe Photoshop. 
Temperature shift assays 
For HS mutants, replicate experimental plates were initially incubated at 40°C 
then moved to 37°C at either 8, 12, 18, or 24 hpi.  Control plates were incubated at 37°C 
or 40°C throughout.  For CS mutants, plates were initially incubated at 37°C (with the 
exception of the 32°C only control) and then moved to 32°C at 8, 12, 18, or 24 hpi.  The 
cells were fixed at 34 hpi (TS) or 58 hpi (CS) with 3.7% formaldehyde.  Inclusions were 
stained as described above with anti-LPS antibody and imaged at 10X on an EVOS 
automated fluorescent microscope (Thermo Scientific).  Four images per well were used 
to calculate the inclusion cross sectional areas, which corresponds to ~500 inclusions at 
an MOI of 0.2 grown at 37°C.  Inclusion cross sectional areas were used to sort the 
mutants into developmental cycle classes based on the first time interval where their 
mean normalized inclusion area was ≤80% of L2-GFP. 
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Progeny formation assays 
HeLa cells were infected at an MOI of 0.1 with 30% MD-76R purified (214) EBs 
or clarified harvests in SPG by centrifugation and rocking.  The SPG was then aspirated 
and DMEM-10 + 1 µg/ml cycloheximide was added.  The infections were incubated at 
32°C, 37°C, or 40°C.  The media was aspirated at 34 hpi (37°C and 40°C plates) or 58 
hpi (32°C plates) and replaced with SPG.  The infected plates were frozen at -80°C.  EBs 
were harvested upon thawing the plates and titered on fresh HeLa cell monolayers as 
described previously (90).  A parallel 96-well plate was infected to titer the inoculum, 
incubated at 37°C, and fixed with 3.7% formaldehyde to normalize fold change 
differences between strains.   
Genome copy number 
 Genomic DNA was extracted from aliquots of samples generated for progeny 
formation assays using a gMax kit according to the manufacturer’s instructions (IBI 
Scientific).  FastStart TaqMan Probe Master mix (Roche) was used to quantitate the 
number of genome copies in 1 uL of purified genomic DNA (gDNA) using the primers 
5’-GTAGCGGTGAAATGCGTAGA-3’ and 5’-CGCCTTAGCGTCAGGTATAAA-3’ 
with a corresponding TaqMan probe specific to the 16S rRNA gene of Chlamydia (5’-
/56-FAM/ATGTGGAAG/ZEN/ACCACCAGT-3’).  Genome copy numbers were 
determined using a standard curve generated from serial dilutions of a plasmid containing 
a cloned copy of a chlamydial 16S rRNA gene run in parallel.  Reactions underwent 40 
cycles of amplification on an Eppendorf Realplex4 using the following conditions: 20 sec 
at 95°C, 1 min at 60°C, and 20 sec at 68°C.  Copy number analysis was performed using 
Realplex software. 
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Transmission electron microscopy 
HeLa cells were infected at an MOI of 0.5 as described above.  Infections were 
fixed at 32 hpi for 1 hour on ice using 4% paraformaldehyde/2.5% gluteraldehyde.  
Sample processing was performed essentially as described in (215).  Briefly, the cells 
were washed with sodium cacodylate, embedded in resin, and stained with osmium 
tetroxide.  Ultrathin sections were further stained with uranyl acetate and lead citrate.  
Images were captured using a JEOL JEM 1011 microscope with a Gatan 890 4k x 4k 
digital camera at the Indiana University Microscopy Center, Bloomington, IN. 
DnaE suppressor screen 
HeLa cell monolayers of 15 T-175 flasks were infected at an MOI of 30 by 
rocking for 2 hours at 37°C.  The inoculum was then replaced with fresh DMEM-10 + 1 
µg/ml cycloheximide, and the infections were incubated at 40°C for 34 hpi.  The 
monolayers were harvested using glass beads.  Host cell debris was removed by 
centrifugation at 500 x g for 5 minutes.  Each supernatant was passaged immediately onto 
fresh HeLa cell monolayers in 2 wells of a 6 well plate and centrifuged to enhance 
infection.  Selection at 40°C for 34 hours was repeated five times.  A portion of the 
resulting progeny was scaled up at 37°C to generate a stock and to isolate genomic DNA 
by alkaline lysis for Sanger sequencing of dnaE using the primers in Table 3.   
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Table 3 Primers used for dnaE Sanger sequencing 
Position Direction Primer 
-200 bp Forward cggctttacaggatggttcg 
312 bp Forward ctctcctctcttgcttacacag 
843 bp Forward ctatttgcagcacatccagagac 
1379 bp Forward cagagagcgcgttattaactatgc 
1894 bp Forward ccacgattcctctagatgacc 
2265 bp Forward gaacagatggtcaaggaacg 
2808 bp Forward gctatccttaatgacctttacgacac 
+297 bp Reverse gttcgtgttgagtatattaatgctattacagg 
 
Statistics 
Statistical analyses were performed using GraphPad Prism version 6.0.  For 
statistical analysis, data were analyzed either by one- or two-way ANOVA followed by 
the post hoc tests indicated in the figure legends to correct for multiple comparisons.  
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CHAPTER III: A Genetic Screen for Conditional Alleles of Essential Genes 
 
Portions of this chapter were published in Brothwell JA, Muramatsu MK, Toh E, Rockey 
DD, Putman TE, Barta ML, Hefty PS, Suchland RJ, and Nelson DE. 2016. Interrogating 
Genes That Mediate Chlamydia trachomatis Survival in Cell Culture Using Conditional 
Mutants and Recombination. J bacteriol. 198, 2131-2139. 
 
Generation of a mutant C. trachomatis library 
C. trachomatis serovar L2 434/Bu transformed with pGFP::SW2 (L2-GFP) was 
used as the parent for the mutant library.  This strain was used because it infects humans 
and has the highest availability of reagents among the C. trachomatis serovars.  Ethyl 
methanesulfonate (EMS), which causes GA transitions, was used to generate random 
point mutations.  EMS has been used previously in other C. trachomatis and C. 
muridarum libraries (87,88,90). 
Higher mutation levels of C. trachomatis serovar L2 can be achieved in Vero cells 
(monkey kidney cell line), since these cells can withstand 20 mg/mL of EMS (88).  
Attempts to use high levels of EMS with L2-GFP failed to produce progeny, as 
evidenced by lack of fluorescent inclusions at 34 hpi.  Titration of EMS down to 10 
mg/mL also failed to produce fluorescent inclusions. 
Mutagenesis was then attempted in McCoy cells (murine fibroblast cell line), 
which could withstand up to 8 mg/mL EMS (90).  Although GFP+ inclusions were 
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evident at 8 mg/mL, the progeny failed to plaque efficiently (data not shown).  A parallel 
culture mutagenized with 4 mg/mL EMS, however, could be plaqued efficiently, and the 
high yield of progeny after mutagenesis suggested a diverse population of mutants was 
present in the stock. 
The mutant population was isolated by plaque cloning in McCoy cells and these 
isolates were arrayed into 96-well plates in SPG for ease of screening.  A library of 4,184 
arrayed plaques was generated from the cells mutagenized with 4 mg/mL EMS. 
Temperature sensitivity (TS) screen 
 Because the natural host of C. trachomatis is humans, genetic screens were 
performed in HeLa cells (human cervical epithelial cell line).  Three replica plates of 
HeLa cells were infected with equi-volume inoculums of mutants from the library (Figure 
4).  The infected monolayers were then incubated at 32°C, 37°C, or 40°C.  These 
temperatures were chosen since large inclusions fail to form in a timely manner below 
32°C and chlamydial death has been seen at higher temperatures (data not shown and 
(216)).  After 34 hpi, monolayers incubated at 37°C and 40°C were fixed with 
formaldehyde; monolayers incubated at 32°C were fixed at 58 hpi, since development 
and inclusion fusion are slower at 32°C (217). 
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Figure 4  Temperature (TS) screen scheme.  Replica plates of HeLa cells were infected with equal 
volumes of EMS-mutagenized C. trachomatis plaque isolates in 96-well plates.  Plates were incubated at 
either the permissive temperature (37°C), or 32°C or 40°C to identify cold (CS) and heat (HS) mutants, 
respectively. 
 
 Monolayers were imaged, and the number of inclusions was determined.  The 
number of inclusions that the isolates formed at 32°C or 40°C compared to 37°C revealed 
isolates with a range of thermal sensitivities.  A threshold of a 15-fold difference between 
37°C and the non-permissive temperature was used to define a TS mutant.  These 
primary screen candidates were re-screened in duplicate alongside the L2-GFP parent.  A 
total of 26 heat sensitive (HS) mutants and 2 cold sensitive (CS) mutants were isolated.  4 
mutants that had produced at least a 15-fold decrease in the number of inclusions at both 
32°C and 40°C relative to at 37°C, but failed to meet this cutoff in the secondary screen 
were also pursued.  Fold change values for the mutants meeting this cutoff are listed in 
Table 4. 
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Table 4  Isolates with a ≥15-fold reduction of inclusion number at the non-permissive temperature 
Isolate Fold Difference 
Primary Screen Secondary Screen 
Heat Sensitive 
 HS 1 30.16 29.84 
 HS 2 16.86 33.36 
 HS 3 20.46 22.12 
 HS 4 16.24 17.13 
 HS 5 152.68 19.04 
 HS 6 26.49 19.29 
 HS 7 15.38 35.39 
 HS 8 16.24 52.73 
 HS 9 23.40 18.95 
 HS 10 17.96 63.02 
 HS 11 31.67 38.58 
 HS 12 58.28 41.46 
 HS 13 28.74 58.56 
 HS 15 17.40 15.12 
 HS 16 98.00 86.25 
 HS 17 118.32 56.49 
 HS 21 39.59 44.82 
 HS 22 30.58 16.57 
 HS 23 53.67 27.27 
 HS 24 102.48 64.48 
 HS 25 19.79 61.62 
 HS 26 56.03 23.52 
 HS 27 46.31 71.88 
 HS 28 37.07 19.84 
 HS 29 67.29 153.81 
 HS 29ba 86.51 24.99 
Cold Sensitive 
 CS 1 16.72 23.76 
 CS 2 15.21 66.09 
a Genome sequence of this isolate matches that of HS 29 
 
 Variation in the fold change of these isolates in the primary and secondary screens 
may have been caused by to the inability to account for varying multiplicity of infection 
(MOI) of different isolates.  Later experiments use identical MOI to avoid this variable.  
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The temperature sensitivity displayed by these isolates is highlighted in the statistical 
summary of the screen in Table 5. 
 
Table 5  Statistical summary of temperature sensitivity in a mutagenized library 
 Cold Sensitive 
(Inclusion number at 
37°/32°) 
Heat Sensitive 
(Inclusion number at 
37°/40°) 
Median 0.961 2.012 
Interquartile Range 0.763-1.272 1.275-3.099 
95th percentile 2.34 12.21 
 
Mutant phenotypes emerge at different times in the developmental cycle  
 Because a single pool of mutagenized L2-GFP was used to generate the library 
and a high proportion of TS mutants were identified, we next wanted to determine the 
diversity of phenotypes in the population and whether or not the mutants had different 
genotypes.  Temperature shift assays were performed to sort the mutants into classes 
based on when they became temperature sensitive during the developmental cycle.  We 
reasoned that if a gene’s function was not required until a certain point during the 
developmental cycle, then incubation at 40°C would have no effect if the culture was 
shifted to 37°C prior to this time.  Temporal gene expression patterns have been 
described in the literature (28), so we chose an 8 hpi timepoint to distinguish if a gene 
was needed for EB-RB transition, a 12 hpi timepoint to define defects during early 
development, a 18 hpi timepoint for early-mid-development defects, and a 24 hpi 
timepoint for late-mid-development.  Mutants exhibiting a late defect would appear 
between 24 hpi and the time at which all of the infections were fixed—34 hpi.  The 
inclusion areas of L2-GFP and the HS mutants were determined and plotted for the 40°C 
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to 37°C shifts (Figure 5).  The inclusion area of CS mutants was assayed using the same 
timepoints, however the plates were shifted from 37°C to 32°C because of the longer 
developmental time at 32°C (58 h v. 34 h) (Figure 6).  Mutants displaying both HS and 
CS phenotypes, but not meeting the 15-fold cut off were also characterized (Figure 7).   
The time of the onset of temperature sensitivity was determined by normalizing 
the inclusion area in each condition to its size at 37°C, thus differences in the sizes of 
mutants at 37°C could be accounted for.  When this value was <80% of the inclusion size 
of L2-GFP, the mutant was considered to have passed the point at which it could be 
rescued.  This time is denoted by arrows in Figures 5-7 for each mutant.  The number of 
TS mutants in each temperature sensitive class is in Table 6.  Defects in the majority of 
the mutants manifested during mid-development (i.e., 12-24 hpi) which was expected 
because de novo expression of most chlamydial genes initiates in mid-development (28). 
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Figure 6 Inclusion area of HS mutants.  HeLa cells were infected with HS mutants at an MOI of ~0.1.  
The infections were incubated at 37°C, 40°C, or were transferred at the times indicated above from 40°C to 
37°C until 34 hpi, when they were fixed.  LPS was stained, and inclusions were imaged at 10X.  Cross-
sectional areas (μm2) of the inclusions were determined using CellProfiler.  Red arrows indicate the time of 
temperature sensitivity, which was defined as when the area was <80% of L2-GFP. 
 
Figure 7 Inclusion areas of dual HS/CS mutants.  HeLa cells were infected with each HS/CS mutant at 
an MOI of ~0.1 and incubated as described in Figures 5 (A) and 6 (B).  LPS was stained, and inclusions 
were imaged at 10X.  Cross-sectional areas (μm2) were determined in CellProfiler.  Red and blue arrows 
indicate the time of heat and cold sensitivity, respectively, which was defined as when the area was <80% 
of L2-GFP. 
Figure 5 Inclusion area of CS mutants.    HeLa cells were infected with each CS mutant at an MOI of 
~0.1.  Infections were incubated at 37°C, 32°C, or were transferred at indicated times from 37°C to 32°C, 
until 58 hpi, when they were fixed.  LPS was stained, and inclusions were imaged at 10X.  Cross-sectional 
areas (μm2) were determined in CellProfiler.  Blue arrows indicate the time of temperature sensitivity, 
defined as when the area was <80% of L2-GFP. 
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Table 6 Distribution of mutants in phenotypic classes 
TS 
type 
Point in Developmental cycle 
Very Early 
(0-8 hpi) 
Early 
(8-12 hpi) 
Early-mid 
(12-18 hpi) 
Mid-late 
(18-24 hpi) 
Late 
(24-34 hpi) 
HS 1 9 19 3 0 
CS 2 1 0 2 1 
 
TS mutants represent a diversity of genotypes 
 Since the temperature shift experiments indicated the TS mutants had diverse 
phenotypes, the genomes of all 26 HS, 2 CS, and 4 dual HS/CS mutants were sequenced 
(Table 7).  One duplicate isolate was identified.  Two isolates differed from each other by 
only two mutations, indicating that they were likely siblings.  All of the other mutants 
were unique, indicating that the screen did not reach saturation. 
 The mutants had between 1 and 11 (average: 6) mutations per genome.  One 
isolate had a single mutation (HS 17; rspH).  Different nonsynonymous mutations were 
detected in the same genes in 22 cases (2-4 occurrences).  No genes known to be 
involved with the heat shock response in chlamydia (groEL, groES, or dnaK) or in other 
bacteria contained mutations (216).  Two TS mutants (HS 15 and HS 27) contained 
mutations in genes involved in the stringent response in other bacteria.  HS 15 encodes 
DksAE61K.  DksA has been shown to be responsive to (p)ppGpp in E. coli and 
downregulate transcription of rRNA transcripts during stress (218).  HS 27 encodes 
ObgEG92E.  ObgE interacts with the 50S subunit of the E. coli ribosome to inhibit 
translation in the presence of ppGpp (219).  Whether ObgE functions similarly in 
Chlamydia spp. is unknown, as C. abortus obgE is unable to complement an E. coli 
ΔobgE mutant (220). 
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Table 7 Mutations in temperature sensitive mutants 
Genome 
Coord. 
Nuc. 
Sub. 
Amino 
Acid 
Sub. 
Codon Gene Gene 
Locus 
Product & Function TS  hpi of 
TS a 
HS 1       HS 8-12 
 319,045 C  T R  K 777 pmpI CTL0254 outer membrane protein   
 402,693 G  A  209  CTL0323 ABC transporter substrate binding protein   
 466,895 G  A V  M 58  CTL0384 ABC transporter permease   
 547,235 C  T P  L 51 sodTi CTL0456 sodium:sulfate symporter   
 687,326 G  A  129 trpC CTL0581 N-(5'-phosphoribosyl)anthranilate isomerase   
 833,253 G  A Q  * 487 gltX CTL0705 glutamyl-tRNA synthetase   
 894,118 C  T  98 dnaB CTL0759 helicase   
 941,515 G  A V  M 345  CTL0815 putative methyltransferase   
 962,561 C  T S  N 87 gspD CTL0835 general secretion pathway protein D   
 1,007,275 G  A S  N 539 uvrD CTL0872 DNA helicase for repair   
HS 2       HS 12-18 
 323,177 C  T P  L 510  CTL0255 hypothetical protein   
 625,575 C  T  232 dnaA CTL0527 chromosomal replication initiation protein   
 724,595 G  A R  W 198  CTL0609 hypothetical protein   
 752,659 G  A P  L 127 phnP CTL0635 metal-dependent hydrolase   
 897,396 C  T  13 lplA CTL0761 lipoate-protein ligase A   
 927,802 C  T G  R 84 aspS CTL0804 aspartyl-tRNA synthetase   
HS 3       HS 12-18 
 60,444 G  A R  H 6 pbpB CTL0051 penicillin-binding protein   
 488,901 G  A G  E 263  CTL0402 putative integral membrane protein   
 597,658 C  T A  T 42 glgP CTL0500 glycogen phosphorylase   
 674,019 C  T V  I 971 rpoB CTL0567 DNA-directed RNA polymerase subunit beta   
 1,029,700 C  T G  E 376 mviN CTL0888 putative virulence protein   
HS 4       HS 12-18 
 644,042 C  T A  T 128 ptsN_2 CTL0543 PTS family membrane transport protein IIA subunit   
 883,313 G  A P  L 16  CTL0749 putative phosphohydrolase   
 907,588 C  T G  R 88 rplR CTL0775 50S ribosomal protein L18   
 982,227 G  A G  S 139 rbsU CTL0851 sigma regulatory family protein-PP2C phosphatase   
 1,004,010 C  T Intergen    between CTL0868 & CTL0689   
 1,028,279 G  A P  S 241  CTL0887 hypothetical protein   
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Genome 
Coord. 
Nuc. 
Sub. 
Amino 
Acid 
Sub. 
Codon Gene Gene 
Locus 
Product & Function TS  hpi of 
TS a 
HS 5       HS 12-18 
 141,878 G  A  219  CTL0111 rRNA SAM-dep. methyltransferase; TrmA family   
 404,846 G  A E  K 343  CTL0325 ABC transporter permease   
 875,332 G  A S  F 270 oppA4 CTL0741 oligopeptide transport binding protein   
HS 6       HS 18-24 
 27,569 G  A  382  CTL0019 putative exported lipoprotein   
 55,081 G  A Intergen    between tRNAlys & tRNAglu   
 147,818 G  A S  F 261 hemN CTL0115 coproporphyrinogen III oxidase   
 150,235 G  A A  V 867 mfd CTL0117 transcription-repair coupling factor   
 244,456 C  T G  R 32 ftsY CTL0192 cell division protein   
 460,138 C  T Intergen    between IncA & CTL0375   
 622,529 C  T  280 mraW CTL0524 S-adenosyl-methyltransferase   
 891,978 C  T G  S 206  CTL0756 putative nucleotide transport protein   
 892,219 C  T  125  CTL0756 putative nucleotide transport protein   
 899,269 C  T D  N 13 ruvA CTL0763 Holliday junction DNA helicase   
HS 7       HS 12-18 
 41,392 G  A E  K 274  CTL0033 phosphopeptide binding protein (to be a TTSS protein)   
 179,699 G  A R  Q 195 miaA CTL0135 tRNA delta(2)-isopentenylpyrophosphate transferase   
 365,543 G  A L  F 146 dcd CTL0294 deoxycytidine triphosphate deaminase   
 490,565 G  A V  I 818  CTL0402 putative integral membrane protein   
 555,911 C  T G  E 251 leuS CTL0461 leucyl-tRNA synthetase   
 729,656 C  T Intergen    between CTL0614 & CTL0613   
 803,532 C  T P  S 1,728 pmpC CTL0671 polymorphic outer membrane protein   
 874,299 C  T  614 oppA4 CTL0741 oligopeptide transport system binding protein   
 888,894 C  T G  E 309 polA CTL0754 DNA polymerase I   
 939,415 C  T  261 dacC CTL0813 D-alanyl-D-alanine carboxypeptidase   
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Genome 
Coord. 
Nuc. 
Sub. 
Amino 
Acid 
Sub. 
Codon Gene Gene 
Locus 
Product & Function TS  hpi of 
TS a 
HS 8       HS 12-18 
 49,730 C  T Intergen    between sctQ & pkn5   
 317,497 G  A  962 pmpH CTL0251 outer membrane protein   
 399,058 C  T A  T 508  CTL0321 ADP/ATP carrier protein   
 663,660 G  A P  S 458 atpA CTL0560 V-type ATPase subunit A   
 887,743 C  T E  K 693 polA CTL0754 DNA polymerase I   
 931,309 G  A A  T 58 dnaE CTL0807 DNA polymerase III subunit alpha   
 952,657 G  A G  E 174 sctL CTL0824 type III secretion system protein   
 992,991 C  T R  Q 46  CTL0858 hydrolase   
HS 9       HS 12-18 
 48,347 G  A G  E 277 sctQ CTL0041 type III secretion system protein   
 69,385 C  T L  F 300 sufS CTL0056 cysteine desulfurase   
 172,972 G  A G  R 103 ftsW CTL0129 cell division protein   
 273,112 C  T G  E 572 pnp CTL0214 polynucleotide phosphorylase/polyadenylase   
 797,655 C  T P  S 1,577 pmpB CTL0670 polymorphic outer membrane protein   
HS 10       HS 18-24 
 436,408 C  T D  N 539 rpsA CTL0353 30S ribosomal protein S1   
 484,238 G  A  23 pkn1 CTL0400 serine-threonine-protein kinase   
 517,348 G  A R  C 228 dsbG CTL0429 disulfide bond chaperone   
 908,097 C  T G  E 109 rplF CTL0776 50S ribosomal protein L6   
 916,562 C  T D  N 276 fmt CTL0792 methionyl-tRNA formyltransferase   
 924,519 C  T Intergen    between tRNAleu & trxA   
HS 11       HS 18-24 
 130,997 G  A P  L 730 ftsK CTL0108 DNA segregation ATPase   
 155,775 G  A Intergen    between AlaS & 16S rRNA   
 401,254 C  T M  I 51  CTL0322 hypothetical protein   
HS 12       HS 12-18 
 150,596 C  T V  I 747 mfd CTL0117 transcription-repair coupling factor   
 216,881 T  C Intergen    between glgA & tRNAgln   
 545,762 C  T  171 oppF CTL0454 oligopeptide transport system ATP-binding protein   
 593,969 C  T P  S 314 pdhB CTL0498 pyruvate dehydrogenase E1 component beta subunit   
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Genome 
Coord. 
Nuc. 
Sub. 
Amino 
Acid 
Sub. 
Codon Gene Gene 
Locus 
Product & Function TS  hpi of 
TS a 
HS 13       HS 12-18 
 106,075 G  A  264 gpsA CTL0083 NADPH- G3P dehydrogenase   
 428,014 C  T V  I 288 sctU CTL0346 type III secretion system protein   
 452,424 G  A S  F 106 pepF CTL0367 oligoendopeptidase F   
 578,442 C  T P  S 57 incC CTL0485 inclusion membrane protein C   
 677,584 G  A  33 rplL CTL0568 50S ribosome L7/L12   
 810,518 C  T P  L 159  CTL0681 metal dependent hydrolase   
HS 14       HS 8-12 
 284,726 C  T P  L 134 fumC  pseudogene: fumerate hydratase   
 337,254 G  A V  I 15 cydB CTL0269 cytochrome d ubiquinol oxidase subunit II   
 525,571 C  T L  F 180 zwf CTL0437 glucose-6-phosphate 1-dehydrogenase   
 605,142 C  T Intergen    between CTL0506 & CTL0507   
 624,545 C  T  109  CTL0526 hypothetical protein   
 640,060 C  T Intergen    between mnmA & CTL0540   
HS 15        HS 12-18 
 310,806 G  A  191 pmpF CTL0249 polymorphic outer membrane protein   
 760,537 C  T S  L 473  CTL0643 hypothetical protein   
 784,211 G  A E  K 61 dksA CTL0664 dnaK suppressor protein   
 1,013,676 C  T  213 rpoD CTL0879 RNA polymerase sigma factor   
HS 16       HS 8-12 
 141,403 C  T D  N 378  CTL0111 rRNA methyltransferase   
 199,418 C  T L  F 17  CTL0152 hypothetical protein   
 411,812 G  A  320 dnaN CTL0331 DNA polymerase III subunit beta   
 485,047 C  T T  I 293 pkn1 CTL0400 serine-threonine-protein kinase   
 518,215 G  A R  H 14  CTL0430 putative integral membrane protein   
 533,764 G  A  8 gyrB CTL0442 DNA gyrase subunit B   
 654,541 G  A P  L 321 pknD CTL0553 serine/threonine-protein kinase   
 723,243 G  A Intergen    between def & ksgA   
 753,018 C  T  7 phnP CTL0635 metal-dependent hydrolase   
 765,491 G  A S  F 307  CTL0648 hypothetical protein   
 932,237 C  T P  L 367 dnaE CTL0807 DNA polymerase III subunit alpha   
HS 17       HS 12-18 
 908,496 G  A A  V 119 rpsH CTL0777 30S ribosomal protein S8   
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Genome 
Coord. 
Nuc. 
Sub. 
Amino 
Acid 
Sub. 
Codon Gene Gene 
Locus 
Product & Function TS  hpi of 
TS a 
HS 18b       HS/
CS 
8-12 
 47,344 G  A V  I 264  CTL0040 hypothetical protein  
 180,826 G  A P  S 123  CTL0136 hypothetical protein  
 233,540 C  T A  V 1061 pmpD CTL0183 outer membrane protein   
 268,424 C  T A  T 46  CTL0211 putative membrane transporter   
 473,407 G  A P  S 79  CTL0388 putative methyltransferase   
 603,056 C  T R  K 75 lgt CTL0504 prolipoprotein DAG transferase   
 827,208 G  A Intergen    between rpsL & CTL0699   
HS 19a       HS/
CS 
8-12 
 309,983 C  T D  N 466 pmpF CTL0249 outer membrane protein  
 627,630 C  T P  S 39 nqrB CTL0530 NADHubiquinone oxidoreductase, subunit 2   
 662,238 C  T G  D 339 atpB CTL0559 V-type ATPase subunit B   
 695,055 G  A  261 uvrA CTL0587 DNA damage recognition   
 703,673 C  T Intergen    between ptsH & CTL0592   
 953,331 G  A D  N 171 sctR CTL0825 type III secretion system protein   
 1,009,794 C  T V  I 206  CTL0875 gamma-glutamyl ligase   
HS 20b       HS 8-12 
 14,768 G  A G  E 369  CTL0009 putative membrane efflux protein CS >24 
 224,695 G  A H  Y 181 ptr CTL0175 exported insulinase/protease   
 536,147 G  A R  W 20 tgt CTL0445 queuine tRNA-ribosyltransferase   
 547,516 G  A G  R 145 sodTi CTL0456 sodium:sulfate symporter   
 665,123 G  A R  W 235  CTL0561 hypothetical protein   
 1,027,647 C  T Intergen    between CTL0886 & CTL0887   
HS 21       HS 12-18 
 73,202 G  A  196  CTL0060 hypothetical protein   
 141,232 G  A S  L 3 yajC CTL0110 preprotein translocase subunit YajC   
 200,637 G  A H  Y 75 rnpA CTL0153 ribonuclease P   
 337,791 C  T  194 cydB CTL0269 cytochrome d ubiquinol oxidase subunit II   
 443,923 G  A C  Y 350  CTL0360 conserved chlamydial hypothetical protein   
 445,731 G  A R  C 47 truA CTL0361 tRNA pseudouridine synthase A   
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Genome 
Coord. 
Nuc. 
Sub. 
Amino 
Acid 
Sub. 
Codon Gene Gene 
Locus 
Product & Function TS  hpi of 
TS a 
HS 22       HS 12-18 
 73,000 C  T S  F 129  CTL0060 hypothetical protein   
 117,829 G  A Intergen    between CTL0095 & CTL0096   
 298,065 G  A Intergen    between tRNAleu & xerD   
 396,999 C  T  603 lepA CTL0320 GTP-binding protein LepA   
 451,917 G  A T  I 275 pepF CTL0367 oligoendopeptidase F   
 472,424 G  A  112  CTL0387 hypothetical protein   
 778,217 G  A Intergen    between sucB & gltT   
 913,763 G  A  168 rplD CTL0789 50S ribosomal protein L4   
 1,020,129 C  T D  N 29  CTL0883 hypothetical protein   
HS 23       HS 8-12 
 245,221 G  A  201 sucC CTL0193 site-specific tyrosine recombinase   
 313,171 G  A M  I 543 pmpG CTL0250 polymorphic outer membrane protein   
 933,691 C  T P  S 852 dnaE CTL0807 DNA polymerase III subunit alpha   
 969,663 G  A G  E 428 copB CTL0841 type III secretion system translocator CopB   
HS 24       HS 8-12 
 255,178 T  C  342 nrdA CTL0199 ribonucleotide-diphosphate reductase subunit alpha   
 442,329 C  T D  N 79 fabI CTL0359 enoyl-(acyl carrier protein) reductase   
 539,803 C  T H  Y 102  CTL0448 hypothetical protein   
HS 25       HS 8-12 
 457,262 G  A Intergen    between CTL0369 & IncD   
 865,032 C  T S  L 38 yagE CTL0733 conserved hypothetical   
 882,286 C  T D  N 115  CTL0748 N6-adenosine methyltransferase   
 931,402 C  T L  F 89 dnaE CTL0807 DNA polymerase III subunit alpha   
 1,038,007 G  A P  L 180  CTL0897 hypothetical protein   
HS 26       HS 12-18 
 63,837 C  T S  F 35  CTL0052 hypothetical protein   
 189,152 C  T R  C 124  CTL0144 1-acyl-sn-glycerol-3-phosphate acyltransferase   
 215,125 G  A  169 pgsA CTL0166 CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase   
 431,207 C  T D  N 208 truB CTL0349 tRNA pseudouridine synthase B   
 490,357 G  A  748  CTL0402 putative integral membrane protein   
 626,971 C  T A  T 182  CTL0529 hypothetical protein   
 710,152 C  T G  R 69  CTL0597 O-sialoglycoprotein endopeptidase   
 876,051 C  T  30 oppA4 CTL0741 oligopeptide transport system binding protein   
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Genome 
Coord. 
Nuc. 
Sub. 
Amino 
Acid 
Sub. 
Codon Gene Gene 
Locus 
Product & Function TS  hpi of 
TS a 
HS 27       HS 0-8 
 652,817 C  T E  K 896 pknD CTL0553 serine/threonine-protein kinase   
 735,802 G  A A  V 227  CTL0619 putative integral membrane protein   
 738,520 C  T P  L 20 aroC CTL0622 chorismate synthase   
 807,286 C  T G  E 92 obgE CTL0675 GTPase ObgE   
HS 28       HS 8-12 
 136,669 A  G Intergen    23S rRNA   
 538,957 G  A  106  CTL0447 putative integral membrane protein   
 804,601 G  A S  N 125  CTL0672 metal ABC transporter substrate-binding protein   
 900,088 C  T D  N 103  CTL0765 hypothetical protein; acetyl coenzyme A carboxylase carboxyltransferase   
 919,922 C  T  452 lnt CTL0796 apolipoprotein N-acyltransferase   
HS 29       HS 8-12 
 27,098 G  T M  I 225  CTL0019 putative exported lipoprotein   
 136,669 A  G Intergen    23S rRNA   
 538,957 G  A  106  CTL0447 putative integral membrane protein   
 804,601 G  A S  N 125  CTL0672 metal ABC transporter substrate-binding protein   
 900,088 C  T D  N 103  CTL0765 hypothetical protein; acetyl coenzyme A carboxylase carboxyltransferase   
 919,922 C  T  452 lnt CTL0796 apolipoprotein N-acyltransferase   
CS 1       CS 8-12 
 46,820 G  A R  K 55  CTL0040 hypothetical protein   
 548,046 G  A W  * 321 sodTi CTL0456 sodium:sulfate symporter   
CS 2       CS 8-12 
 182,608 C  T Q  * 443  CTL0137 hypothetical protein   
 619,657 C  T  90 murE CTL0521 UDP-N-acetylmuramoylalanyl-D-glutamate-2, 6-diaminopimelate ligase   
 675,514 C  T  472 rpoB CTL0567 DNA-directed RNA polymerase subunit beta   
 715,353 G  A G  E 148 xerC CTL0601 site-specific tyrosine recombinase (interacts with FtsK)   
 858,744 C  T D  N 14  CTL0724 HAD superfam hydrolase; phosphoglycolate phosphatase   
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Genome 
Coord. 
Nuc. 
Sub. 
Amino 
Acid 
Sub. 
Codon Gene Gene 
Locus 
Product & Function TS  hpi of 
TS a 
CS 3b       HS 8-12 
 394,511 G  A  88 tyrS CTL0318 tyrosyl tRNA synthetase CS >24 
 460,134 G  A Intergen    between IncA & CTL0375   
 527,030 C  T T  M 150 devB CTL0438 6-phosphogluconolactonase   
 548,409 G  A W  * 442 sodTi CTL0456 sodium:sulfate symporter   
 755,200 C  T Intergen    between CTL0638 & CTL0639   
 929,330 G  A Intergen    between hisS & uhpC   
 1,008,128 C  T  187 rpoN CTL0873 sigma 54   
Abbreviations used: nuc..: nucleic acid; sub.: substitution; hpi: hours post infection; Intergen: intergenic mutation 
a time at which the normalized cross-sectional area falls to <80% of L2-GFP in the same condition 
b dual heat/cold sensitive mutants 
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The fitness of some TS mutants is compromised 
  The ability of the mutants in which the TS allele was mapped (discussed in the 
section below) to produce viable progeny was assayed (Figure 8).  Approximately half of 
the mutants generated progeny at 37°C comparable to that of the L2-GFP parent (within 
~2-fold) (Figures 8A and B).  Notably, all of the dual HS/CS isolates produced 
approximately 50-fold fewer infectious progeny compared to L2-GFP (Figures 8A and 
8B).  Two other isolates, HS 10 and HS 27 produced far fewer progeny at 37°C 
compared to L2-GFP (Figure 8B).   
TS mutants produced fewer EBs at 32°C or 40°C compared to 37°C than did L2-
GFP (Figures 8C-E).  The difference in the ratios formed by L2-GFP versus mutants 
ranged from ~10-1000-fold.  Since the burst size of C. trachomatis is 500 inclusion 
forming units (IFU)/inclusion (27,60), we consider mutants with a defect of 1000-fold to 
be lethal.  The phenotypes seen in the progeny assays were also generally reflected by 
cross-sectional inclusion area (Figures 5-7), suggesting that inclusion size and progeny 
production are linked (221,222).   
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Figure 8  Progeny production of select TS mutants.  HeLa cells were infected at an MOI of 0.2 and 
incubated at either 37°C or 40°C for 34 hpi or at 32°C for 58 hours.  Infections were stopped by freezing in 
SPG.  EBs were titered on fresh HeLa cell monolayers to count progeny.  Normalization to input EBs 
allowed determination of the burst sizes of (A) prepped and (B) clarified stocks of different mutants.  The 
differences in the number of progeny produced at 37°C/40°C or 37°C/32°C by these strains were 
normalized to L2-GFP (C-E).  Black bars, ratio for 37°C/40°C.  Gray bars, ratio for 37°C/32°C.  a, early 
mutants; b, mid-development mutants; c, late mutants.  *, p<0.05, ANOVA with Dunnett’s post hoc test. 
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Negative selection lateral gene transfer (LGT) maps 14 TS mutants 
We attempted to identify the temperature sensitive alleles in the TS mutants.  An 
antibiotic-driven LGT mapping approach was initially attempted but was abandoned 
because the antibiotic resistance alleles altered phenotypes of some parents and 
recombinants (data not shown).  We next reasoned that since the TS alleles decreased the 
fitness of the mutants, we could select against these alleles to enrich for recombinant 
progeny.   
To become non-temperature sensitive, a TS allele would have to be replaced by 
recombination, revert, or be suppressed.  In the case of recombination, the recombined 
region could be as small as a single base or could be a substantial portion of the entire 
genome.  This could be differentiated by linkage analysis of other genetic markers that 
transferred from the donor parent, although this could be complicated by multiple 
recombination events.  HS 1, HS 13, and HS 23 were chosen as parents for the first 
crosses.  These strains were chosen because they had strong phenotypes in progeny 
assays (Figure 8A) and could not be rescued after 18 h at 40°C (Figure 5).  Whole 
genome sequencing identified the mutations in these strains (Table 7).  HS 1 had 10 
mutations, HS 13 had 6, and HS 23 had 4.   
We reasoned that HS 1 would be the most useful for determining how much DNA 
was exchanged since it had the most mutations, which could be used as silent markers 
throughout different regions of the genome.  Alternatively, if large fragments of DNA 
were transferred and recombined, HS 23 would have the best chance of donating wild 
type sequence since it had the fewest mutations.  Passaging of the progeny from the 
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above TS mutant crosses twice at 40°C was sufficient to eliminate most of the parents 
and temperature sensitive recombinants (~10-1000X enrichment/well) (Figure 9). 
 
Figure 9  Selection at 40°C enriches for temperature resistant progeny.  HeLa cells were infected at a 
total MOI of 4 with either one or two temperature sensitive strains and were grown until 34 hpi at 37°C.  
EBs were released by freeze-thaw and bead agitation.  Temperature resistant progeny were enriched for by 
two rounds of growth (34 hours each) at 40°C.  The number of infectious progeny in each well was 
determined at 37°C.  Single strain infections were performed in 2 independent wells and double strain 
infections were performed in 4 independent wells.  Each bar represents a well.   
 
Recombinants were isolated from wells that contained high numbers of progeny 
by limiting dilution followed by plaque cloning.  Alleles that differed in the parents were 
Sanger sequenced in the recombinants (i.e., all mutations in both parents).  Negative 
selection LGT generated some recombinants that lacked the TS allele but which were 
otherwise isogenic to one parent used in the cross (Figures 10B and 33).  Genome 
sequencing confirmed that one recombinant from an HS 1 x HS 13 crosses was isogenic 
to HS 1.  The HS 1 recombinant identified gltXC1459T (encoding GltXQ487*) as the TS 
allele, and this recombinant rescued both inclusion size (Figure 10C) and the number of 
progeny (Figure 10D) compared to either mutant parent. 
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Figure 10  Generation of an isogenic recombinant by negative selection LGT.  (A) Co-infections with 
two different parents can yield recombinants that are isogenic to one parent or that are mosaics, which 
contain combinations of different alleles from the parents.  Sequencing demonstrated that one recombinant 
from the HS 1 x HS 13 was isogenic to HS 1 (B).  Inclusion area (C) and progeny production (D) of this 
recombinant were similar to L2-GFP. 
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 Analysis of the genomes of the 6 recombinants isolated from these crosses (2 
each: HS 1 x HS 13, HS 1 x HS 23, and HS 13 x HS 23) suggested that crosses with HS 1 
tended to produce recombinant progeny that contained mostly HS 1 genome (Figures 33, 
37, and data not shown).  Therefore, progeny from the HS 13 x HS 23 cross helped 
identify the TS allele in these other mutants.  Both CTL0681ts (P159L) in HS 13 and 
dnaEts (P852S) in HS 23 could be identified by Sanger sequencing (Figure 37).  Whole 
genome sequencing confirmed the ctl0681 recombinant was isogenic to HS 13. 
 We attempted to map the remaining HS mutants using negative selection LGT.  
HS 23 served as one of the parents for these crosses because it was reliably eliminated by 
two passages at 40°C and only contained 4 mutations, which reduced the amount of 
sequencing reactions required for recombinant mapping. 
 We attempted to map the TS alleles in all the mutants using the negative selection 
LGT approach and succeeded in generating temperature resistant phenotypic revertants of 
HS 2, HS 10, HS 11, HS 19, HS 20, HS 24, and HS 26 (Table 8).  Sanger sequencing 
determined that many of the phenotypic revertants were mosaics, which confirmed that 
recombination—not reversion—was occurring in these populations.  Using phenotypic 
linkage analysis (88), TS alleles were mapped in some of these strains using as few as 2 
different mosaic recombinants (Appendix II). 
 Unsuccessful HS 23 crosses were re-attempted using HS 27.  HS 27 has 4 
mutations (Table 7) and cannot be rescued by temperature shift after 12 hpi (Figure 5).  A 
recombinant from a HS 2 x HS 27 cross narrowed down the possible TS alleles in HS 2 
to mutations in CTL0609 or phnP (Table 8 and Figure 34).  These crosses also 
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determined that obgEG275A was the temperature sensitive allele in HS 27 (Table 8 and 
Figure 42) (223). 
 Our TS screen identified two CS mutants and four dual HS/CS mutants with 
sensitivities below the 15-fold threshold (Table 4).  Both of the CS strains were 
successfully mapped using the negative selection approach.  Some dual HS/CS mutants 
could not be mapped with CS 1, so recombination with CS 2 was performed.  This 
allowed mapping of HS 20 (Figure 39) and CS 3 (Figure 44). 
 A summary of the mapped strains is in Table 8.  Genotypes of recombinants are in 
Appendix II.  Putative roles of the mapped TS alleles are in diverse aspects of chlamydial 
biology from carbon metabolism, energy usage, lipid synthesis, protein synthesis, cell 
division, and stress responses.  One TS allele was also mapped to a conserved chlamydial 
hypothetical protein (ctl0322). 
 
Table 8  Summary of mapped mutants in this study 
Mutant Gene Amino Acid 
Substitution 
Function 
HS 1 gltX Q487* Glutamyl-tRNA synthestase 
HS 2 ctl0609 
phnP 
R198W 
P127L 
Unknown 
Phosphonate metabolism 
HS 10 rplF 
fmt 
G109E 
D276N 
Ribosomal protein 
Methionyl-tRNA formyltransferase 
HS 11 ctl0322 M51I Unknown 
HS 13 ctl0681 P159L rRNA processing 
HS 17 rpsH A119V Ribosomal protein 
HS 19 atpB G339D ATPase 
HS 20 ctl0456 G145R Dicarboxylate transport 
HS 23 dnaE P852S DNA replication 
HS 24 fabI D79N Fatty acid biosynthesis 
HS 26 ctl0597 G69R t6A37 tRNA modification 
HS 27 obgE G92E Ribosome regulation 
CS 1 ctl0456 W321* Dicarboxylate transport 
CS 2 ctl0137 Q443* Unknown 
CS 3 ctl0456 W442* Dicarboxylate transport 
*= stop codon 
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Caveats of recombination 
 A caveat of our mapping approach was that TS alleles were inferred from 
multiple recombinants in cases where we failed to generate isogenic recombinants.  It 
was also not possible to distinguish if the isogenic strains we generated in LGT 
experiments arose from recombination, reversion, or acquisition of suppressor mutations 
from just the Sanger sequencing of marker mutations.  For example, genome sequencing 
of a recombinant that Sanger sequencing indicated was nearly isogenic to CS 1 revealed 
an additional mutation (C656A) in uhpC that targeted re-sequencing confirmed was 
absent in the recombinant’s parents.  Whether this is a suppressor or a random mutation is 
unclear.  A likely suppressor mutant arose from a cross of HS 18 with HS 23.  This 
isolate acquired a deletion that resulted in a frameshift of the mutant ctl0211 allele in HS 
18.  This may have been a viable option to correct the temperature sensitivity because 
ctl0211 is a paralog of ctl0210.  
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CHAPTER IV: Characterization of a Temperature Sensitive DnaE Mutant 
DNA replication is inhibited in a DnaEP851S mutant 
 Negative selection LGT determined the TS allele in in HS 23 was dnaEC2554T.  
HS23 had a reduction in inclusion number (Table 4), inclusion area (Figure 5), and burst 
size (Figure 8C) at 40°C compared to L2-GFP.  Genome replication begins after the EB 
has differentiated into an RB, and dnaE transcripts have been observed as early as 2 hpi 
(27).  We tested if dnaEC2554T (hereafter referred to as dnaEts) could replicate its genome 
at 40°C using qPCR.  Genome replication of L2-GFP, dnaEts, and its isogenic 
recombinant (hereafter referred to as dnaEWT) were similar at 37°C and started to increase 
between 8 and 12 hpi (Figure 11).  However, dnaEts genomes did not increase at 40°C, 
whereas L2-GFP and dnaEWT genome copies increased similar to what was seen at 37°C 
(Figure 11). 
 
 
Figure 11  Genome replication in dnaEts is impaired at 40°C.  L2-GFP, dnaEts, and dnaEWT genome 
copy number at 37°C (black lines) or 40°C (red lines) was measured by qPCR throughout development.  
The mean of 2 independent experiments in duplicate is shown. 
 
 We tested if genome replication of dnaEts was restored when the mutant was 
shifted from 40°C to 37°C.  The number dnaEts genomes at a total of 34 hpi appeared to 
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correlate with the proportion of time spent at 37°C versus 40°C (Figure 12).  Thus, the 
DNA replication defect of dnaEts was reversible. 
 
 
Figure 12  Impaired genome replication of dnaEts at 40°C can be rescued by shifting to 37°C.  HeLa 
cells infected with L2-GFP, dnaEts, and dnaEWT were incubated for 34 hpi at 37°C or 40°C only or the 
infections were initially incubated at 40°C and then moved to 37°C at the times indicated.  Genomic DNA 
was extracted and genomes were counted by qPCR.  The mean of two independent experiments in 
duplicate is shown. 
 
Disruption of DNA replication alters inclusion size 
 To see if inclusion size is impacted by a lack of DNA replication, infections were 
shifted between 37°C and 40°C.  Chlamydia were labeled with an anti-LPS antibody in 
these experiments to circumvent the complication of uneven GFP expression in cells.  
Shifting dnaEts from 37°C to 40°C prior to 18 hpi caused a sharp decrease in inclusion 
size and number at 34 hpi (Figure 13).  Similarly, shifting from 40°C to 37°C caused a 
decrease in inclusion size and number if the shift occurred after 12 hpi (Figure 13). 
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Figure 13  Inclusion size is dependent on functional DnaE.  HeLa cells were infected with L2-GFP 
(black bars), dnaEts (red bars), and dnaEWT (pink bars).  The cells were either incubated at 37°C, 40°C, or 
were moved between these temperatures at the times indicated.  Inclusions were measured at a total of 34 
hpi in all cases.  Bars represent the mean of four frames/well of two independent experiments performed in 
triplicate.  Two-way ANOVA and Tukey’s post hoc test were used to determine statistical significance.  †, 
p<0.01; ‡, p<0.001;  §, p<0.0001 
 
 Results of a recent study suggested that growth of inclusions was independent of 
genome replication but not protein synthesis (125).  We tested this hypothesis by 
comparing the sizes of inclusions formed by L2-GFP, dnaEts, or dnaEWT at 37°C and 
40°C in cells treated with rifampicin or chloramphenicol to inhibit chlamydial 
transcription or translation, respectively.  dnaEts inclusions were smaller than L2-GFP or 
dnaEWT inclusions at 40°C as expected (Figure 14A).  The small size of dnaEts inclusions 
at 40°C indicated that most bacterial metabolism had likely ceased, but further inhibition 
by either chloramphenicol or rifampicin did have a slight impact on inclusion size, 
although this was not significant. 
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Figure 14 Lack of DNA replication in dnaEts is associated with smaller inclusions.  HeLa cells on 
coverslips were infected with L2-GFP, dnaEts, or dnaEWT at MOI of ~ 0.2 and were incubated at 37°C or 
40°C (A). Inclusions were fixed at 34 hpi, stained for LPS, and imaged at 40X.  In some cases, 
chloramphenicol or rifampicin were added at the time of infection and again when the inoculum was 
replaced with media (B).  Inclusion sizes are normalized to L2-GFP at 37°C.  Ten inclusions per condition 
were measured and error bars indicate the 95% confidence interval. 
 
Inclusion ultrastructure 
 dnaEts does not replicate its genome at 40°C or produce infectious EBs, so we 
tested if dnaEts EBs could differentiate into RBs at 40°C.  No typical EBs were observed 
in dnaEts inclusions at 32 hpi, indicating that EBs differentiated into RBs, but most of the 
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apparent RB that were observed had atypical morphologies that suggested that the 
bacteria were stressed (Figures 15B-H).  Many dnaEts inclusions also contained circular 
membranes that appeared to be extensions of the periplasm (Figures 15D-E).  Areas 
containing numerous vesicles, separated from what may be non-membrane bound 
inclusion lumen-derived glycogen, were be observed in other dnaEts infected cells 
(Figure 15F).  In some cases, fragmentation of dnaEts inclusions was associated with 
cytosolic protrusions into the inclusion lumen (Figures 15G and 15H).   
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Figure 15 Inclusion Ultrastructure of dnaEts.  HeLa cells were infected with dnaEts at either 37°C (A) or 
40°C (B-H) for 32 hpi and fixed.  Growth at 37°C produced normal inclusions; however, growth at 40°C 
produced comparably smaller inclusions that contained aberrant RB forms (B-D), enlarged periplasms (D 
and E), destroyed inclusion membranes (F), and potential inclusion fragmentation (F-H). 
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A screen identifies dnaEts suppressors 
 DNA replication is essential, so we hypothesized that incubation of dnaEts at 
40°C would select for revertants that restored DnaE function.  Attempts to isolate 
revertants from ~6x107 EBs failed (data not shown), so we tried a larger inoculum.  We 
infected fifteen T-175 flasks at an MOI of 30 (~1x1010 EBs total) and incubated them at 
40°C for 34 hours.  EBs harvested from these flasks were used to infect new plates of 
fresh cells.  The entire process was repeated 5 times.  GFP+ inclusions became visible in 
some of the lineages as early as the second round of passage and were evident in 12/15 
lineages by the fifth passage (Table 9).  Sanger sequencing revealed that the C2554T 
mutation was retained in all 12 of these populations. 
 
Table 9 Summary of dnaEts Suppressor Screen 
Flask Passage when Positive Suppressors Present 
1 None  
2 3 E1061K 
3 2 D828Y and E1061K 
4 2 D828Y and E1061K 
5 2 E1061K 
6 None  
7 4 D828Y and E1061K 
8 3 E1061K 
9 4 E1061K 
10 3 E1061K 
11 4 E1061K 
12 4 E1061K 
13 None  
14 4 E1061K 
15 2 E1061K 
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Suppressors are intragenic 
 Isolates were plaque-cloned from each of the 12 populations.  Sequencing of 
dnaE revealed that the isolates all contained one of two different mutations that caused 
either E1061K or D828Y amino acid substitutions in DnaE and confirmed that the 
mutants all retained dnaEC2254T, which indicated that they were suppressor mutants 
(Table 9). 
 COBALT was used to perform a primary sequence alignment of C. trachomatis 
serovar L2 DnaE (CtDnaE), E. coli DnaE (EcDnaE), and T. aquaticus DnaE (TaDnaE) to 
gain insight into how the suppressor mutations might restore the function of mutant DnaE 
(Figure 16).  P852 is the second proline in an LPPD motif that is conserved in all three 
DnaE sequences.  E1061 and D828 are located in less conserved regions of DnaE.  D828 
aligns with an aspartate in EcDnaE and a glutamate in TaDnaE, suggesting that a 
negatively charged residue is important at this location.  The substitution in the 
suppressor mutant introduces a polar aromatic residue in place of this negatively charged 
residue.  E1061 is preceded by an aspartate that is conserved in all three homologs.  Like 
CtDnaE, TaDnaE codes for a glutamate, however EcDnaE codes for an arginine at the 
analogous position, indicating that a charged residue is important in this position. 
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We next interrogated the possible effects of the amino acid changes in the 
suppressor mutants on the tertiary structure of DnaE by generating a model using Phyre2. 
CtDnaE was modeled with >90% confidence due to the high similarity of the EcDnaE 
and TaDnaE crystal structures (PDB accession codes 2HQA and 3E0D, respectively) 
(Figure 17).  P852 is in the β-clamp binding subdomain (224); however, the β-clamp 
binds distal to this site (225,226).  The mutation is predicted to be located in a three-
stranded β-sheet that is a conserved structural feature in both EcDnaE and TaDnaE.   
 
 
Figure 16  Alignment of DnaE from C. trachomatis, E. coli, and T. aquaticus.  C. trachomatis (Ctr), E. 
coli (Eco), and T. aquaticus (Taq) DnaE were aligned using COBALT software.  The C-terminal portion of 
DnaE is shown.  Identical residues are in red.  CtDnaEP852 is shown in the blue box.  Two independent 
suppressors are also shown and are in either the magenta (CtDnaED828) or yellow (CtDnaEE1061) boxes. 
 76 
 
Our model predicts that P852S does not a directly interact with amino acids that 
are altered in the DnaE suppressor mutants.  D828 falls in another well conserved 
structural feature—the helix-hairpin-helix (HhH) motif—at the edge of the helix-hairpin 
transition.  E1061 is proximal to the oligonucleotide-binding (OB)-fold domain.  Both of 
these motifs could interact with the DNA template during DNA polymerization (111).  
Interaction of DnaE with the DNA template is in part mediated by residues in the HhH 
motif.  The positively charged residues in the HhH sequence interact with the sugar-
phosphate backbone of the DNA template and have evolved to balance polymerization 
speed and accuracy (227).  The OB-fold may interact with the single stranded template, 
and this subdomain moves 30° upon binding DNA template (111). 
 
Figure 17  Modeling predicts that dnaEts  DnaE-DNA interaction is altered.  Relevant amino acids are 
shown in spacefill on the ribbon diagram of a CtDnaE model.  P852, blue; D828, magenta; E1061, yellow.  
(A) Forward view of DnaE.  The PHP domain is mostly blue, the β-clamp binding domain is mostly 
orange, the OB-fold domain is mostly red, and the catalytic core is yellow and green.  (B) View looking 
down through the channel where the DNA template passes through.  The structure of C. trachomatis L2 
434/Bu was modeled using Phyre2 software and manipulated in PyMol. 
 77 
Suppressor phenotypes 
 We compared phenotypes of the suppressor mutants, dnaEts, and various controls 
(Figure 18).  L2-GFP, dnaEts, dnaEWT, and the two suppressor mutants (DnaED828Y P852S 
and DnaEP852S E1061K) formed similar sized inclusions at 37°C.  However, dnaEts 
inclusions were much smaller than those of L2-GFP at 40°C.  At 40°C, DnaEP852S E1061K 
inclusions were similar in size to those of L2-GFP and dnaEWT, whereas DnaED828Y P852S 
inclusions were smaller, but still larger than dnaEts inclusions (Figure 18A).  Both of the 
suppressor mutants produced far fewer progeny than did L2-GFP at 40°C (Figure 18B).  
Chlamydial genomes were counted in the same samples using qPCR.  Interestingly, the 
37°C/40°C genome copy ratios of both the suppressor mutants were indistinguishable 
from L2-GFP or dnaEWT, but differed from dnaEts by ~100-fold (Figure 18C), indicating 
that DNA replication was restored in the suppressors. 
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Figure 18  dnaEts suppressors partially rescue growth.  The sizes of inclusions strains formed at 37°C 
(black bars) or 40°C (red bars) was measured (A).  The ratio of progeny formed at 37°C/40°C was 
normalized to L2-GFP at the same temperatures (B), and genome copy numbers were measured by qPCR 
(C).  Results are means of 3 independent experiments ± SD.  Statistical significance was assessed by one- 
(B and C) or two-way (A) ANOVA followed by Tukey’s post hoc test.  *, p<0.05; **, p<0.01; ****, 
p<0.0001 
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CHAPTER V: Characterization of a Temperature Sensitive GltX Mutant 
Sequence analysis predicts a truncation in the glutamyl-tRNA synthetase GltX 
 We isolated a C. trachomatis L2-GFP mutant by EMS mutagenesis (HS 1 in 
Chapter III) whose temperature sensitive allele was gltXC1459T (hereafter referred to as 
gltXts).  This mutation generates a stop codon in codon 487 that truncates GltX 20 amino 
acids from the C-terminus (Table 6).  To better understand why fitness of gltXts was 
normal at 37°C (Figures 8 and 9), we generated a CtGltX model using Phyre2 software.  
X-ray crystal structures of GltX from Mycobacterium tuberculosis (MtGltX) and 
Thermotoga maritima (TmGltX) are available (PDB accession numbers 2O5R and 
3AKZ, respectively).  The high similarity of these proteins permitted construction of 
>90% confidence model of CtGltX (Figure 19). 
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Figure 19 A model of CtGltX predicts that the structure of GltXts is not altered.  A model of C. 
trachomatis serovar L2 GltX was generated using Phyre2.  (A) The 20 residue truncation (shown in pink) 
in CtGltX deletes two alpha-helices that do not interact with the rest of the structure.  (B) Modeling of 
CtGltX with a bound tRNA suggests that the truncation does not disrupt the catalytic or the anticodon 
recognition sites.  CtGltX (magenta) aligned with MtGltX (cyan; PDB: 2O5R) (C) and TmGltX (yellow; 
PDB: 3AKZ) (D). 
 
 The CtGltX model suggested that the last 20 amino acids form two small alpha-
helices that are not present in either MtGltX or TmGltX.  A general search for GltX 
homologs using the basic search alignment tool for proteins (BLASTp) algorithm showed 
that the longer GltX sequence is rare, but not unique to Chlamydia spp.  For example, 
Bacteroides fragilis GltX is approximately the same length as CtGltX, although tertiary 
structural information of this protein is not available. 
 The core GltX enzyme is highly conserved in Chlamydia spp., and GltX 
sequences are nearly identical in C. trachomatis serovars.  However, alignment of 
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chlamydial GltX proteins determined that the C-terminal amino acids of these proteins 
are more variable than any other part of the protein (Figure 20). 
 
 
Figure 20 Conservation of the GltX C-terminus in Chlamydia spp.  GltX from C. trachomatis serovars 
L2 and D, C. muridarum (MoPn), C. pneumoniae (CPn), and C. caviae (GPIC) were aligned using 
ClustalO.  Residues predicted to be absent in GltXts are shown in bold. 
 
Growth characteristics of an aminoacyl-tRNA synthetase mutant 
 We characterized gltxts using progeny forming assays and qPCR. The mutant 
produced significantly fewer EB than did L2-GFP or gltXWT by 24 hpi, and this trend 
continued to 34 hpi (Figure 21A).  While gltxts formed a few EBs at the 18 hpi and 24 hpi 
timepoints, fewer EBs were formed than were used for the initial infection, indicating 
that these were either carry over EBs from the infection or the result of non-productive 
infections.  
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Figure 21 gltXts progeny production is impaired at 40°C.  HeLa cells were infected with L2-GFP, gltXts, 
or gltXWT and grown at 37°C, 40°C, or were shifted from 40°C to 37°C.  Infections were stopped at the 
indicated times by freezing the infected cells in SPG.  Part of each sample was used to count infectious EBs 
(A).  The other part was used to count genome copies using qPCR (B).  Values are normalized to the 
number of inclusion forming units of the inoculum.  Progeny assays were performed four times in 
triplicate; genome copy number experiments were performed two times in duplicate.  Error bars in (A) 
represent standard deviation. Values were log transformed and analyzed by two-way ANOVA followed by 
Tukey’s post hoc test to correct for multiple comparisons.  gltXts produced fewer progeny at 24 and 34 hpi 
compared to L2-GFP or gltxWT at 40°C, but not at 37°C.  *, p<0.0001 
 
 A lack of charged tRNAs can induce the general amino acid stress response in 
eukaryotes and the stringent response in bacteria.  Tryptophan-limiting conditions cause 
some Chlamydia spp. to enter a viable but non-cultivatable state termed persistence that 
is characterized by aberrant RBs that fail to divide but continue to replicate their genomes 
(122).  We measured the numbers of genomes gltXts formed at 37°C and 40°C to test if 
this mutant continued to replicate its genome at the non-permissive temperature. 
Differences in the number of genomes produced by the gltX mutant were evident early in 
infection (i.e., 12 hpi), and genome copies increased only slightly by the end of the 
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infection (34 hpi), culminating in an ~3 log decrease in the at 40°C/ 37°C ratio compared 
to L2-GFP or ~2 log decrease when compared to gltXWT (Figure 21B).   
The lack of progeny production and genome replication suggested that the mutant 
was likely dead after extended incubation at 40°C.  We tested whether gltXts growth 
could be rescued by determining the number of infectious progeny and genome copies 
from infections that were shifted from 40°C to 37°C during the course of infection.  
Shifting the gltX mutant at 12 hpi to 37°C rescued genome production, while shifting at 
18 hpi only partially rescued the defect.  Since inclusions could be seen and genome 
replication could be detected if shifted to 37°C by mid-development, we hypothesize that 
gltXts is still alive early in development and that it enters a stress response from which it 
can be rescued by returning to the permissive temperature by mid-cycle. 
Temperature shifting identifies when the growth defect occurs 
 Extended incubation in stressful conditions (i.e., incubation at the non-permissive 
temperature) is lethal.  Therefore, we wondered if shifting between 37°C and 40°C during 
the course of infection could either rescue or inhibit inclusion growth.  Because we had 
shown that gltXts (HS 1) had a decrease in inclusion size between 12-18 hpi (Figure 7), 
we concentrated on these early/early-mid timepoints.  gltXts inclusion size could not be 
rescued after 18 hours of incubation at 40°C (Figure 22).  The reverse conditions—
incubation at 37°C followed by a shift to 40°C—indicated that growth at the permissive 
temperature for early and early-mid development could not overcome the small inclusion 
phenotype.  Inclusion size decreased more dramatically at 8 hpi compared to 12 hpi, 
indicating that a longer amount of time at 37°C increased inclusion growth.  L2-GFP and 
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gltXWT inclusion areas were minimally affected and nearly identical in all tested 
conditions. 
 
 
Figure 22 gltXts inclusions are smaller at 40°C.  HeLa cell monolayers were infected with L2-GFP (black 
bars), gltXts (purple bars), or its isogenic recombinant (lavender bars).  Infections were incubated either 
continually at 37°C or 40°C, or were transferred between these temperatures at the times indicated. All 
infections were fixed at 34 hpi, and inclusions were stained for chlamydial LPS.  Bars represent the mean 
of two independent experiments.  A two-way ANOVA and Tukey’s post hoc test were used to determine 
statistical significance.  *,p<0.05; †, p<0.01; ‡, p<0.001;  §, p<0.0001 
 
gltXts EBs differentiate into RBs at 40°C 
 Higher magnification (≥10X) and staining with anti-chlamydial LPS antibody 
showed the presence of numerous small gltXts inclusions compared to L2-GFP or gltXWT 
at 40°C that were not detected during our initial screen, which was performed at 4X 
magnification (Figure 22).  The presence of inclusions, reduction in recovered progeny 
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and number of genomes, and our knowledge of the IFN-γ persistence model prompted us 
to examine what chlamydial developmental forms were present in the gltXts inclusions at 
40°C.  Transmission electron microscopy of gltXts inclusions revealed that gltXts could 
still differentiate into RBs, indicating that GltX function is not required for the EB to RB 
transition.  Inclusions grown continuously at 40°C for 32 hours contained aberrant RBs 
as well as intermediate bodies (IBs) (Figure 23).  This was not observed with either L2-
GFP or gltXWT (data not shown).  Inclusions shifted from 40°C to 37°C at 12 hpi, and to a 
lesser extent at 18 hpi, contained normal RB by 32 hpi, confirming that the growth 
inhibition at the mutant at 40°C is reversible (data not shown). 
 
 
Figure 23 Ultrastructure of the gltXts inclusion.  Transmission electron microscopy was used to examine 
the inclusion content of HeLa cells infected with gltXts at 37°C (A) or 40°C (B) for 32 hpi.  While normal 
EBs and RBs were present at 37°C, the presence of intermediate bodies (green arrowhead) and aberrant 
bodies (red arrowhead) could be seen at 40°C.  
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CHAPTER VI: Conclusions 
Summary 
 Our study generated important new tools for future Chlamydia research.  First, we 
generated a large C. trachomatis library for future genetic screens.  Second, we 
developed the first unmarked LGT mapping approach in Chlamydia spp.  Unlike earlier 
LGT mapping approaches, negative selection LGT does not require the introduction of 
genetic markers and can be used, theoretically, in any Chlamydia strain or species 
capable of LGT.  Finally, we developed a suite of conditional mutants that permit 
interrogation of the order of critical developmental processes in Chlamydia spp.    
 
Section I: Chlamydial Genetics 
Development of conditional mutants 
 Results of the temperature sensitive screen in Chapter III indicate that a larger 
screen might identify additional TS mutants.  183 unique mutations were identified in the 
33 sequenced isolates.  Nonsynonymous mutations were detected in the same gene in 
different mutants in 22 cases (2-4 occurrences).  Identical alleles were identified in three 
of the HS mutants identified in that screen; one strain was a duplicate and another was a 
sibling.  Because we did not identify the same alleles in strains with other background 
mutations, the screen was not saturated. 
The TS mutants differed from the parent by 6 mutations on average (range 1-11) 
(Table 7).  Mutants isolated from the same library in other screens had similar numbers of 
mutations, indicating that the number of mutations in the TS mutants generally reflects 
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the mutation load of the library (228).  The number of mutations per genome has 
generally not proven to be too challenging for mapping mutations and allows for good 
coverage of the genome while condensing the number of isolates that need to be 
screened.   
 The TS mutants we isolated have defects in diverse processes including carbon 
acquisition, energy utilization, protein synthesis, cell replication, and lipid synthesis 
(Table 8) and are summarized in Figure 24.  gltX, dnaE, and atpB are essential in other 
organisms.  fabI is essential in C. trachomatis, since chemical inhibition of FabI reduced 
inclusion size and prevented progeny production (229).  ctl0322 may encode a histone-
like protein (230) and this gene is regulated by a non-coding RNA—lhtA—that regulates 
a known chlamydia histone, HctA (64).  We predict that CTL0322 plays a similar role to 
HctA in the RB-EB transition.  TS alleles in 13 TS mutants were identified in total, and 
the TS allele of two additional TS mutants was narrowed down to two possible mutations 
(Table 8).  These strains are further discussed in Chapter VII. 
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Figure 24 TS mutant provide insights into essential chlamydial processes.   Genes of which we 
identified TS alleles in this study may mediate multiple aspects of chlamydial growth and development and 
are expressed at different developmental stages (Figures 5-7).  Multiple TS alleles of genes involved in 
protein synthesis at either the ribosomal level (ObgE, RpsH, and YbeY) or tRNA level (GltX and 
CTL0597) were identified.  Other mapped TS alleles relate to genome replication (DnaE) and chromosome 
management (CTL0137 and CTL0322).  Mutants in energy acquisition (AtpB), fatty acid metabolism 
(FabI), and carbohydrate acquisition (CTL0456) were also identified. 
 
 Temperature shift assays showed that while the majority of genes need to function 
in mid-development, there are genes that are needed earlier and later in infection (Figures 
5-7).  Because few chlamydial protein antibodies are available to detect when specific 
proteins are expressed and because of developmental asynchrony, these temperature shift 
assays inform us as to when these genes function in the developmental cycle, which has 
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not been previously possible.  The temperature shift timepoints used in this study were 
broad, but finer time intervals can be considered in further characterization studies of 
individual mutants to examine time of function more carefully.  When comparing 
multiple TS mutants simultaneously, the order in which processes such as DNA 
replication and protein synthesis, for example, are needed can be determined. 
 The number of progeny produced by TS strains also helps to define how critical a 
gene is to the developmental cycle.  A reduction of 10-fold in progeny production 
compared to the L2-GFP parent does not suggest essentiality.  The TS allele in these 
mutants may result in a partially inactive protein at 40°C or the presence of an alternative, 
redundant pathway to circumvent the mutation.  Progeny reductions of ~1000-fold or 
more suggest lethality and essentiality of a gene product to complete the developmental 
cycle, since a reduction of this size would require fewer infectious progeny to be 
produced than were originally used in the infection.  While some of these mutants 
produced a number of progeny comparable to that of L2-GFP at 37°C (e.g., gltXC1459T), 
others produced far fewer progeny (e.g., obgEG275A) (Figure 8).  Mutants with severely 
decreased fitness at 37°C speak to the general essentiality of these genes to normal cell 
growth.  These mutants are still valuable tools for investigating gene function. 
A caveat to our TS screening strategy and interpretation of the phenotypes of the 
mutants is that host and bacterial physiology differ at 32°C, 37°C, and 40°C.  For 
example, our results suggest that more glycogen accumulates in the inclusions when C. 
trachomatis is grown at 40°C (Figure 23).  It is also intriguing that three different TS 
alleles were identified in the dicarboxylate transporter ctl0456.  While these all displayed 
growth defects at 37°C (Figure 8), decreased survival of the mutants that contained 
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nonsense alleles (W321* and W442* in CS 1 and CS 3, respectively) at 32°C (Figures 6, 
7, 8C, and 8E) suggests that the host cell cytosol may contain less free glutamate and 
more 2-oxogluterate at lower temperatures compared to 37°C.  Thus, although redundant 
carbon acquisition transporters (e.g., GltT) may be sufficient to allow these ctl0456 
mutants to grow at 37°C, they are not sufficient at 32°C.  
Extending the chlamydial genetic toolbox 
We used negative selection LGT to map multiple TS alleles.  There are 
advantages and disadvantages to using negative selection over antibiotic selection to 
generate recombinants.  Negative selection uses inherent phenotypes (e.g., temperature 
sensitivity) of mutants to enrich for recombinants.  Enrichment can be sufficient after 
only a few rounds for mutants with robust phenotypes, but mutants with weaker 
phenotypes represent a challenge.  In contrast, selection is consistently robust in 
antibiotic driven lateral gene transfer, which requires the generation of drug resistant 
mutants.  Positive selection LGT is time intensive and may generate strains with altered 
phenotypes (231,232).  Positive selection LGT in C. trachomatis is also limited to 
antibiotics for which either spontaneous mutation causes resistance or that a resistance 
cassette can be moved onto the chromosome.  Rifampicin, ofloxacin, lincomycin, and 
spectinomycin have been used in positive selection LGT for C. trachomatis.  The 
spontaneous resistance in these genes restrains and biases recombination events to 
include the genomic regions near rpoB, gyrA, 23S rRNA, or 16S rRNA, respectively.  In 
addition, these genes are not evenly dispersed throughout the genome.  Finally, because 
the positive selection marker (i.e., antibiotic resistance) must be present, no isogenic 
strain can be generated without backcrossing (Figure 25). 
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Figure 25 Comparison of recombinants from LGT crosses.  Positive selection LGT relies on two 
different antibiotic markers to select for recombined progeny.  The antibiotic resistance marker results from 
spontaneous mutation of the wild type allele, so the location of the selection markers is fixed. The 
proportion of DNA acquired each parent varies and is determined by unknown factors (blue v. purple).  
Phenotypic analysis of recombinants allows deduction of the mutation.  Negative selection LGT relies on a 
loss-of-function mutation (e.g., temperature sensitivity) being replaced during recombination (red regions). 
 
While negative selection LGT is a valuable strategy for generating isogenic 
recombinants, the recombinants will contain other background mutations unique to the 
parent used.  This means that comparisons cannot be made to a common wild-type parent 
and that phenotypes of recombinants must be considered in the context of the parent’s 
genotype.  Negative selection LGT also prevents associating the presence of an allele 
with a given phenotype, since the mutant allele is replaced with a wild type copy during 
recombination.  In contrast, positive selection LGT generates new recombinant strains 
that express the mutant phenotype when the mutant allele is present on the chromosome, 
and these can be compared to a common parent strain. 
Negative selection LGT is not restricted to use in temperature sensitive crosses.  It 
has also been used to map mutants that could not survive IFN-γ induced persistence by 
enriching for recombinants using the same conditions used to identify the mutants (228).  
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Furthermore, the lack of a second mutant with the same phenotype does not preclude the 
use of negative selection.  An IFN-γ sensitive C. muridarum mutant was crossed with a 
temperature sensitive C. muridarum isolate (Amanda M. Giebel, et al., unpublished data).  
Selection at 40°C and IFN-γ resulted in recombinants.  One of these isolates contained all 
of the alleles of the IFN-γ sensitive parent except for one allele, and this recombinant was 
IFN-γ resistant. 
Negative selection LGT is applicable to at least two chlamydial species and can 
harness a variety of selection conditions.  We also used the technique to generate C. 
trachomatis serovar L2 x C. muridarum crosses (see Appendix I).  These chimeric strains 
could facilitate investigation of the molecular bases of chlamydial tropism.  For instance, 
using these strains, we could investigate why C. trachomatis serovars cannot ascend the 
murine genital tract.  Identifying a gene or locus from C. muridarum that led to a gain-of-
function for a primarily C. trachomatis derived genome could facilitate murine modeling 
studies for urogenital and/or LGV C. trachomatis studies.  These genes would also be 
potential vaccine targets, since they would relate to spread of disease and disease 
severity. 
Mapping of TS alleles of some HS mutants with HS 23 failed.  Many 
recombinants from these crosses were isogenic or nearly isogenic to HS 23 (dnaEts).  
There are a few possible explanations for these results.  The use of mis-matched 
phenotype strengths (i.e., the other parent has a weaker TS phenotype) may allow the 
parent to produce enough progeny at 40°C to overwhelm the smaller population of 
recombinants.  Additional rounds of enrichment might rectify this issue.  Another 
possibility is that several mutants that could not be mapped had mutations in known type 
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III secretion system genes or hypothetical genes whose products could be secreted.  Here, 
we speculate that cross-complementation of secreted effectors could have mitigated 
selection if the enrichment infections were performed at an MOI ≥2.   
Some mutants failed to produce diverse recombinant populations when crossed 
with HS 23, and this may provide insight into the mechanism of gDNA transfer.  It is 
unknown whether recombinants are the products of natural transformation or 
conjugation.  Crosses between two purified strains or two crudely harvested strains 
tended to yield more diverse recombinants than crosses of crudely harvested strains with 
purified strains.  For example, when purified HS 23 was crossed with other crudely 
prepared strains, isogenic dnaE recombinants predominated (data not shown).  This 
suggests that the source of gDNA in some recombination events may be extracellular 
gDNA.  This hypothesis could be tested by co-infecting a purified TS mutant with a 
different crudely harvested TS mutant that had or had not been treated with DNase to 
remove any extracellular gDNA.  If the hypothesis is correct, then more genomic 
diversity of the recombinants should result from the cross with DNase, since this should 
be analogous to crossing two purified strains.  In contrast, the cross that did not use 
DNase should have a backbone that is predominately derived from the first, purified 
parent.  The observation that bias is created based on how strains were harvested also 
suggests that a strain is more likely to be the donor if it is dominant in the co-infection 
inoculum.  This could be tested by varying the ratio of recombinant parents to each other 
in the initial co-infection. 
The chlamydial genome encodes homologs of several genes that mediate 
conjugation in other bacteria (4).  Recent work from the Hefty group suggests that C. 
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trachomatis has a functional conjugation system.  Disruption of the comEC homolog by 
transposon insertion precludes the ability to act as a recipient in LGT crosses (P. Scott 
Hefty, unpublished). 
Regardless of the mechanism governing DNA transfer and recombination, 
Chlamydia spp. can exchange DNA.  The molecular mechanism for how the Tet island 
transferred in vivo into C. suis (233) and in vitro from C. suis to C. muridarum (84) is not 
known.  Numerous examples of transformation with shuttle plasmids now exist 
(92,93,95), which supports competency of DNA uptake in vitro, although the molecular 
mechanism for how and when the plasmid enters the bacterium is not known.  Linearized 
plasmids have been taken up by electroporated C. psittaci (85), although these were no 
longer than ~4 kb.   
Our work suggests that some recombinants incorporated up to ~500 kb of DNA 
based on Sanger sequencing of divergent allele loci between the two parents (see 
Appendix II).  The recombinants produced in this study were not biased for higher 
frequencies of DNA transfer from one part of the chromosome compared to others, as 
would be expected for Hfr conjugation in E. coli (234).  Rather, the sometimes small 
areas of recombination and mosaicism is more reminiscent of the horizontal gene transfer 
seen in Mycobacterium spp. (235). 
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Section II: Chlamydial Genome Replication 
A TS DnaE mutant fails to replicate its genome 
Our data indicates that DNA replication is inhibited in dnaEts, but not L2-GFP or 
dnaEWT, at the non-permissive temperature of 40°C (Figure 11).  DNA replication 
resumes upon shifting from 40°C to 37°C (Figure 12).  However, temperature shift assays 
indicate that dnaEts inclusion size is not rescued after 18 hpi (Figure 13).  This may 
reflect of how the assay was performed, since all infections were stopped at 34 hpi, and 
therefore the longer an infection spent at 40°C, the shorter amount of time it spent at 
37°C.   
The DnaE suppressors display an intermediate growth phenotype.  While there is 
only a slight defect for genome replication of either the D828Y or E1061K suppressor 
compared to L2-GFP or dnaEWT, inclusions formed by the suppressors are noticeably 
smaller and still produce fewer progeny at 40°C (Figure 18).  In all cases, the suppressors 
grow better than dnaEts.  This suggests that even a small advantage in the ability to 
replicate the genome increases the chances of completing the developmental cycle and 
expanding the inclusion.  Since an equal number of genome copies are seen in the 
suppressors compared to strains with dnaE, we hypothesize that the suppressors rescue 
DNA replication, but not to the wild-type kinetics.  The probe used to assay genome 
copies by qPCR anneals approximately 200,000 bp from the origin of replication.  It is 
possible that genome replication appears to be completely restored in the suppressors if 
genome replication has passed this point but that progeny are not produced because 
genome replication is not complete (approximate genome size 1 Mb).  Extended 
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incubation of the suppressors at 40°C may allow them to complete RB-EB differentiation 
so that progeny production is rescued. 
Nature of the DnaEP852S mutation 
 The HS 23 genome contained four mutations (Table 7).  The temperature 
sensitive allele was mapped using negative selection LGT to dnaEts, which is predicted to 
code for DnaEP852S.  Primary sequence alignment of CtDnaE with EcDnaE and TaDnaE 
suggested that the mutation falls in the β-clamp binding domain (Figure 16).  Phyre2 
modeling of CtDnaE places P852 in a loop of a three-stranded β-sheet (Figure 17).  
Structural modeling of this mutation failed to suggest an obvious mechanism for DNA 
replication inhibition.  Both EcDnaE and TaDnaE have analogous prolines in their 
sequence that are part of a conserved (V/I)LPPD(I/V)N motif found in all three DnaE 
homologs (Figure 16).  The analogous proline residue in the EcDnaE and TaDnaE crystal 
structures falls into the same three-stranded β-sheet as in the CtDnaE model.  Structure-
function studies have analyzed this region of DnaE.  The presence of two prolines in a 
loop between two β-strands is a hallmark of a tight hairpin turn, since proline allows 
tighter turns that are not favorable conformations for the other 19 amino acids.  Thus, the 
P852S mutation may result in a protein with looser local structure that becomes further 
denatured at 40°C.  A TS screen of EMS-mutagenized E. coli that could synthesize 
protein but could not replicate their DNA (236) identified a TS E. coli dnaE allele 
(dnaE486) that encodes EcDnaES885P (237).  The residue in CtDnaE at the analogous 
position is A922 (Figure 17).  Interestingly, when modeled on the tertiary structural 
model of CtDnaE, A922 is predicted to directly contact P852—the location of our TS 
mutation.   
 98 
To better understand how DnaEP852S would be defective, a suppressor screen was 
performed.  Two intragenic suppressors were isolated that conferred temperature 
resistance in the presence of the dnaEts mutation.  Fifteen independent cultures containing 
a total of 1x1010 EB were passaged five times at 40°C.  Sanger sequencing of dnaE from 
the twelve positive cultures revealed that the original mutation was still present, 
confirming that reversion did not occur.  All twelve cultures contained a suppressor that 
would be predicted to encode DnaEP852S E1061K (dnaE C2554T G3181A).  However, this 
suppressor did not become evident in the infected wells at the same time and was absent 
in three of the fifteen original cultures (Table 9), suggesting that this suppressor arises 
independently and frequently.  The other suppressor that encodes DnaED828Y P852S (dnaE 
G2482T C2554T) was found in three independent cultures.  It was dominant in one population, 
but was a sub-population in two other DnaEE1061K-dominant populations in the other two 
cases.  Sequencing of dnaE from clonal isolates from these mixed populations confirmed 
that these were independent suppressors and that no dnaE G2482T C2554T G3181A strain was 
present.  Due to the high frequency of recovering duplicate suppressor alleles in dnaEts, it 
is unlikely that other intergenic suppressors are present in these strains, although this 
must be confirmed with whole genome sequencing.  Whole genome sequencing is 
especially important, since E. coli dnaE486 is predicted to increase the mutation 
frequency by ~6-fold (237) and may have a similar TS mechanism to dnaEts. 
How either DnaE suppressor permits DNA replication at 40°C is not obvious 
from modeling.   The D828Y mutation falls in the conserved hairpin of the HhH motif of 
the β-clamp binding domain.  Extrapolating from the TaDnaE DNA-ligand bound 
structure (111), D828 is proximal to the DNA template strand.  The HhH motif mediates 
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processivity in response to in vitro salt concentration in other polymerases (227).  The 
D828Y mutation raises several possibilities as to how this could support DNA 
replication.  The charged polar to polar aromatic amino acid change may reduce charge 
repulsion of the incoming DNA template through the channel, slowing polymerization 
speed.  Tyrosine may be preferred to either serine or threonine because the hydroxyl 
group extends further into the channel.  Alternatively, the aromaticity of tyrosine may 
allow more extensive interaction with DNA, since the phenyl group could participate in 
hydrophobic base stacking interactions with bases of the DNA template.  This may be 
important, since no other hydrophobic residues are in the immediate vicinity of position 
828 and the tyrosine residue is otherwise solvent exposed (Figure 17).   
The E1061K suppressor is proximal to the characteristic β-barrel of the OB-fold 
domain.  During polymerization, this domain is hypothesized to show substantial rotation 
compared to the apoenzyme form of TaDnaE (111).  E1061 is preceded by an aspartic 
acid residue (Figure 17).  The mutation thus suggests that a salt bridge would form, that 
the local pI would be lowered further, and that less electrostatic repulsion would be 
present, which should produce more rigid local structure.  EcDnaE has an asparagine at 
this location, while TaDnaE has a glutamate like CtDnaE (Figure 17).  Both are preceded 
by an aspartate.  This suppressor mutation is thus surprising in that to become more 
temperature resistant, CtDnaE became more like the mesophilic EcDnaE and less like the 
thermophilic TaDnaE. 
Inclusion expansion is dependent on genome replication 
No EBs were observed in our TEM samples of dnaEts at 40°C (Figures 14B-H), 
suggesting that genome replication is not required for EB-RB differentiation.  However, 
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the inclusion ultrastructure for these cells requires further investigation.  Few bacteria 
were observed in these inclusions, indicating that cell division is severely impaired.  This 
is expected, since cell division requires partitioning of the replicated chromosome into 
daughter cells.  We did not observe enlarged RB forms, which have been associated with 
chlamydial stress responses to IFN-γ and penicillin; however, the presence of multiple 
empty vacuoles and an enlarged RB periplasm suggests that the bacteria were stressed 
(Figure 15).  The multi-vesicular nature of these rare, nearly empty, and small inclusions 
may indicate that the inclusion is susceptible to host immune clearance mechanisms, such 
as autophagy (Figures 15B-H).  Since our microscopy data indicated that dnaEts 
inclusions are rare, DNA replication may be required to produce secreted, protective 
effectors. 
 Interestingly, the surviving population of dnaEts cells can reactivate DNA 
replication up until ~18 hpi (Figure 12).  We hypothesize that dnaEts denatures at 40°C, 
inhibiting its polymerase activity, but can be renatured when returned to 37°C.  
Renaturation of TS proteins involved in DNA replication has been seen previously with 
TS E. coli dnaA and dnaC mutants—two proteins that are required for replication fork 
initiation (238).   
Inclusion size at 40°C correlated with the number of genomes, and changes in 
inclusion size during temperature shifts were reflected in the number of genomes (Figures 
12 and 13).  In contrast, the UhpC inhibitor KSK120, which was previously shown to 
inhibit DNA replication (125), did not inhibit inclusion expansion.  Inhibition of protein 
synthesis with chloramphenicol inhibited both genome replication and inclusion 
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expansion, indicating that carbohydrate transport and protein synthesis differentially 
impact genome replication capacity (125).   
Genome replication and inclusion expansion are impaired in dnaEts at 40°C 
(Figures 11, 13 and 14).  Because inclusion size is severely reduced for dnaEts at 40°C 
alone, inhibitors of transcription and translation had a negligible effect on inclusion size 
at 40°C (Figure 14). Treatment of dnaEts with rifampicin or chloramphenicol at 37°C 
resulted in inclusions of similar size to what is observed at 40°C (Figure 14B).  
Therefore, the inhibition of DNA replication by KSK120 (125) is likely a side-effect of 
decreased glucose-6P levels that is independent of inclusion expansion.  One possible 
reason that inhibition of UhpC has an effect on DNA replication is that uhpC lies directly 
upstream of dnaE in the same direction on the chromosome (9).  Although transcription 
of dnaE begins earlier than uhpC (28), which suggests that these genes are not part of an 
operon, we cannot exclude that KSK120 may effect transcription of the uhpC-dnaE 
locus. 
 
Section III: Chlamydial Protein Synthesis 
Protein synthesis substrates are required mid-development 
 C. trachomatis begins de novo protein synthesis within the first few hours after 
invasion of a host cell (48); however, gltXts does not display a noticeable phenotype until 
mid-development (i.e., 15-18 hpi) (Figure 21).  Transcriptome analysis of C. trachomatis 
serovar D developmental cycle, which is slightly longer than that of serovar L2, showed 
that transcription of all 18 aaRSs has begun by 8 hpi and increases to a steady state by 16 
 102 
hpi (28).  Several proteomics studies have identified individual aaRSs in EB (198-201).  
Although the whole set of 18 aaRS has not been found in any one study, this is likely due 
to the low peptide count.  Whether the chlamydial aaRSs are functional throughout the 
developmental cycle or if they can be inactivated by post-translational modifications is 
unknown. 
 A lack of charged tRNA activates stress responses in other organisms.  In 
bacteria, amino acid deprivation activates the stringent response.  The ribosome interprets 
the ratio of aminoacylated to non-aminoacylated tRNA that enters the A-site rather than 
detecting lowered cytoplasmic concentrations of an amino acid (149).  Induction of the 
stringent response causes the upregulation of amino acid biosynthesis genes in a 
(p)ppGpp-dependent manner (239).  In high-persistence (hip) E. coli mutants, GltX is 
inactivated by phosphorylation as part of the stringent response (240,241).  In eukaryotes, 
the general amino acid stress response is induced and upregulation of amino acid 
biosynthetic genes occurs in conjunction with eIF-2α phosphorylation (242,243).  This 
halts translation since phospho-eIF-2α cannot interact with tRNAMet.  Additionally, in 
response to heat shock, yeast develop heat-activated granules, which precipitate several 
initiation and elongation factors, multiple aaRSs, as well as other cytoplasmic proteins, 
which refold upon stress termination (244).  The goal of these responses is to halt 
translation until the appropriate levels of protein precursors are available.  If translation is 
not stopped, cellular energy will be wasted on unusable aminoacylated-tRNAs and stalled 
ribosomes.  Stalled ribosomes eventually disassemble and release their partial 
polypeptides, which ultimately results in the cytoplasm filling with aggregates of protein 
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fragments and subsequent death.  Pathways involved in amino acid starvation have not 
been described in chlamydia, so how amino acid stress is mitigated is not known. 
In actively replicating E. coli, the aminoacylated tRNA pool turnover is complete 
within one E. coli generation (245).  Furthermore, the ester bond linking the amino acid 
to the tRNA is extremely labile (at least in vitro) and is highly sensitive to high 
temperature and basic pH.  Given these facts, how chlamydiae differentiate and survive 
until mid-development seems quite unusual.  However, it remains possible that truncated 
CtGltX experiences either a great reduction in catalytic rate or mischarges tRNAs rather 
than completely ablating aminoacylation activity.  Future experiments will be needed to 
address if translation is active in gltXts at 40°C, and, if so, whether tRNAGlu and tRNAGln 
are properly charged (discussed in Chapter VII). 
 gltXts was able to differentiate and replicate at a low level at the non-permissive 
temperature (Figure 21A).  However, replication was not robust, the RBs present had 
aberrant morphology (Figure 23), and genome copy numbers stayed low (Figure 21B).  
Growth could be rescued up until 15 hpi by shifting from 40°C to 37°C (Figure 21).  The 
presence of IBs and large aberrant RBs argues against this mutant dying by 32 hpi post 
infection when grown at 40°C (Figure 23).  Rather, this suggests that despite typically 
residing in a very consistent and predictable environment inside the host cell, chlamydia 
evolved a way to persist in the absence of ideal aminoacyl-tRNA conditions for several 
hours post infection.  Taken together, our data suggests that chlamydial EB must contain 
sufficient pools of aminoacylated tRNA for early de novo protein synthesis, since a 
morphological phenotype is not observed until mid-development.   
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CHAPTER VII: Future Directions 
Section I: Investigation into Essential Biological Processes with TS Mutants 
Translation 
 When and how translation is initiated in chlamydia is poorly understood.  The EB 
is believed to be largely metabolically inactive, and cannot translate proteins de novo, 
since cell-free RBs, but not EBs, can incorporate  [35S]-methionine (246).  However, de 
novo protein synthesis during infection was detected by 2 hpi using [35S]-methionine 
pulse-chase experiments followed by 2D gel electrophoresis (48).  Our temperature 
sensitive screen identified mutants with defects in multiple steps of translation, which 
could provide insight into how translation is controlled.   
Translation requires many different proteins and substrates ranging from amino 
acids to tRNAs to the ribosome.  We have identified mutants that are suspected to have 
defects in post-transcriptional modification of tRNA (HS 26; CTL0597ts), aminoacylation 
of tRNA (HS 1; gltXts), processing of 16S rRNA (HS 13; CTL0681ts), and a ribosomal 
protein (HS 17; rpsHts).  We may have also identified a mutant (HS 10) that encodes 
either another temperature sensitive ribosomal protein (rplF) or a methionyl-tRNA 
formyltransferase (fmt).  Another TS mutant that we identified suggests that some 
components of the E. coli stringent response may function in chlamydia (HS 27; obgEts). 
 Translation requires that many components act together in a highly regulated 
manner.  tRNAs constitute a major population of RNA in EBs (197).  When de novo 
tRNA transcription begins in chlamydia is not known.  However, nascent tRNA 
transcripts are not functional until 5’ and 3’ cleavage, -CCA addition, and various post-
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transcriptional base modifications occur, and these enzymes are not transcribed until 3 
hpi (28).  These steps produce tRNAs that are of the correct size, adopt the appropriate 
stem-loop formation, can accept an amino acid, and are structurally stable enough for 
accurate decoding at the ribosome.  tRNA aminoacylation gives tRNAs the ability to 
translate mRNAs at the ribosome.  Ribosomes are large nucleoprotein complexes 
composed of over 20 proteins and 3 rRNAs, which also contain a high percentage of 
modified bases (167).  Stress responses can alter the proteome, and this is mediated by 
different components of the translational machinery.  For example, IFN-γ treatment 
reduces the amount of tryptophan that is available to chlamydia, and this is reflected in 
the proteins that are preferentially synthesized (247,248); proteins that contain high 
proportions of tryptophan residues are downregulated while the upregulated persistence-
associated proteins tend to be tryptophan poor (249,250).  We identified multiple mutants 
that could provide insights into how translation is regulated during chlamydial 
development and stress responses.   
 CTL0597 is annotated as an O-sialoglycoprotein endopeptidase, but BLAST 
predicts that CTL0597 is actually a TsaB homolog and therefore a t6A modifying 
enzyme.  TsaB forms a heterotrimer with TsaD and TsaE.  TsaD recognizes tRNAs with 
anticodons that decode ANN codons, while TsaB adds the threonyl group to the 6-
position of A37 (251).  TsaE may stabilize the complex (252).  Inactivation of TsaB 
would be predicted to prevent modification of twelve out of 37 chlamydial tRNAs, since 
it would impact tRNAArg, tRNAAsn, tRNAIle, tRNALys, tRNAMet, and tRNAThr (some have 
multiple isoacceptors).  Threonylation of A37 is believed to improve translation fidelity.  
Yeast mutants of the CTL0597 homolog have impaired growth (253).  Consistent with 
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this, HS 26 (ctl0597ts) formed smaller inclusions and fewer progeny under normal 
conditions, and these defects are exacerbated at 40°C (Figures 5 and 8).  A Phyre2 model 
of CTL0597 indicates that the G69R mutation is located at the TsaB-TsaD interface 
(Figure 26) (252), suggesting that the temperature sensitivity of HS 26 is caused by 
disruption of the TsaB-TsaD complex.   
 
 
Figure 26 Model of CTL0597.  CTL0597 was modeled using Phyre2 software.  Glycine-69 is shown in 
magenta space-fill.  CTL0597 is a homolog of TsaB, which has been shown to interact with TsaD using the 
helix that the mutation is found in (252). 
 
The impact of tRNA modification on chlamydial growth could be further 
investigated by identifying how tRNAs are modified in vivo using tRNA sequencing 
(185,186).  How HS 26 modifies tRNAs is of particular interest.  Impaired growth of HS 
26 at 37°C (Figures 5 and 8) indicates that CTL0597 may not be fully functional.  Further 
investigation will be needed to determine if the mutant ctl0597 allele in HS 26 causes 
these growth defects.  The number of transcripts for the serovar D homolog of ctl0597, 
 107 
ct343, was decreased ~2-fold in a model of IFN-γ persistence (204), indicating that 
ctl0597 expression is responsive to stress stimuli and that tRNA modifications may play a 
role in the chlamydial stress response.   
How chlamydia normally modify their tRNAs is unknown, and insight into how 
these modifications change during stress or potentially even the developmental cycle 
could reveal potential drug targets.  Multiple tRNA modifications occur sequentially, so 
inactivation of CTL0597 at 37°C could block downstream tRNA modifications.  
Comparison of tRNA modifications by tRNA sequencing (185) could reveal if other 
putative tRNA modifying enzymes are active in Chlamydia spp. and determine if these 
modifications still occur at 40°C.  Additionally, because CTL0597 is predicted to act in a 
complex and because the CTL0597G69R mutation is predicted to interrupt the TsaB-TsaD 
binding interface, co-immunoprecipitiation assays could be used to test if the complex is 
intact in HS 26 at 40°C.  
Once mature tRNAs are produced, they can be aminoacylated.  The rate of 
translation can be controlled by the availability of the different aminoacylated tRNA 
species.  While non-synonymous mutations were identified in multiple aaRSs in our 
screen (HS 1, HS 2, and HS 7), only a mutation in GltX conferred temperature 
sensitivity, although the TS allele in HS 7 has not been mapped.  HS 1 was further 
investigated in Chapter V and potential future directions are discussed later in this 
chapter. 
 Once aminoacyl-tRNAs are produced, the ribosome can begin translating mRNA.  
Several TS mutants identified in the screen have mutations in genes involved in ribosome 
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biogenesis.  Given their large size, multiple components, and heavy level of 
modifications, producing ribosomes is a resource intensive process.  Not having the 
appropriate number of active ribosomes can be detrimental: too few, and growth is 
inhibited from a lack of necessary proteins and an inability to adapt; too many, and 
nutrients will be exhausted.  Therefore, the availability of free ribosomes regulates 
translation rate (254).   
Ribosome biogenesis can be regulated at the level of synthesis of mature 16S 
rRNA.  The first steps in generation of mature 16S rRNAs are the 5’ and 3’ cleavage of 
the primary transcript by the endoribonucleases RNase G and RNase E, respectively.  A 
BLASTp search of CTL0681 identified that this protein shares homology with the 
endoribonuclease YbeY.  YbeY further cleaves the 3’ end of 16S rRNA transcripts in 
conjunction with RNase R (157,158).  The TS allele in HS 13 codes for CTL0681P159L 
that is lethal early in development (Figure 5).  YbeY has been annotated as an essential 
bacterial gene since it is highly conserved across the bacterial kingdom, and its 
inactivation leaves the cell vulnerable to stresses (255). 
 An E. coli ΔybeY mutant accumulated 30S and 50S ribosomal subunits and had 
fewer polysomes (157).  The mutant also displayed slow growth kinetics and heat shock 
intolerance (157).  Progeny production in HS 13 is normal at 37°C, but is impaired at 
40°C (Figure 8).  Deletion of ybeY in E. coli decreases the number of functional 
ribosomes.  Therefore, analysis of polysome profiles in HS 13 at 37°C and 40°C at 12 
and 18 hpi could provide insight into how CTL0681P159L impacts translation in C. 
trachomatis.  Polysome profiling could also reveal if abnormal “damaged” ribosomes 
result from inadequate ribosomal maturation (158).  Northern blotting could be used to 
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test if HS 13 produces mature 16S rRNA at 40°C.  Because all of the ribosomes in HS 13 
EBs should contain properly processed 16S rRNA since they were harvested from cells 
grown at 37°C, how frequently new ribosomes are formed and how many defective 
ribosomes are tolerated by the cell could be monitored by comparing the percentage of 
processed to non-processed 16S rRNA throughout development.  We hypothesize that the 
percentage of processed 16S rRNA is adequate until 18 hpi, when we see that the mutant 
can no longer be rescued by temperature shift (Figure 5). 
 Functions of the protein components of the ribosome are poorly understood.  It is 
believed that ribosomal proteins stabilize the large rRNA species, which align the mRNA 
and interact with tRNAs to maintain the reading frame.  Our screen identified one 
isogenic TS mutant (HS 20), which has a missense mutation in a ribosomal protein 
(RpsHA119V ) (Table 7).  HS 20 has decreased fitness at 37°C (Figures 5 and 8).  E. coli 
RpsH stabilizes 16S rRNA of the 30S ribosomal subunit so that the mRNA will be 
properly aligned with the 50S ribosomal subunit and incoming tRNAs (256).  Thus, the 
small inclusion size and inability to adapt to an increase in temperature could be expected 
in HS 20.  HS 20 could provide insights into how RpsH interacts with 16S rRNA.  
Protein footprinting studies, which utilize reversible cross-linking and mass spectrometry, 
could be performed to identify residues that directly contact the rRNA to determine if 
RpsH still binds the 16S rRNA in HS20 using the same residues or if an interaction is 
missing at 40°C. 
 Cells employ many mechanisms to adapt to changes in their environments, 
whether that be an increase (or decrease) in temperature, sensing of immune effector 
mechanisms, or nutrient depletion.  One classical pathway used to respond to stresses is 
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the stringent response.  In E. coli and other gram-negative organisms, nutrient deprivation 
is signaled by production of the second messenger (p)ppGpp.  The ribosome accessory 
protein ObgE is bound to the ribosome under normal growth conditions.  When EcObgE 
binds ppGpp, protein synthesis is downregulated (154,155).  The structure of (p)ppGpp-
bound ObgE is thought to mimic a tRNA in the A-site of the ribosome (219), inhibiting 
incoming tRNAs from interacting with the mRNA.  Binding of ObgE to the ribosome 
also increases the transcription of amino acid biosynthesis genes and inhibits DNA 
replication, although the mechanism for this is unknown (257).  Chlamydia spp. possess a 
truncated ObgE homolog that can bind the ribosome, but CtObgE cannot functionally 
substitute EcObgE (220).  However, like the EcObgE mutants, HS 27 also displays 
growth defects (Figure 8). 
 EcObgE function has been explored during induction of the stress response.  In 
contrast, when HS 27 was shifted from 40°C to 37°C, it could not be rescued even very 
early (0-8 hpi) in infection, which indicates that the EB-RB transition cannot occur 
(Figure 5).  It is possible that CtObgE inhibits translation in the spore-like EB.  Co-
immunoprecipitation studies could be used to investigate when ObgE interacts with the 
ribosome during chlamydial development.  Whether chlamydia use an alternative 
secondary messenger to (p)ppGpp to alert the cell to nutrient stress could also be 
investigated.  For example, other second messengers such as cyclic di-AMP, which is 
found in chlamydia (203), may be able to interact with CtObgE to pause translation.    
Cell division and differentiation 
 Chlamydial cell division does not to follow the classical paradigm, and the 
chlamydiae lack several key E. coli cell division proteins.  For example, Chlamydia spp. 
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lack a FtsZ homolog, so how chlamydia determine septum location and eventual fission 
is not known.  Chlamydial homologs for FtsL and FtsQ have recently been described 
(66).  Furthermore, how chlamydia transition between EB and RB is poorly understood.  
Recent studies suggest that the initial EB to RB transition may be a process more akin to 
budding rather than binary fission (68), but whether this same process occurs during mid-
development as RB divide or runs in reverse for the RB to EB transition at the end of the 
developmental cycle has not been investigated.  Chlamydial differentiation is also unique 
in that it uses histone-like proteins to compact its chromosome.  These are made late in 
development and are thought to be important for DNA condensation during the RB-EB 
transition (120). 
 The TS allele in CS 2 mapped to ctl0137, and a BLAST search identified the 
presence of an Smc domain within ctl0137.  Smc-domain proteins are primarily coiled-
coil proteins that contain a hinge near their centers (258).  The N- and C-termini are 
globular and can associate with each other in an ATP-dependent manner (258).  Smc-
domain containing proteins are involved in chromosomal segregation during cell division 
and function by wrapping around the chromosomal DNA and closing around it by 
interactions between the two globular domains.  The closed protein can then pull the 
chromosome along with it when in contact with other cell division proteins that are 
attached to the membrane. 
 The ctl0137 allele in CS 2 is predicted to truncate CTL0137 at position 443 of the 
560 residue protein, which would result in near complete loss of the C-terminal globular 
domain (Table 7).  Whether or not CTL0137 interacts with DNA has not been 
demonstrated.  However, if this protein does bind DNA and localizes to the division 
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septum in wild type cells, a redundant mechanism for chromosomal segregation at 37°C 
must be present, since ctl0137ts is truncated.  This redundant pathway would be predicted 
to be non-functional at 32°C, leading to lethality.  Gel-shift assays could determine if 
CTL0137ts interaction is less than or equivalent to the interaction of CTL0137 with DNA.  
Localization of CTL0137 to the division plane could be visualized with the development 
of an antibody to detect CTL0137, staining of the DNA, and tagging of the division 
septum (67).  TEM of CS 2 at 32°C could also reveal if ctl0137ts results in defects in RB-
EB differentiation or enlarged RB due to impairment of cytokinesis.  If chromosomal 
segregation is impaired, we would anticipate that unusual sized organisms would be 
present and that a portion of these cells would lack a chromosome, while others would 
contain multiple chromosomes. 
The TS allele in HS 11 mapped to ctl0322.  This TS mutant is predicted to have 
defects in packaging of DNA during division and differentiation.  CTL0322 is a DNA 
binding nucleoprotein (230).  Late in development, chlamydial DNA is wrapped around 
histone-like proteins to produce the condensed chromosomes characteristic of EBs.  The 
long non-coding RNA lhtA represses CTL0322 expression until late in development 
(259).  Whether ctl0137ts transcript is regulated by lhtA at 40°C is unknown and could be 
tested in a heterologous system using a reporter for translation (259).  Chromatin 
immunoprecipitation (ChIP) experiments could determine if mutant CTL0322 can still 
bind to DNA at 40°C.  If there are any functional differences between CTL0322 and the 
other chlamydial histone-like proteins HctA and HctB remains to be investigated.  ChIP-
seq could be used to test if CTL0322 binds similar DNA sequences to HctA and/or HctB.   
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DNA replication 
 The signal to begin genome replication in chlamydia is unknown, but, assuming 
that there is one complete genome per EB, at least one round of replication must precede 
the first cell division.  Previous studies indicate that DNA replication is required for 
progeny production, but not for growth of the chlamydial inclusion (125).  We identified 
a temperature sensitive dnaE mutant (HS 23) that we have further characterized and 
which is the focus of Chapter IV.  This shows that inclusion expansion requires DNA 
replication. 
 Proton gradient maintenance 
 The proton motive force is important for securing metabolites and generating 
ATP.  ATP generating proteins are increased in RB compared to EB, and this is 
associated with the high energy demands of replication and an active metabolism (199).  
We identified a dual HS/CS mutant (HS 19) whose TS allele mapped to the V-type 
ATPase subunit beta encoded by atpB.  The V-type ATPase typically acidifies 
intracellular compartments.  The dysfunction of this protein would be predicted to result 
in a more basic compartment.   
To test if ATP builds up in the bacterial cells, FRET studies utilizing the ATeam 
system, which consists of a translationally fused cyan fluorescent protein (CFP) and 
Venus FRET pair linked by the ATP-binding domain of the ε-subunit of the ATPase, 
could be transformed into chlamydia and the levels of ATP could be measured by FRET 
for HS 19 and L2-GFP (260).  Alternatively, it may be possible to measure pH based on 
fluoresecent pH indicators such as seminaphthorhodaﬂuors (SNARFs) (261).  C.SNARF-
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1 is a rhodamine-based molecule with a pKa=7.5 that shows shifts in the excitation and 
emission spectra based on whether the molecule is in the phenol or phenolate form.  
Although these dyes have been shown to be dispersed evenly throughout the cell, whether 
or not the dye can penetrate into chlamydia is not known. 
Carbohydrate metabolism 
 The reduced genome of chlamydia raises questions regarding what substrates can 
be used to generate ATP.  The uptake of radiolabeled-dicarboxylate compounds into 
chlamydia and their subsequent ability to generate ATP has been studied (59).  Later 
genome sequencing showed the first enzymes (citrate synthase, aconitase and isocitrate 
dehydrogenase) involved in the tricarboxylic acid cycle (TCA) are absent (4).  If the 
truncated TCA cycle can produce ATP has been questioned. 
 Our screen identified three alleles of ctl0456 that conferred temperature 
sensitivity in CS 1 (W321*), CS 3 (W442*), and HS 20 (G145R).  CTL0456 is a 
homolog of the dicarboxylate transporter SodTi in plants (59) and of VcINDY in Vibrio 
cholerae.  VcINDY has been recently crystalized with glutamate bound (262).  Given that 
chlamydia was shown to import 2-oxaloacetate (59) which is classically produced by the 
second enzyme in the TCA cycle, isocitrate dehydrogenase, and used by the third 
enzyme, α-ketogluterate dehydrogenase,  we hypothesize that chlamydia does utilize its 
truncated TCA cycle using metabolites imported from the host cell.  Chlamydia spp. 
possess two potential high-affinity transporters that could feed 2-oxogluterate into the 
truncated TCA cycle.  Direct transport of 2-oxogluterate could be achieved through 
CTL0456, or 2-oxogluterate could be obtained indirectly by deamination of glutamate 
transported via GltT.  A predicted GltT null mutant was isolated from an EMS-
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mutagenized L2-rifR library (91), suggesting that GltT is non-essential.  The ctl0456 
alleles in CS 1 and CS 3 are predicted to be null alleles.  Taken together, these studies 
indicate that redundant pathways exist: either GltT and CTL0456 can substitute for each 
other or potentially the low-affinity 2-oxogluterate porin, PorB, could be sufficient for 
survival (263).   
All three temperature sensitive alleles of ctl0456 have growth defects when grown 
at 37°C (Figures 6 and 7), suggesting that CTL0456 is important for fitness, but is not 
absolutely essential unless stressed.  The truncated CTL0456 mutants (CS 3 and HS 20) 
are dual HS/CS mutants, providing genetic evidence that host cell levels of glutamate (the 
GltT substrate) may be too low at 32°C or 40°C to compensate for the lack of functional 
CTL0456.  Metabolomics studies of the available carbon sources in host cells at 32°C, 
37°C, and 40°C could better inform the phenotypes of these mutants.  Generation of a 
ctl0456-gltT- double mutant using TargetTron® (96) or FRAEMing (95) may inform if 
the pathways are redundant or if yet another pathway, such as PorB import, can still 
compensate.  Experiments conducted by the McClarty group (59) to define the 
chlamydial carbon metabolites should be revisited with the  ctl0456 (89) and gltT (91) 
mutants to determine if the TCA cycle is active or if energy is being obtained via an 
alternative pathway such as glycolysis or the pentose phosphate pathway. 
Fatty acid biosynthesis 
 Chlamydia encode a bacteria-specific fatty acid biosynthetic pathway that is used 
to generate branched chain fatty acids at the 2-position of some phospholipids (56,229).  
These enzymes have been shown to be druggable targets in vitro in other organisms, such 
as Staphylococcus aureus (264).  C. trachomatis FabI, which converts trans-2-enoyl-
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ACP to acyl-ACP, is inhibited by the same inhibitor as for Staphylococcus aureus FabI 
(229).  Blocking FabI activity early during C. trachomatis infection was lethal, since 
growth stops in the RB stage.  We isolated a temperature sensitive FabI mutant (HS 24; 
FabID79N) that could not be rescued after being grown at 40°C for 18 hpi (Figure 5).  D79 
is a conserved residue in both C. trachomatis and S. aureus FabI, although it does not 
appear to participate in substrate binding (Figure 27; (229)). 
 
 
Figure 27 Model of FabI.  Regions of FabI have been highlighted on the crystal structure (PDB ID 
4Q9N;(229)).  The “lid” loop (green spacefill) and “flipping lid” loop (blue spacefill) contact the inhibitor 
AFN-1252 (not shown), which binds to the catalytic cleft that is normally occupied by trans-2-enoyl-ACP 
(229).  The location of D79 is colored in magenta spacefill. 
 
 Because the FabI inhibitor AFN-1252 blocked development past EB-RB 
differentiation, determining what developmental forms are present in cells infected with 
this mutant at 40°C by transmission electron microscopy would elucidate if the inhibitor 
and mutation inhibited growth in the same manner and to the same degree.  Quantitative 
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mass spectrometry could be used to test if inhibition of FabI causes accumulation of 
trans-2-enoyl-ACP and a decrease in the amount of acyl-ACP in the cell (265). 
 
Section II: TS alleles as Genetic Tools 
 As more genetic tools are developed, more advanced genetic manipulation 
strategies become feasible.  Theoretically any non-essential gene can be deleted using 
FRAEM, which replaces a gene of interest with a bla-gfp cassette (95).  While this 
cassette aids in the selection and visual identification of knock out mutants, introduction 
of this much foreign DNA can have notable caveats.  For instance, promoter sequences 
for downstream genes may be destroyed or novel promoter sequences may be created by 
inserting gfp upstream of a gene, resulting in unanticipated gene products or altered 
expression of downstream genes.  Also, antibiotic resistance cassettes have also been 
shown to affect fitness (232). 
 Ideally, deletion of a gene would be complete and leave no antibiotic resistance 
cassette.  In E. coli, clean deletions can be performed by sequential allelic recombination 
events.  In the first recombination, a suicide plasmid is designed to carry a cassette 
containing a positive selection marker, such as bla, and a negative selection marker, such 
as sacB (266), that is flanked by homologous sequence to the gene that is being deleted.  
After the E. coli is transformed with the suicide plasmid carrying the cassette, successful 
recombinants are selected for with ampicillin.  In a second recombination event, a second 
suicide plasmid containing the desired sequence at that location flanked by homologous 
sequence is then transformed into the E. coli bla-sacB mutant generated from the first 
transformation.  This sequence could simply be a clean deletion of the gene by joining of 
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sequence between the up- and downstream genes or be some derivative of the gene of 
interest, such as a catalytically inactive allele.  Recombinants are selected for by growth 
in high sucrose media. 
 SacB expression is unlikely to act as a negative selection marker in Chlamydia 
spp., since the bacteria are intracellular and the high sucrose levels needed for selection 
are likely toxic to the host cells.  However, it may be possible to engineer a selection 
cassette that contains bla and a TS allele.  Because the genes identified in this screen are 
functional at 37°C, it is possible that additional expression of these would be detrimental 
to the fitness of the organism.  We were unable to isolate stable transformants of six 
different TS alleles that were under the control of a Tet-On promoter in a pASK vector 
(data not shown).  One possible reason for this is that the tet promoter is leaky as 
demonstrated by the presence of low levels of GFP from the pASK-GFP control vector 
even in (anhydro)tetracycline-free conditions (data not shown).  Thus, overexpression of 
the tested TS alleles in the absence of induction may be detrimental even at 37°C.  
Development of tighter expression control systems may allow for direct assessment of 
dominant negativity of the mapped TS alleles.  Alternatively, overexpression of the TS 
alleles may not be as severe if these were located on the chromosome.  Quantification of 
shuttle vector copy number of a similar plasmid (pBR325::SW2) indicated that there are 
16-19 plasmids/genome (92).  However, only one copy of the marker would be present if 
inserted into the chromosome. 
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Section III: Understanding how DNA Replication impedes Development 
Entry into the cell cycle 
Previous studies showed that genome replication begins by 6 hpi (27), and our 
work shows that replication begins prior to 12 hpi (Figure 11).  The inability to replicate 
the genome does not become lethal until mid-development.  DNA replication can still be 
rescued at later time points even though immunofluorescence microscopy shows an 
absence of mature inclusions for infections shifted from 40°C to 37°C at 18 hpi (Figure 
12 and 13).  The temperature shift assays performed in this work were all stopped at the 
same time post-infection (34 hpi).  One possibility for the discrepancy between the 
genome copy number and microscopy results is that if no genomes are replicated and the 
differentiated RB sits idly for 18 hpi or longer, then shifting to 37°C for the remaining 16 
hours or less may not be enough time to generate sufficient RB populations that would 
subsequently result in inclusion expansion.  To test this possibility, the temperature shift 
assays could be modified so that, after various amounts of time at 40°C, an equivalent 
amount of time would be spent at 37°C, such as 24 h post shift, to standardize the time 
for genome replication.  This would allow an equivalent amount of time for cell division 
and inclusion expansion to occur in infections that are shifted later in development.  
Constant time at 37°C would allow for distinguishing between if growth at 40°C is truly 
lethal or if a period of lag time before re-entry into the normal cell cycle is responsible 
for the smaller inclusion size and minimal genome replication for infections shifted from 
40°C to 37°C at 18 hpi. 
TEM micrographs suggest that the EB-RB transition is completed by 32 hpi.  
However, the RBs have an aberrant morphology, which is characteristic of stress (Figures 
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15B-H).  Whether these RBs have initiated de novo transcription or translation due to the 
lack of DNA replication is unknown.  Temperature sensitive mutants of various DNA 
replication proteins in E. coli were identified in the 1970s by screening for the lack of 
radiolabeled thymine incorporation into the DNA despite the incorporation of 
radiolabeled leucine into the proteins of cells (236).  A similar strategy could be 
employed here to determine if dnaEts is still synthesizing protein. 
The beginning of the developmental cycle is characterized by the transcriptional 
upregulation of several early genes including euo, omcA, and the histone-like proteins.  
The activation of these genes could be assayed by qRT-PCR in both dnaE and dnaEts at 
the end of a typical developmental cycle (i.e., 34 hpi).  If these genes are activated, 
testing of mid-cycle genes (27) should be performed.  Mass spectrometry could be used 
to determine whether these potential defects in transcription manifest at the protein level.  
For example, the proteome of dnaEts at 40°C by 18 hpi may be characteristic of early 
development proteins or may be alternatively shifted to reflect upregulation of a stress 
response. 
Requirements to set up a successful niche 
Our TEM data suggests that DNA replication is required to protect the inclusion 
from host clearance mechanisms (Figure 15).  Some inclusions formed by dnaEts at 40°C 
appeared to be in the process of being cleared (Figures 15G and 15H).  The localization 
of both host and bacterial proteins by immunofluorescence microscopy could be studied 
to clarify if an active clearance mechanism is activated.  Specifically, because of the 
numerous vacuoles, autophagic markers from the host, such as LC3, could be localizing 
to the inclusion.  Rab4 and Rab11 have also been shown to interact with the chlamydial 
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inclusion early in infection, and their recruitment to the inclusion membrane is thought to 
label the inclusion as a typical endocytic vesicle that can intercept ER derived vesicles 
(267).  In contrast, Rab5 and Rab7, which typically label endosomes destined for 
lysosomal fusion, are excluded from the inclusion (267).  Which, if any, of these proteins 
is recruited to the inclusion membrane of dnaEts at 40°C by the end of development could 
be tested by immunofluorescence microscopy.   
If secretion of type III secreted effectors that protect the inclusion from lysosomal 
fusion occurs in dnaEts is unknown.  Comparison of inclusion proteomes (268) in the 
mutant versus its isogenic recombinant at 40°C could define what virulence factors are 
necessary to avoid clearance.  Attempts to stain for IncA, which is normally secreted 
beginning at 10 hpi (269), were unsuccessful for L2-GFP inclusions grown at 40°C (data 
not shown).  Since IncA is only required for homotypic fusion of inclusions and our 
assays were carried out at MOI <1, the absence of IncA would be predicted to have little, 
if any, effect on growth.  Whether IncA is not secreted at 40°C or if the epitope is not in 
the proper conformation for antibody recognition is not known.  Antibodies to other, 
earlier Incs (e.g., IncDEFG) (270) may be alternative options to stain inclusions to 
measure inclusion size. 
Protein structure and function 
The mechanism behind DNA replication inhibition in dnaEts at 40°C is unknown.  
The functions of the various DnaE domains have been investigated in model organisms.  
One approach to understanding the defect in dnaEts is to compare the function of mutant 
replisomes reconstituted using recombinant CtDnaE or CtDnaEP852S.  While all 20 protein 
components of the E. coli replisome are now commercially available, whether CtDnaE is 
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compatible with the E. coli proteins is unknown.  This could be quickly tested by ectopic 
expression of CtDnaE in a conditional dnaE knock out strain of E. coli (such as dnaE486) 
before further investing in in vitro complex formation studies, since purification of all the 
chlamydial components could prove challenging.   
The ability of the mutant to polymerize DNA from a plasmid template in the 
presence and absence of the β-clamp in vitro at 37°C and 40°C would be of particular 
interest because P852S is in the β-clamp binding domain.  The size of the resulting DNA 
fragments produced could be analyzed by gel electrophoresis.  If DnaEts is capable of 
binding to the β-clamp, longer DNA products should be produced.  However, if DnaEts 
cannot bind the β-clamp, processivity should be lost and short (~100 bp) DNA fragments 
should be present.  If DnaEts cannot bind DNA at all, no DNA product will be produced 
in the presence or absence of the β-clamp.  Another possibility is that DnaEts is 
functional, but has a drastically decreased polymerization rate.  Single-molecule 
polymerization rates of DnaE versus DnaEts could be determined using DnaE attached to 
a lipid bilayer in a flow cell and monitoring the quantity and length of DNA product 
produced in real time (271). 
The interaction of DnaEts with the β-clamp could be confirmed with fluorescence 
anisotropy experiments to verify if the β-clamp is able to bind at 40°C.  A reaction of 
fluorescently labeled recombinant DnaE or DnaEP852S, oligonucleotide “template”, and 
the β-clamp could be combined and heated to 40°C.  The amount of spin could then be 
measured.  Since all reaction components would be expected to bind DnaE, a slower spin 
speed would be expected upon addition of the oligonucleotide and β-clamp, whereas a 
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relatively higher speed would be expected for the mutant if the β-clamp and/or the 
oligonucleotide did not bind. 
The inability of DnaEts to bind to either the DNA template or the β-clamp could 
be due to denaturation of the protein at 40°C.  Circular dichroism studies could be used to 
test if DnaEP852S denatures at 40°C.  These studies could provide insight into whether the 
mutation causes localized misfolding (i.e., only the β-clamp binding domain) or if more 
extensive structural changes are present based on the amount of α-helical character that is 
lost. 
A previous suppressor screen for EcDnaE has been performed (272).  The D430K 
dominant negative mutant parent they used was capable of binding to the DNA template, 
but could not elongate (273).  Five distinct suppressors that allowed for elongation were 
found in the editing (PHP), OB-fold, and β-clamp binding domains (272), although none 
of these directly corresponds to our suppressors.  It may be possible to generate 
additional suppressors of dnaEts in other domains by screening larger populations.  
Finding suppressors for CtDnaE has been logistically challenging, but, if CtDnaE can 
fully substitute for EcDnaE function and still remain temperature sensitive, these screens 
could be performed in E. coli to discover more telling suppressor mutants to further 
investigate the nature of the P852S defect.  Performing this suppressor screen in parallel 
with E. coli dnaE486 (EcDnaES885P) could potentially reveal similar suppressors, since 
P852 and the residue analogous to EcDnaES885 in CtDnaE (A922) potentially interact. 
We identified two distinct DnaEP852S suppressors (DnaED828Y P852S and DnaEP852S 
E1061K) that rescued DNA replication.  As a precautionary measure to interpretation of 
these suppressors, whole genome sequencing should be performed.  Although it is 
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unlikely that both an intragenic and extragenic suppressor appeared in the same strain, 
this cannot be excluded.  Sequencing of the suppressor strains is also important since E. 
coli dnaE486 had an increased rate of spontaneous mutation (237). 
A better understanding of how DnaED828Y P852S and DnaEP852S E1061K function 
could be explored using the fluorescent anisotropy and circular dichroism experiments 
described above.  
Our TS screen identified three other strains with mutations in DnaE, although the 
TS alleles have not been mapped for these strains.  Mutations in dnaE of HS 8 and HS 25 
(DnaEA58T and DnaEL89F, respectively) are predicted to fall within the PHP domain that is 
responsible for proofreading and interactions with the ε and θ subunits that heighten 
proofreading activity.  The mutation in dnaE from HS 16 (DnaEP367L) is predicted to fall 
in the palm domain, which contacts the DNA template.  If the TS allele in any of these 
three strains maps to dnaE, then further investigation of how DnaE functions during the 
developmental cycle could be gleaned by suppressor analysis of these mutants. 
Relationship between DNA replication and protein synthesis in development 
The existence of small inclusions that rarely contain typical RBs or that display 
abnormal inclusion membrane morphology in dnaEts at 40°C suggests that DNA 
replication machinery must be functional to maintain bacterial and inclusion membrane 
morphology (Figure 15).  This same morphology is not seen in gltXC1549T at 40°C (Figure 
23), suggesting that DNA replication is required to maintain inclusion integrity, while 
protein synthesis is not.  Temperature shifts from 37°C to 40°C also indicated that 
inhibition of protein synthesis via GltX is not as detrimental as inhibition of DNA 
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replication via DnaE (Figures 13 and 22).  In both cases, genome replication ceases 
(Figures 11 and 21), but whether there is a difference in the transcriptome or proteome of 
these mutants that mediates these phenotypic differences remains to be explored by 
RNAseq.   
The mechanism for cessation of DNA replication in cells treated with the uhpC 
inhibitor KSK120 likely differs from when the DNA polymerase is non-functional, since 
the same phenotypes were not observed for either dnaEts and gltXts, which are both 
impaired for genome replication at 40°C.  Inclusions of C. trachomatis serovar L2 treated 
with KSK120 contain normal RBs (125), but dnaEts inclusions at 40°C contain RBs that 
appear stressed (Figure 15).  Thus, the aberrant RB morphology characteristic of some of 
the gltXts RBs at 40°C (Figure 23) and persistent inclusions from IFN-γ treated cells 
(228) may be dependent on active DNA replication.  Whether aberrant RBs form in 
persistence in the absence of DNA replication in other models is unknown, but could be 
investigated by treatment of persistent cells with chloramphenicol.  The lack of cell 
division during persistence would suggest that DNA replication should otherwise be 
expendable. 
 
Section IV: Investigation of Protein Synthesis in a GltX Mutant 
Protein inactivation 
We hypothesize that truncation of GltX either removes important residues for the 
structural stability of the protein at higher temperatures or removes the binding site for an 
essential interaction partner at 40°C.  If these residues are important for structural 
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stability, purified recombinant GltX and GltXQ487* could be compared at temperatures 
from 37°C to 40°C using circular dichroism to detect a decrease in the α-helicity of the 
proteins, indicating protein denaturation.  If the residues are important for an interaction 
partner, tagged recombinant GltX and GltXQ487* could be used to pull-down these 
partners from chlamydial lysates that could then be identified by mass spectrometry.  We 
hypothesize that GltXQ487* is destabilized at the high temperatures, since, to our 
knowledge, no binding partners have been described that bind to the C-terminal region of 
GltX in other bacteria.  Comparison of the discriminating EcGluRS and EcGlnRS 
indicates that GluRS has a more rigid structure than GlnRS, and GlnRS is thought to have 
evolved from GluRS after a gene duplication event (274).  Evolution of GlnRS to 
specifically interact with a new substrate is hypothesized to be mediated by a C-terminal 
domain with looser structure that becomes more structured upon substrate binding (274).  
It is tempting to speculate that the non-discriminating GltX may represent a compromise 
between the two discriminating aaRSs.  Whether binding of tRNAGlu versus tRNAGln to a 
non-discriminating GltX results in different protein conformations in GltX remains to be 
determined. 
Characterization of GltXQ487* expression 
A transcriptomic dataset showed that gltX transcripts begin to be transcribed by 8 
hpi in C. trachomatis serovar D (28).  We assume that, based on the shorter 
developmental cycle of serovar L2, expression of gltX occurs earlier in our strain.  Gene 
expression of gltX in serovar L2 could be determined by qRT-PCR at 0, 2, 6, 8, 12, 18, 
24, and 34 hpi.  Our modeling studies suggest that GltX is truncated, but what, if any, 
effect this has on transcription at 37°C is unknown.  Therefore, gltXts and gltXWT should 
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also be assayed at both the permissive 37°C and the non-permissive 40°C to investigate 
whether the transcript is still stable throughout development. 
EBs are generally not regarded as being metabolically active.  EBs can take up 
glucose in anexic media, but glucose uptake was unable to drive EB to RB differentiation 
(31,32).  What drives the differentiation event and what players are required has not been 
determined.  Both proteomic and transcriptomic profiles show evidence for temporal 
expression of proteins and genes, respectively.  There is also overlap between the 
proteomes of EBs and RBs despite the former being metabolically inactive (198-200).  
One possibility for the difference in metabolism of EBs and RBs, despite the presence of 
a core set of proteins involved in metabolism, is differential post-translational 
modifications (PTMs) such as phosphorylation (201).  PTMs would support the quick 
activation (or inactivation) of proteins during differentiation.  For example, the aaRSs 
may be phosphoregulated during development.  Phosphopeptides from two aaRSs were 
found in a global phosphoproteome study of C. caviae (201).  How any developmental 
cycle-linked kinase-phosphatase system is regulated and what its substrates are in 
chlamydia is unknown.  Targeted phosphoprotein studies of aaRSs, including GltX, could 
elucidate whether phosphorylation of aaRSs plays a role in the EB-RB and/or RB-EB 
transitions.  Antibodies to chlamydial aaRSs could be developed, and the presence of a 
post-translational modification in EBs could be seen by the presence of a doublet by 
western blot and confirmed by mass spectrometry of the protein bands.   
Advances in genetic manipulation of C. trachomatis may allow for investigation 
of GltX function in vivo using tagged versions of these proteins that can be inserted into 
the chromosome by allelic recombination.  Attempts to generate a strain with GltX-
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FLAG were unsuccessful.  Sequence corresponding to gltX and ~2 kb upstream of the 5’ 
end of gltX was amplified and a C-terminal FLAG tag and ~2kb downstream of gltX was 
added by fusion PCR.  This sequence was then inserted into pUC18 for expression in E. 
coli.  However, no E. coli clones containing the entire insert were identified, and the E. 
coli colonies that did emerge grew extremely slowly, suggesting that the insert was toxic.  
Whether toxicity was due to overexpression of CtGltX or expression of the chlamydia-
specific transcription factor euo, a conserved chlamydial hypothetical protein ctl0704, or 
the cysteine-rich outer membrane protein omcA that were contained in the ~± 2 kb 
flanking gltX is unknown.  Because an intact vector could not be isolated from E. coli, we 
could not transform it into gltXts and select for recombinants.  Future attempts to generate 
the FLAG-tagged mutant may include using shorter flanking regions of DNA homology 
that do not encode any promoters of neighboring genes to avoid toxicity in E. coli.  More 
sophisticated genetic manipulation strategies to allow for ectopic expression of gltX while 
the endogenous copy is inactivated and replaced with a FLAG-tagged allele using allelic 
recombination could be attempted if a conditional mutant is not available for 
transformation. 
Determination of available protein synthesis substrates 
We hypothesize that tRNAGlu and/or tRNAGln are not being aminoacylated in 
gltXts.  The aminoacylation status of tRNAs in EBs can be directly probed using northern 
blots (275).  An attached amino acid causes an approximately 100 dalton shift in the size 
of the tRNA that can be visualized when probing for the tRNA.  The ratio of 
aminoacylated to non-aminoacylated tRNA can then be calculated.  We have attempted 
to perform these blots, and have been unsuccessful at detecting the three tRNAs being 
 129 
probed: tRNAMet (the control), tRNAGlu, and tRNAGln.  An alternative approach to 
address this question is the use of a chlamydial tRNA microarray to compare levels of 
aminoacylated tRNAs (276).  In this assay, the 3’-OH of non-aminoacylated tRNAs are 
destroyed with periodate, and the aminoacylated tRNAs are then deacylated and labeled 
with Cy3 since their 3’-OH is functional.  This sample is then compared to an identical 
sample representing the total number of tRNAs that has been deacylated to remove any 
attached amino acids before the labeling with Cy5.  The relative amount of a given 
aminoacyl-tRNA can then be calculated as a ratio of Cy3-labeled to Cy5-labeled tRNA.  
Because aminoacylation levels of individual tRNA isoacceptors in chlamydia have not 
been previously described, this method also has the advantage of being non-biased since 
individual chlamydial tRNAs do not have to be used as controls.  Currently, we must 
make the assumption that gltXts does not alter global aminoacyl-tRNA levels of EBs 
harvested at 37°C when selecting controls for northern blot analysis. 
The functionality of tRNAs as protein synthesis substrates can also be 
investigated in vivo using polysome profiling assays (277).  These assays use a sucrose 
gradient to separate ribosomal subunits, monosomes, and polysomes into fractions.  The 
RNA in these can either be detected based on absorbance at 254 nm or by qRT-PCR.  
High protein synthesis rates produce multiple, strong polysome peaks; low protein 
synthesis rates produce weak, if any, polysome peaks and instead have an abundance of 
ribosomal subunits and monosomes (277).  Therefore, we hypothesize that gltXts would 
have much fewer polysomes when grown at 40°C compared to at 37°C.  Furthermore, if 
the truncation of GltXts causes mischarging of tRNAs, protein synthesis should gradually 
decrease throughout development as toxic proteins accumulate in the cell. 
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 Infection with C. trachomatis increases the amount of free amino acids in HeLa 
cells (Matthew M. Muramatsu, unpublished data).  Whether this increase is in the host 
cell, the bacteria, or both has not been determined, but the increase in free amino acids 
could suggest that chlamydia may recruit amino acids at a rate that increases host cell 
production of amino acids.  In E. coli, amino acid poor conditions activate the stringent 
response.  While this response affects many bacterial processes, one outcome is the 
expression of biosynthetic genes for amino acids.  In C. trachomatis, treatment of HeLa 
cells with IFN-γ induces persistence (278).  IFN-γ causes a reduction of the host 
tryptophan pool, thus starving chlamydia for this amino acid (279).  By expressing 
tryptophan synthase (TrpAB), chlamydia is able to synthesize tryptophan from indole and 
serine to survive in a viable but non-cultivatable state (280).   
Whether a more general stress pathway akin to the stringent response is activated 
when a particular amino acid is missing in chlamydia is unknown.  Both protein and 
RNA synthesis decreased in an E. coli valSts mutant at the non-permissive temperature, 
and deletion of relA, which synthesizes (p)ppGpp, restored RNA but not protein synthesis  
(281). While studies of tryptophan starvation give some clues as to how chlamydia 
respond to amino acid stress, they also require the use of IFN-γ, which alters many facets 
of the host cell environment (282).   
The gltXts mutant could be used to directly investigate how amino acid starvation 
impacts chlamydia.  RNAseq studies comparing the differences in gene expression at 
40°C in gltXts and gltXWT could identify genes that are alternatively regulated when either 
aminoacylated tRNAGlu and/or tRNAGln are absent.  These results could be compared to 
IFN-γ treatment (204) to determine if there is any overlap in the responses.  Additionally, 
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this data would answer whether there is a coordinated downregulation of genes involved 
in translation—from tRNAs to the ribosome—when the necessary protein precursors are 
lacking as seen in other organisms, and potentially uncover a chlamydial amino acid 
stress response akin to the stringent response. 
  
 132 
APPENDIX I: Generation of C. trachomatis x C. muridarum Chimeras 
Power of LGT to investigate homolog functionality between species 
C. muridarum and C. trachomatis have similar genomic synteny and share high 
nucleotide sequence identity; however, they exhibit distinct host and tissue tropisms.  No 
pathogenicity islands have been described for chlamydia, although the plasticity zone was 
hypothesized to contribute to tropism and protect from immune clearance (283).  
Determining the genes that mediate host and tissue tropism are of interest, since these 
could serve as targets for vaccine or pharmaceutical intervention. 
 Genes that mediate chlamydial host and tissue tropism could potentially be 
identified by comparison of interspecies chimeras.  Previous studies used positive 
selection LGT to generate chimeras, but the phenotypes of these chimeras have not been 
fully described, nor have they been tested in animal models.  Genetic manipulation is far 
more advanced in C. trachomatis serovar L2 than C. muridarum, so most genetically 
engineered strains have only been assayed in cell culture models.  Only a few C. 
muridarum mutants have been tested in the mouse model, including chlamydial plasmid 
variants (97,284), multiply mutated EMS mutants (90), and an incA knock out strain 
(285). 
 The genes required for differences in chlamydial tropism and pathogenesis are 
largely unexplored.  For example, which genes allow L2 to become systemic?  Which C. 
muridarum genes are important for sustained infection in the mouse model, and why do 
the C. trachomatis homologs not allow this?  Generation of chimeric C. trachomatis and 
C. muridarum strains by LGT could address these questions; however, these studies are 
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not in the literature.  We suspect that the inherent fitness defects of strains carrying the 
endogenous antibiotic resistance markers may have confounded interpretation of studies 
using these chimeric strains.  Antibiotic driven LGT is also limited by the location of the 
genes that become resistant to the antibiotic on the chromosome.  Thus, the closer a gene 
is to the antibiotic marker, the more likely the gene is to co-segregate, which leads to 
biased populations of recombinants.  Since we were able to isolate recombinants using 
negative selection LGT, which does not introduce additional fitness defects, we 
wondered if we could use this strategy to generate C. trachomatis x C. muridarum 
chimeras. 
Generation of C. trachomatis serovar L2 x C. muridarum (L2 x MoPn) chimeras 
 Previous work in our lab identified two C. muridarum TS mutants from an EMS-
mutagenized plaque library that exhibited greater than 50-fold reduction in mature 
inclusion formation by LPS staining (Shuai Hu, unpublished data).  Whole genome 
sequencing revealed that CmHS 1 had 21 mutations while CmHS 2 had 15 mutations 
(Table 10).  Using phenotypic linkage analysis, the TS allele in CmHS 1 was narrowed 
down to either tc0238G127A resulting in a G43R substitution in a hypothetical protein or 
rpoBC3091T resulting in a R1031C substitution in RNA polymerase subunit B (Figure 28).  
The identity of CmHS 2 has been narrowed down to eight mutations that fall into proteins 
of diverse functions and are summarized in Figure 28.  An additional set of isolates from 
a CmHS 2 and an interferon-gamma sensitive mutant (igs4) confirmed that one of the 
eight remaining mutations should confer temperature sensitivity, but did not further 
decrease the number of candidate TS alleles (Amanda M. Giebel, unpublished data). 
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Table 10 Genome sequences of C. muridarum HS mutants 
Reference 
Position 
Nucleotide 
Change 
Amino 
Acid 
Change 
Gene Function 
CmHS 1     
 41636 G1012A G338R tc0035 Hypothetical protein 
 88645 C878T S293F tc0076 GTPase Der 
 141409 + A  tc0118 pseudogene; RNA methyltransferase 
 142115 C  T  tc0118  
 182169 G1181A R394K tc0149 hypothetical protein 
 194644 C289T P97S tc0160 hypothetical protein 
 234843 G211A G71R tc0199 hypothetical protein 
 278107 G127A G43R tc0238 hypothetical protein 
 432812 G859A E287K infB translation initiation factor IF-2 
 459068 C170T A57V rpe ribulose-phosphate 3-epimerase 
 473544 788ΔT V264fs tc0412 hypothetical protein 
 548457 G443A G148D tc0450 membrane protein 
 588656 G119A G40E tc0483 hypothetical protein 
 651865 C240T  tc0541 hypothetical protein 
 705743 C3091T R1031C rpoB DNA-directed RNA polymerase subunit beta 
 803183 G1301A G434E proS proline-tRNA ligase 
 825043 C  T    
 830078 C1922T T641M pmpB/C-1 polymorphic membrane protein 
 888570 C  T  prfB peptide chain release factor 2 
 921114 G2488A E830K polA DNA polymerase I 
 969645 C845T P282L tc0834 membrane protein 
CmHS 2     
 44872 G30A  sctN ATP synthase 
 58829 A988G K330E ompA porin 
 473675 919ΔC P307fs tc0412 hypothetical protein 
 563815 G203A G68E tc0463 hypothetical protein 
 625074 G328A G110R pdhB pyruvate dehydrogenase subunit beta 
 709093 G  A    
 759833 G768A  tc0634 hypothetical protein 
 772280 C329T S110F aroA 3-phosphoshikimate 1-carboxyvinyltransferase 
 839840 C33T  tc0698 metal ABC transporter permease 
 862608 C730T R244* tc0725 peptidase S41 
 883628 C137T T46I tc0741 hypothetical protein 
 899518 G665A G222E tc0757 hypothetical protein 
 978087 C417T  tc0843 helicase, Snf2 family 
 979469 C1799T P600L tc0843 helicase, Snf2 family 
 1042365 C270T  tc0899 RNA polymerase factor sigma-54 
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Gene 
nt 
Change 
AA 
Change CmHS 1 CmHS 2 1a, b 2a, b 3a, b 4a 
tc0035 G1012A G338R             
sctN G30A 
 
            
ompA A988G K330E             
tc0076 C878T S293F             
tc0118 + A 
 
            
tc0118 C  T 
 
            
tc0149 G1181A R394K             
tc0160 C289T P97S             
tc0199 G211A G71R             
tc0238 G127A G43R             
infB G859A E287K             
rpe C170T A57V             
tc0412 788ΔT V264fs             
tc0412 919ΔC P307fs             
tc0450 G443A G148D             
tc0463 G203A G68E             
tc0483 G119A G40E             
pdhB G328A G110R             
tc0541 C240T 
 
            
rpoB C3091T R1031C             
Intergenic G  A 
 
            
tc0634 G768A 
 
            
aroA C329T S110F             
proS G1301A G434E             
Intergenic C  T 
 
            
pmpB/C-1 C1922T T641M             
tc0698 C33T 
 
            
tc0725 C730T R244*             
tc0741 C137T T46I             
prfB C  T 
 
            
tc0757 G665A G222E             
polA G2488A E830K             
tc0834 C845T P282L             
tc0843 C417T 
 
            
tc0843 C1799T P600L             
tc0899 C270T 
 
            
 
Figure 28 Mapping of TS alleles in C. muridarum crosses.  CmHS 1 and CmHS 2 were crossed using 
negative selection LGT.  Four clonal progeny strains from independent crosses were isolated and their 
genomes were sequenced.  Genes are listed in the order that they appear on the chromosome.  Black boxes 
indicate the presence of the wild type allele.  Purple boxes indicate the presence of the mutant allele from 
the CmHS 1 parent.  Red boxes indicate the presence of the mutant allele from the CmHS 2 parent.  a, 
additional mutations: G at genome coordinate 126406 is deleted and an A is inserted at genome coordinate 
126416.  b, additional CT mutation in tc_r02 at nucleotide 1464. 
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 The crosses to generate interspecies chimeras were performed prior to knowing 
the genome sequences of the C. muridarum TS mutants, so C. trachomatis parents were 
selected so that the L2 TS allele would occur in different locations throughout the 
genome.  Where multiple mapped HS alleles clustered, mutants with the strongest 
phenotype were selected.  Six C. trachomatis parents were crossed with both CmHS 1 
and CmHS 2 (Figure 29). 
 
 
 
Figure 29 L2 parents used in L2 x MoPn crosses.  Six mapped L2-GFP TS mutants were selected as 
parents for crosses with MoPn because the mapped TS alleles were dispersed throughout the genome.  
Arrows indicate the location of the mapped allele in the genome.  Temperature resistant progeny was 
recovered from mutants in black type, while all progeny tested from crosses in mutants in gray type 
remained temperature sensitive. 
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Generation of L2 x MoPn crosses using negative selection LGT 
 Five independent wells of each cross between the six L2 and two MoPn isolates 
were attempted.  The strains were allowed to recombine at 37°C until 34 hpi in McCoy 
cells.  The media was then aspirated and replaced with 500 μL of SPG, and the infection 
was frozen at -80°C.  20 μL of thawed lysate was used to infect a fresh monolayer of 
McCoy cells followed by incubation at 40°C for 34 hpi before harvesting.  Selection was 
repeated a second time.  The number of inclusions present in L2 x MoPn cross wells 
tended to be lower than in wells with L2 x L2 or MoPn x MoPn crosses, although control 
wells containing either L2 or MoPn parents only showed greater decreases in inclusion 
number compared to the L2 x MoPn crosses (personal observation), suggesting that 
recombination at an interspecies level is rarer than with intraspecies crosses. 
 Not all wells produced progeny.  Progeny from positive wells were clonally 
isolated by plaque cloning.  The plaques were screened for temperature resistance by 
staining for LPS in replica plates grown at either 37°C or 40°C for 34 hpi and fixed with 
formaldehyde.  A maximum of two isolates from each well were pursued: one that would 
be predicted to be an L2 recipient because it was GFP+ and one that would be predicted 
to be an MoPn recipient because it was GFP-.  These plaqued populations were subjected 
to a second round of clonal isolation and expanded.  Only three of the TS L2 strains (HS 
1, HS 10, and HS 23) produced recombinants with the TS MoPn strains.   
Genotyping the recombinants 
 Initial attempts to distinguish if a recombination event occurred relied on PCR.  
Since the TS allele was not mapped for the MoPn strains, the TS alleles of the L2 strains 
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were targeted.  L2- or MoPn-locus specific primers were designed to produce 
approximately 700 bp amplicons.  Each locus was amplified with both sets of primers, 
and three loci throughout the genome were assayed, however MoPn primers tended not to 
amplify any product despite being able to amplify specific product from wild type MoPn 
DNA (data not shown).  We therefore turned to using whole genome sequencing of nine 
strains believed to phenotypically be recombinants. 
Confirmation of chimera generation 
 A draft genome sequence for the HS 1 x CmHS 2 chimera was assembled.  
Predicted gene coding sequences were aligned to either C. trachomatis serovar L2 
434/Bu or C. muridarum Nigg reference genomes (accession numbers:  AM884176 and 
AE002160.2, respectively).  Geneious software was used to align the chimera genome 
sequence to each of the parents.  The recombinant was largely L2 based.  Interestingly, 
the C-terminal domain of C. trachomatis gltX was repaired with C. muridarum gltX 
sequence, producing a chimeric protein that further confirms that gltXts is a temperature 
sensitive allele (Figure 30).  The region of recombination extended from nt 862,694 to nt 
867,696 of C. trachomatis L2 (Figure 30).  This equates to a maximal integration of 
5,003 bp of C. muridarum gDNA into the chimera.  There are 5 deletions within the 
recombined regions that will need to be sequence confirmed.  Four of these deletions 
range from 2-8 nt, and one deletion is predicted to be 74 nt. 
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Figure 30 Region of recombination in an HS 1 x CmHS2 chimera.  Geneious software was used to find 
regions of homology between the genome of the chimeric strain and the genomes of C. trachomatis L2 and 
C. muridarum.  The parental origin of each gene is colored green if originating from C. trachomatis or pink 
if originating from C. muridarum.  The gene order and content are highly conserved in this locus, so 
hypothetical genes were labeled according to C. trachomatis (ctl) locus number.  The recombination event 
produced chimeric Tsp and GltX proteins.  No other regions of recombination were observed. 
 
 Because recombination produced two chimeric proteins, protein sequence 
alignments were performed for both Tsp (Figure 31) and GltX (Figure 32).  The CtTsp 
and CmTsp homologs share 89.7% identity, while CtGltX and CmGltX share 94.6% 
identity.  Recombination at nucleotide position 815 produced the chimeric tsp allele, 
which occurs in the second position of the codon that would code for alanine in CtTsp 
(Figure 31A).  Tsp degrades proteins with nonpolar amino acid termini in E. coli (286) 
and begins to be transcribed 16 hpi in C. trachomatis serovar D (28).  This chimeric Tsp 
is likely fully enzymatically active, since the proteolytic domain is completely derived 
from C. muridarum (Figure 31B).  The PDZ domain is chimeric.  Since this is a 
promiscuous binding domain and there is high homology with CtTsp, this is unlikely to 
negatively affect enzymatic function.  Interestingly, this domain swap is likely favored 
due to the CmHS 2 tsp (tc0725) allele coding for a truncated Tsp of only 243 amino acids 
in length.  The truncation occurs before both the PDZ and proteolytic domains (Table 10 
and Figure 31B), so Tsp in CmHS 2 is most likely non-functional.  Mapping efforts using 
CmHS 1 as the other parent did not exclude tspC730T as the potential TS allele (Figure 28).  
Based on the region of recombination in this chimera, it is tempting to speculate that tsp 
may be the temperature sensitive allele in CmHS 2. 
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Figure 31 Protein alignment of chimeric Tsp.  (A) ClustalO was used to generate a primary sequence 
alignment of CtTsp (L2), CmTsp (MoPn), and the chimeric Tsp.  Protein sequence derived from C. 
trachomatis is in black; protein sequence from C. muridarum is in gray.  Identical residues between C. 
trachomatis and C. muridarum are indicated by a *.  (B) Schematic of the location of recombination in the 
protein with major domains labeled according to GenBank. 
 
Because the vast majority of the genomic backbone originates from HS 1, it is 
interesting that the recombination event occured in the temperature sensitive allele 
(gltXC1459T; GltXQ487*).  The recombination event produces a chimeric GltX that is 
derived from C. trachomatis until L345 and C. muridarum from W346 (Figure 32A).  
The chimeric protein contains a predicted catalytic core (residues 5-330) originating from 
L2, but an anticodon recognition region originating from C. muridarum (Figure 32B).  
Since the chimera is no longer temperature sensitive and since GltX is essential for 
aminoacylating both tRNAGlu and tRNAGln, the chimeric GltX must be functional at 
40°C.  Because of the nearly 95% protein identity and the high likelihood that similar 
residues would be used to recognize the anticodons of tRNAGlu and tRNAGln in such 
closely related organisms, it makes sense that this region could be interchangeable.  Since 
both C. trachomatis and C. muridarum have “tails” compared to the M. tuberculosis 
(PDB ID 2O5R) and T. maritima (PDB ID 3AKZ) structures, the chimeric protein would 
be predicted to have functionally reverted this truncation. 
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Figure 32 Protein alignment of chimeric GltX.  (A) ClustalO was used to generate a primary sequence 
alignment of CtGltX (L2), CmGltX (MoPn), and the chimeric GltX.  Protein sequence derived from C. 
trachomatis is in black; protein sequence from C. muridarum is in gray.  Identical residues between C. 
trachomatis and C. muridarum are indicated by an *.  (B) Schematic of the location of recombination in the 
protein with major domains labeled according to GenBank. 
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The other C. muridarum proteins that are now incorporated into the C. 
trachomatis L2 genetic background are all predicted to localize to membranes.  Cysteine 
rich protein A (CrpA) localizes to the inclusion membrane, is immunogenic in mouse 
models, and is predicted to have two transmembrane helices (287,288).  CrpA is located 
at the end of and in the same direction as the omcAB operon.  OmcA and OmcB are 
known cysteine-rich proteins that are found in the outer membrane.  Both are found in 
appreciable quantities in the COMC (198), which gives Chlamydia spp. EBs structural 
rigidity in lieu of peptidoglycan.  Increases in CrpA and OmcB at both the transcript and 
protein levels have been associated with the RB to EB transition in C. pneumoniae (289).  
OmcB has also been found to be the only true substrate of CPAF, which cleaves OmcB in 
mid-late development (290).  CTL0704 is a putative lipoprotein, although nothing is 
known about its function. 
Because of the small area of recombination in the chimera, new studies of how 
the COMC forms and the important protein interactions within it can be performed.  First, 
the chimeric nature could be confirmed with antibody staining against OmcB.  OmcB 
processing by CPAF has been shown to occur in C. trachomatis (290,291) and the C-
terminal cleavage fragment is secreted into the host cytoplasm (291).  While CPAF from 
both C. trachomatis and C. muridarum can cleave the same cytoskeletal proteins in HeLa 
cells lysed in an SDS-based buffer (data not shown), whether CtCPAF can act on 
CmOmcB has not been shown.  OmcB is the second most prevalent COMC protein and is 
highly immunogenic (292).  Conservation of OmcB sequence across medically relevant 
Chlamydia spp. has resulted in high serocrossreactivity (292).  CtOmcB and CmOmcB 
share 89.9% amino acid identity, so it is possible that there would be no effect on 
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seroreactivity to the C. muridarum OmcB peptide unless key differences exist at the 
cleavage site that would prevent its release.  Additionally, inhibition of CPAF, and 
therefore OmcB processing, led to decreases in progeny production (290).  The ability of 
the chimera to produce progeny has not yet been evaluated. 
Alternatively, the composition of the COMC may be altered by the inclusion of C. 
muridarum proteins.  Since the rigidity of the structure is dependent on the interprotein 
disulfide linkages of the COMC proteins, it may be that CmOmcA and CmOmcB make 
altered contacts with the other CtCOMC proteins, such as major outer membrane protein 
(MOMP).  Alterations in COMC structure could be probed with atomic force 
microscopy. 
Interactions with both host- and chlamydial-derived heparan sulfates is mediated 
at least in part by OmcB.  OmcB isoforms from different C. trachomatis serovars have 
varying dependencies on OmcB to bind to heparin or heparan sulfate.  For example, 
OmcB of C. trachomatis serovar E (293) or serovar B (294) do not bind heparan sulfate, 
whereas OmcB from C. trachomatis serovar L2 does despite only differing by 11 out of 
553 residues compared to either the serovar E or B homologs.  The ability to interact with 
heparan sulfate is even stronger for C. pneumoniae OmcB and this interaction was 
maximal in the presence of both heparin binding motifs (XBBXBX) and a proline that is 
in the immediate vicinity C-terminal of these motifs (293,295).   
The ability of CmOmcB to interact with host cells has not been well described.  
One study found that C. muridarum infection increases 6-O-sulfation of heparan sulfate 
via decreased expression of the heparan sulfate proteoglygan-specific endosulfatase 
SULF2 and this results in higher levels of attachment and entry (296).  Furthermore, 
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intranasal infection in a murine pneumonia model with C. muridarum using sulf1-/-sulf2-/- 
mice showed a 25-fold increase in the number of progeny collected from the lung (296).  
Thus, host expression of heparan sulfates plays an important role in chlamydial 
pathogenesis.   
The role of CmOmcB in murine infection and its ability to interact with heparan 
sulfates has not been investigated.  OmcB isoforms are highly similar (297) especially in 
the C-terminal domains.  An alignment of the N-terminal residues of CtOmcB and 
CmOmcB indicated that the heparin binding motif is perfectly conserved (Figure 33).  
The downstream proline conferring heparan sulfate binding dependence in serovar L2 
versus independence in serovar E (293) is not conserved in C. muridarum.  Since binding 
to heparin sulfate is through electrostatic interaction, it is also of note that the predicted pI 
of CtOmcB is 8.4 versus 6.62 of CmOmcB, indicating that CtOmcB is a more basic 
protein, and this difference is present in the extracellularly exposed N-terminal domain. 
 
 
Figure 33 OmcB sequence alignment.  Protein sequences of OmcB from C. trachomatis serovar L2 and 
C. muridarum Nigg were aligned using ClustalO.  The positively charged residues are colored blue and, in 
the case of the XBBXBX heparin binding motif (residues 63-68 in L2 and 58-63 in MoPn), are bolded.  
The ability of OmcB to bind heparan sulfate was found to be mediated by proline-72 (293) and this residue 
is underlined for L2. 
 
Future studies with this chimera should focus on biochemical characterization of 
CmOmcB to bind heparin in comparison to CtOmcB (293-295,298).  Growth kinetics 
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will also need to be studied to determine how compatible the C. muridarum locus is with 
C. trachomatis.  Studying the binding properties of OmcB isoforms has relied on the 
expression of various OmcB constructs in E. coli (298) or Saccharomyces cerevisiae 
(293) and evaluating if the ability of these recombinant organisms to bind host cells was 
altered.  This chimera permits comparison of different OmcB isoforms in a largely 
conserved genetic background for the first time. 
Murine female genital infection models using C. trachomatis are limited to 
studies involved in the acute phase of infection, as C. trachomatis does not ascend to the 
upper genital tract or elicit hydrosalphinx.  Why C. muridarum but not C. trachomatis 
can ascend and cause disease in mice is unclear.  Differences in host IFN-γ signaling 
pathways have been shown to play a role (283).  However, differences in IFN-γ signaling 
pathways do not completely account for why C. trachomatis cannot establish chronic 
infection, since some mouse lines are more permissible to C. trachomatis infection (299).  
It is possible that an adhesion factor, such as OmcB, may play a role in ascension.  This 
could be tested using the chimera, the HS 1 parent, and wild type C. muridarum.  We 
hypothesize that the C. muridarum omcB locus would confer a gain-of-function in 
progeny production and duration of infection in a murine genital tract model compared to 
C. trachomatis. 
 Genomes of other chimeras are still being assembled. 
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APPENDIX II: Recombinant Genome Sequences 
 
Portions of this chapter were published in Brothwell JA, Muramatsu MK, Toh E, Rockey 
DD, Putman TE, Barta ML, Hefty PS, Suchland RJ, and Nelson DE. 2016. Interrogating 
Genes That Mediate Chlamydia trachomatis Survival in Cell Culture Using Conditional 
Mutants and Recombination. J bacteriol. 198, 2131-2139. 
 
 
Figure 34 Recombinant mapping HS 1.  An isogenic recombinant mapped HS 1 to GltXQ487* 
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Figure 35 Recombinants mapping HS 2.  A cross between HS 2 and HS 23 narrowed down the possible 
TS alleles in HS 2 to dnaA, ctl0609, or phnP.  The TS allele was unlikely to be the dnaA allele since it is a 
silent mutation.  This was confirmed by a cross between HS 2 and HS 27, which definitively narrowed the 
TS allele to either be in ctl0609 or phnP. 
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Figure 36 Recombinant mapping HS 10.  A cross between HS 10 and HS 23 produced a recombinant that 
possessed the majority of the HS 10 backbone, but that had recombined in wild type alleles of rplF and fmt 
from HS 23. 
 
 
Figure 37 Recombinants mapping HS 11.  A cross between HS 11 and HS 23 produced several 
recombinants that mapped the TS allele to CTL0322M51I, since the mutant ftsK allele was tolerated.  The 
intergenic mutation could not be Sanger sequenced due to its location surrounded by duplicated sequence. 
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Figure 38 Recombinants mapping HS 13.  A cross between HS 13 and HS 23 identified an isogenic 
recombinant of HS 13, revealing that the TS allele coded for CTL0681P159L. 
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Figure 39 Recombinants mapping HS 19 and HS 23.  A cross between HS 19 and CS 1 mapped CS 1 to 
the allele encoding CL0456W321*.  It also eliminated the possibilities of the TS allele in HS 19 being either 
the pmpF or nqrB alleles.  Because HS 19 has dual temperature sensitivity, it was also possible to cross this 
mutant with HS 23.  This cross identified an isogenic recombinant of HS 23 that showed that the TS allele 
was DnaEP852S and D8 is referred to as dnaEWT in the preceding chapters.  In addition to the phenotypic 
linkage analysis with the CS 1 cross, it also identified the atpB allele as conferring temperature sensitivity 
in HS 19. 
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Figure 40 Recombinants mapping HS 20.  A cross between HS 20 and CS 2 yielded progeny that 
mapped the TS allele in HS 20 to ctl0456 by phenotypic linkage analysis.   
 
 
Figure 41 Recombinants mapping HS 24.  A cross between HS 24 and HS 23 identified an isogenic 
recombinant of HS 24.  This definitively mapped the TS allele to fabI. 
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Figure 42 Recombinant mapping HS 26.  Identification of an isogenic recombinant from a cross between 
HS 26 and HS 23 definitively mapped the TS allele in HS 26 to CTL0597. 
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Figure 43 Recombinant mapping HS 27.  A cross between HS 16 and HS 27 produced a near isogenic 
recombinant, which reduced the TS allele in HS 27 to being either in pknD or obgE.  However, results of 
the HS 2 x HS 27 cross (Figure 23) indicate that pknD can be present and still allow the production of 
temperature resistant progeny.  This maps the TS allele in HS 27 to obgE. 
 
 
Figure 44 Recombinants mapping CS 1 and CS 2.  Crosses between CS 1 and CS 2 identify the TS allele 
in CS 1 as ctl0456 and in CS 2 as ctl0137. 
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Figure 45 Recombinants mapping CS 3.  A cross between CS 3 and HS 23 narrowed down the identity of 
the TS allele in CS 3 to be either a mutant devB or ctl0456.  The dual HS/CS phenotype allowed for 
crossing of CS 2 with CS 3, which showed that the temperature resistance was achieved despite variable 
devB alleles.  Thus, the gene conferring temperature sensitivity in CS 3 is the mutant ctl0456 allele. 
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